ERK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | T537 | Sugiyama | SHTN1 KIAA1598 | TKTALNKKTLEAEFNsPsPPtPEPGEGPRKLEGCTSSKVTF |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A6NKT7 | T1475 | Sugiyama | RGPD3 RGP3 | DSFKKIFDEAKTAQEKDsLItPHVsRsstPREsPCGKIAVA |
| A6NMY6 | S22 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | stVHEILCKLsLEGDHstPPsAyGsVKAytNFDAERDALNI |
| C9JLW8 | S21 | SIGNOR|EPSD|PSP | MCRIP1 FAM195B GRAN2 | MtssPVSRVVYNGKRtssPRsPPsssEIFtPAHEENVRFIy |
| C9JLW8 | T30 | SIGNOR|EPSD|PSP | MCRIP1 FAM195B GRAN2 | VYNGKRtssPRsPPsssEIFtPAHEENVRFIyEAWQGVERD |
| O00115 | S70 | Sugiyama | DNASE2 DNASE2A DNL2 | QYKyLDEssGGWRDGRALINsPEGAVGRSLQPLyRSNTSQL |
| O00151 | S90 | Sugiyama | PDLIM1 CLIM1 CLP36 | IKGCTDNLtLtVARsEHKVWsPLVtEEGKRHPYKMNLASEP |
| O00170 | T162 | Sugiyama | AIP XAP2 | QQNPQPLIFHMEMLKVEsPGtYQQDPWAMTDEEKAKAVPLI |
| O00213 | S175 | SIGNOR | APBB1 FE65 RIR | GEAEEEEEDDDDEEEEEDLSsPPGLPEPLESVEAPPRPQAL |
| O00213 | S287 | SIGNOR | APBB1 FE65 RIR | GTYYWHIPTGTTQWEPPGRAsPsQGSSPQEESQLTWTGFAH |
| O00213 | S347 | SIGNOR | APBB1 FE65 RIR | MELGLKEPEEGTLTFPAQSLsPEPLPQEEEKLPPRNTNPGI |
| O00213 | T709 | SIGNOR | APBB1 FE65 RIR | VRRGVQSLWGSLKPKRLGAHtP___________________ |
| O00232 | S335 | Sugiyama | PSMD12 | MRWSTLVEDYGMELRKGsLEsPAtDVFGsTEEGEKRWKDLK |
| O00410 | S974 | Sugiyama | IPO5 KPNB3 RANBP5 | VIQSADSKTKENVNAtENCIsAVGKIMKFKPDCVNVEEVLP |
| O00429 | S126 | Sugiyama | DNM1L DLP1 DRP1 | EIRQEIENETERISGNNKGVsPEPIHLKIFSPNVVNLTLVD |
| O00429 | S616 | SIGNOR|EPSD|PSP | DNM1L DLP1 DRP1 | SKAEELLAEEKsKPIPIMPAsPQKGHAVNLLDVPVPVARKL |
| O00571 | S70 | Sugiyama | DDX3X DBX DDX3 | KGFyDKDSSGWsssKDKDAyssFGsRsDsRGKssFFsDRGs |
| O14497 | S363 | Sugiyama | ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1 | AAAAAAASGGAQQRsHHAPMsPGssGGGGQPLARtPQPssP |
| O14545 | S327 | Sugiyama | TRAFD1 FLN29 | DHQTSCNPSRALPsLNtGsssPRGVEEPDVIFQNFLQQAAS |
| O14545 | S480 | Sugiyama | TRAFD1 FLN29 | ATYNQLSRstsGPRPGCQPssPCVPKLsNsDsQDIQGRNRD |
| O14715 | T1474 | Sugiyama | RGPD8 RANBP2ALPHA RANBP2L1 RANBP2L3 | DSFKKIFDEAKTAQEKDsLItPHVsRsstPREsPCGKIAVA |
| O14745 | S280 | Sugiyama | NHERF1 NHERF SLC9A3R1 | tNGEIQKENsREALAEAALEsPRPALVRsAssDtsEELNsQ |
| O14994 | S470 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | SYN3 | PQRSGsPsQQRLsPQGQQPLsPQsGsPQQQRSPGsPQLSRA |
| O15027 | T593 | PSP | SEC16A KIAA0310 SEC16 SEC16L | GETDETTVSQNYRGSVSQPStPSPPKPTGIFQTSANSsFEP |
| O15047 | S468 | Sugiyama | SETD1A KIAA0339 KMT2F SET1 SET1A | GPsPEREEVRtsPRPAsPARsGsPAPEttNESVPFAQHSSL |
| O15061 | S1181 | Sugiyama | SYNM DMN KIAA0353 SYN | AAsPtGASRSVRHVTLGPGQsPLsREVIFLGPAPACPEAWG |
| O15067 | S1062 | Sugiyama | PFAS KIAA0361 | SYCLPPTFPKAsVPREPGGPsPRVAILREEGSNGDREMADA |
| O15143 | S336 | Sugiyama | ARPC1B ARC41 | AAGAGLDsLHKNsVsQIsVLsGGKAKCSQFCTTGMDGGMSI |
| O15160 | S258 | Sugiyama | POLR1C POLR1E | DITLLEPVEGEAAEELSRCFsPGVIEVQEVQGKKVARVANP |
| O15230 | S422 | Sugiyama | LAMA5 KIAA0533 KIAA1907 | GVNCERCLPGFYRSPNHPLDsPHVCRRCNCESDFTDGtCED |
| O15446 | S285 | Sugiyama | POLR1G ASE1 CAST CD3EAP PAF49 | EDKTVKQEQINTEPLEDtVLsPtKKRKRQKGTEGMEPEEGV |
| O15523 | S70 | Sugiyama | DDX3Y DBY | KGFHDKDSSGWSCSKDKDAyssFGsRDSRGKPGYFSERGSG |
| O15525 | S124 | PSP | MAFG | LDALRSKYEALQTFARtVARsPVAPARGPLAAGLGPLVPGK |
| O43175 | S251 | Sugiyama | PHGDH PGDH3 | VVNCARGGIVDEGALLRALQsGQCAGAALDVFTEEPPRDRA |
| O43521 | S69 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | BCL2L11 BIM | GGEGDSCPHGsPQGPLAPPAsPGPFATRsPLFIFMRRSsLL |
| O43524 | S12 | EPSD|PSP | FOXO3 FKHRL1 FOXO3A | _________MAEAPAsPAPLsPLEVELDPEFEPQSRPRsCt |
| O43524 | S294 | SIGNOR|EPSD|PSP | FOXO3 FKHRL1 FOXO3A | LQTAPEsADDsPsQLsKWPGsPtSRssDELDAWTDFRsRTN |
| O43524 | S344 | SIGNOR|EPSD|PSP | FOXO3 FKHRL1 FOXO3A | LSPIMAsTELDEVQDDDAPLsPMLYSSSASLSPSVSKPCTV |
| O43524 | S425 | SIGNOR|EPSD|PSP | FOXO3 FKHRL1 FOXO3A | GGLMQRSSsFPYTTKGsGLGsPtssFNstVFGPssLNsLRQ |
| O43561 | T184 | SIGNOR | LAT | VLPDSTPATSTAAPSAPALStPGIRDSAFSMESIDDyVNVP |
| O43707 | T615 | Sugiyama | ACTN4 | QRIAESNHIKLsGsNPyttVtPQIINsKWEKVQQLVPKRDH |
| O43707 | Y611 | Sugiyama | ACTN4 | HKEAQRIAESNHIKLsGsNPyttVtPQIINsKWEKVQQLVP |
| O43852 | T65 | Sugiyama | CALU | FDyDHDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKD |
| O60244 | S986 | EPSD|PSP | MED14 ARC150 CRSP2 CXorf4 DRIP150 EXLM1 RGR1 TRAP170 | FVDSNQDARRRsVNEDDNPPsPIGGDMMDsLIsQLQPPPQQ |
| O60245 | T325 | Sugiyama | PCDH7 BHPCDH | SPRFEKSVYEADLAENSAPGtPILQLRAADLDVGVNGQIEY |
| O60331 | S650 | EPSD|PSP | PIP5K1C KIAA0589 | EEDAPATDIyFPTDERSWVysPLHYSAQAPPAsDGEsDT__ |
| O60610 | T768 | SIGNOR | DIAPH1 DIAP1 | PPPPPFGFGVPAAPVLPFGLtPKKLYKPEVQLRRPNWSKLV |
| O60664 | S91 | Sugiyama | PLIN3 M6PRBP1 TIP47 | TAAAVsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQ |
| O60674 | S523 | SIGNOR | JAK2 | PKDKSNLLVFRTNGVsDVPtsPTLQRPTHMNQMVFHKIRNE |
| O60716 | T308 | PSP | CTNND1 KIAA0384 | sMGyDDLDyGMMsDyGtARRtGtPsDPRRRLRsyEDMIGEE |
| O60716 | T310 | PSP | CTNND1 KIAA0384 | GyDDLDyGMMsDyGtARRtGtPsDPRRRLRsyEDMIGEEVP |
| O60716 | T906 | SIGNOR|PSP | CTNND1 KIAA0384 | EEIQMSNMGsNtKsLDNNystPNERGDHNRtLDRsGDLGDM |
| O75030 | S180 | SIGNOR | MITF BHLHE32 | CPNQPGDHVMPPVPGSSAPNsPMAMLTLNSNCEKEGFYKFE |
| O75179 | S2041 | Sugiyama | ANKRD17 GTAR KIAA0697 | NTAPTNATYPMPTAKEHyPVssPssPsPPAQPGGVsRNsPL |
| O75179 | S2045 | Sugiyama | ANKRD17 GTAR KIAA0697 | TNATYPMPTAKEHyPVssPssPsPPAQPGGVsRNsPLDCGs |
| O75369 | S1505 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | PSQEGPYMVSVKYADEEIPRsPFKVKVLPTYDASKVtAsGP |
| O75369 | T994 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | QGKLDVtILsPsRKVVPCLVtPVtGRENsTAKFIPREEGLY |
| O75369 | T997 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | LDVtILsPsRKVVPCLVtPVtGRENsTAKFIPREEGLYAVD |
| O75369 | Y1604 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | KtGRYMIGVTYGGDDIPLsPyRIRAtQTGDASKCLAtGPGI |
| O75410 | S276 | Sugiyama | TACC1 KIAA1103 | GtPLPKAsYHFsPEELDENtsPLLGDARFQKsPPDLKETPG |
| O75533 | T207 | Sugiyama | SF3B1 SAP155 | AAAsQPPsKRKRRWDQtADQtPGAtPKKLssWDQAEtPGHt |
| O75533 | T211 | Sugiyama | SF3B1 SAP155 | QPPsKRKRRWDQtADQtPGAtPKKLssWDQAEtPGHtPsLR |
| O75533 | T223 | Sugiyama | SF3B1 SAP155 | tADQtPGAtPKKLssWDQAEtPGHtPsLRWDEtPGRAKGsE |
| O75533 | T227 | Sugiyama | SF3B1 SAP155 | tPGAtPKKLssWDQAEtPGHtPsLRWDEtPGRAKGsEtPGA |
| O75534 | S598 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | KVNKtHsVNGItEEADPTIysGKVIRPLRSVDPTQTEYQGM |
| O75581 | S1490 | EPSD|PSP | LRP6 | SSSSssTKGtYFPAILNPPPsPAtERsHYTMEFGYSsNsPs |
| O75581 | T1572 | EPSD|PSP | LRP6 | TAKGYTSDLNyDSEPVPPPPtPRSQYLSAEENyESCPPsPY |
| O75582 | S360 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RPS6KA5 MSK1 | RDELDVsNFAEEFtEMDPtYsPAALPQssEKLFQGYsFVAP |
| O75582 | S376 | SIGNOR|iPTMNet | RPS6KA5 MSK1 | DPtYsPAALPQssEKLFQGYsFVAPsILFKRNAAVIDPLQF |
| O75582 | T581 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RPS6KA5 MSK1 | IKIIDFGFARLKPPDNQPLKtPCFTLHYAAPELLNQNGYDE |
| O75582 | T700 | GPS6 | RPS6KA5 MSK1 | GLRYNEWLQDGSQLSSNPLMtPDILGSSGAAVHTCVKAtFH |
| O75676 | S343 | GPS6 | RPS6KA4 MSK2 | RsELDVGNFAEEFTRLEPVysPPGsPPPGDPRIFQGYsFVA |
| O75676 | T568 | GPS6 | RPS6KA4 MSK2 | KIIDFGFARLRPQSPGVPMQtPCFTLQYAAPELLAQQGYDE |
| O75828 | S56 | Sugiyama | CBR3 SDR21C2 | TARDVARGQAAVQQLQAEGLsPRFHQLDIDDLQsIRALRDF |
| O75909 | S36 | Sugiyama | CCNK CPR4 | NLDHTKPCWYWDKKDLAHTPsQLEGLDPATEARYRREGARF |
| O94855 | S266 | Sugiyama | SEC24D KIAA0755 | PAQMAGPPQPQKKLDPDSIPsPIQVIENDRASRGGQVYATN |
| O94868 | S688 | Sugiyama | FCHSD2 KIAA0769 SH3MD3 | PsPDKRssLYFPRsPsANEKsLHAEsPGFsQAsRHtPETSY |
| O94868 | S693 | Sugiyama | FCHSD2 KIAA0769 SH3MD3 | RssLYFPRsPsANEKsLHAEsPGFsQAsRHtPETSYGKLRP |
| O94979 | S188 | Sugiyama | SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334 | PEDISCIAWNRQVQHILAsAsPsGRATVWDLRKNEPIIKVS |
| O94979 | S799 | Sugiyama | SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334 | IMQLRDRLCRAQGEPVAGHEsPKIPyEKQQLPKGRPGPVAG |
| O95067 | S392 | Sugiyama | CCNB2 | KLLKISMIPQLNSKAVKDLAsPLIGRs______________ |
| O95359 | S2321 | Sugiyama | TACC2 | RPKMKKtPEKLDNtPAsPPRsPAEPNDIPIAKGTYTFDIDK |
| O95359 | T2514 | Sugiyama | TACC2 | DYPQPSDLSTFVNETKFssPtEELDyRNsYEIEyMEKIGss |
| O95365 | S525 | Sugiyama | ZBTB7A FBI1 LRF ZBTB7 ZNF857A | GGAPDPsPGAtAtPGAPAQPssPDARRNGQEKHFKDEDEDE |
| O95456 | S183 | Sugiyama | PSMG1 C21LRP DSCR2 PAC1 | QITILTCRHVTDYKTSEsTGsLPsPFLRALKTQNFKDSACC |
| O95456 | S186 | Sugiyama | PSMG1 C21LRP DSCR2 PAC1 | ILTCRHVTDYKTSEsTGsLPsPFLRALKTQNFKDSACCPLL |
| O95644 | S172 | SIGNOR|EPSD|PSP | NFATC1 NFAT2 NFATC | PstATLSLPsLEAYRDPsCLsPAssLSSRSCNSEAsSYESN |
| O95817 | S289 | SIGNOR|EPSD|PSP|Sugiyama | BAG3 BIS | sVQGAssREGsPARsstPLHsPsPIRVHtVVDRPQQPMTHR |
| O95817 | S377 | SIGNOR|PSP | BAG3 BIS | PPSEKVEVKVPPAPVPCPPPsPGPsAVPssPKsVAtEERAA |
| O95817 | T285 | SIGNOR|EPSD|PSP | BAG3 BIS | PFRssVQGAssREGsPARsstPLHsPsPIRVHtVVDRPQQP |
| O95997 | S165 | SIGNOR | PTTG1 EAP1 PTTG TUTR1 | PLMILDEERELEKLFQLGPPsPVKMPsPPWESNLLQsPssI |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00367 | T409 | Sugiyama | GLUD1 GLUD | TKSNAPRVKAKIIAEGANGPttPEADKIFLERNIMVIPDLY |
| P00533 | T693 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | EGFR ERBB ERBB1 HER1 | IVRKRtLRRLLQERELVEPLtPsGEAPNQALLRILKETEFK |
| P00966 | T219 | Sugiyama | ASS1 ASS | KNQAPPGLytKtQDPAKAPNtPDILEIEFKKGVPVKVTNVK |
| P01100 | S362 | GPS6|SIGNOR | FOS G0S7 | VFTYPEADSFPSCAAAHRKGsSsNEPSSDSLSsPTLLAL__ |
| P01100 | S374 | GPS6|SIGNOR|ELM|PSP | FOS G0S7 | CAAAHRKGsSsNEPSSDSLSsPTLLAL______________ |
| P01100 | T232 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | FOS G0S7 | FPEEMSVASLDLTGGLPEVAtPESEEAFTLPLLNDPEPKPS |
| P01100 | T325 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | FOS G0S7 | PLHsGSLGMGPMATELEPLCtPVVTCtPSCTAYTSSFVFTY |
| P01100 | T331 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | FOS G0S7 | LGMGPMATELEPLCtPVVTCtPSCTAYTSSFVFTYPEADSF |
| P01106 | S77 | PSP | MYC BHLHE39 | PPAPSEDIWKKFELLPtPPLsPsRRsGLCsPSyVAVTPFsL |
| P02686 | T232 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MBP | GRTQDENPVVHFFKNIVtPRtPPPSQGKGRGLSLSRFsWGA |
| P03372 | S104 | SIGNOR|EPSD|PSP | ESR1 ESR NR3A1 | SEAAAFGSNGLGGFPPLNsVsPsPLMLLHPPPQLsPFLQPH |
| P03372 | S106 | SIGNOR|EPSD|PSP | ESR1 ESR NR3A1 | AAAFGSNGLGGFPPLNsVsPsPLMLLHPPPQLsPFLQPHGQ |
| P03372 | S118 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ESR1 ESR NR3A1 | PPLNsVsPsPLMLLHPPPQLsPFLQPHGQQVPYYLENEPSG |
| P03372 | T311 | ELM | ESR1 ESR NR3A1 | LWPsPLMIKRSKKNsLALSLtADQMVSALLDAEPPILYSEY |
| P03973 | T78 | Sugiyama | SLPI WAP4 WFDC4 | PGKKRCCPDTCGIKCLDPVDtPNPTRRKPGKCPVTYGQCLM |
| P04040 | S515 | Sugiyama | CAT | ALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL________ |
| P04040 | T511 | Sugiyama | CAT | SHIQALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL____ |
| P04049 | S289 | SIGNOR|EPSD|PSP | RAF1 RAF | tLPVDSRMIEDAIRsHsEsAsPsALsssPNNLsPtGWsQPK |
| P04049 | S296 | SIGNOR|EPSD|PSP | RAF1 RAF | MIEDAIRsHsEsAsPsALsssPNNLsPtGWsQPKtPVPAQR |
| P04049 | S301 | SIGNOR|EPSD|PSP | RAF1 RAF | IRsHsEsAsPsALsssPNNLsPtGWsQPKtPVPAQRERAPV |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | S34 | Sugiyama | ANXA1 ANX1 LPC1 | IENEEQEyVQtVKssKGGPGsAVsPyPtFNPssDVAALHKA |
| P04083 | T265 | Sugiyama | ANXA1 ANX1 LPC1 | KHDMNKVLDLELKGDIEKCLtAIVKCATSKPAFFAEKLHQA |
| P04083 | T41 | Sugiyama | ANXA1 ANX1 LPC1 | yVQtVKssKGGPGsAVsPyPtFNPssDVAALHKAIMVKGVD |
| P04083 | Y39 | Sugiyama | ANXA1 ANX1 LPC1 | QEyVQtVKssKGGPGsAVsPyPtFNPssDVAALHKAIMVKG |
| P04150 | S226 | SIGNOR|ELM|EPSD|PSP | NR3C1 GRL | KETNEsPWRSDLLIDENCLLsPLAGEDDSFLLEGNSNEDCK |
| P04181 | T39 | Sugiyama | OAT | HSSVASATSVATKKtVQGPPtSDDIFEREyKyGAHNyHPLP |
| P04198 | S62 | PSP | MYCN BHLHE37 NMYC | STPPGEDIWKKFELLPtPPLsPsRGFAEHSSEPPSWVTEML |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04424 | S417 | PSP | ASL | MAETKGVALNQLSLQELQTIsPLFSGDVICVWDYGHSVEQY |
| P04626 | T701 | EPSD|PSP | ERBB2 HER2 MLN19 NEU NGL | KIRKYtMRRLLQETELVEPLtPsGAMPNQAQMRILKETELR |
| P04637 | S15 | SIGNOR|EPSD|PSP | TP53 P53 | ______MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPL |
| P04637 | S392 | EPSD|PSP | TP53 P53 | KKGQstsRHKKLMFKtEGPDsD___________________ |
| P04637 | T55 | ELM | TP53 P53 | LPsQAMDDLMLsPDDIEQWFtEDPGPDEAPRMPEAAPPVAP |
| P04792 | S176 | Sugiyama | HSPB1 HSP27 HSP28 | sLsPEGtLTVEAPMPKLAtQsNEItIPVtFEsRAQLGGPEA |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | T184 | Sugiyama | HSPB1 HSP27 HSP28 | TVEAPMPKLAtQsNEItIPVtFEsRAQLGGPEAAKsDETAA |
| P05187 | S177 | Sugiyama | ALPP PLAP | RAKKAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADVP |
| P05387 | S74 | Sugiyama | RPLP2 D11S2243E RPP2 | VIAQGIGKLAsVPAGGAVAVsAAPGsAAPAAGsAPAAAEEK |
| P05387 | S79 | Sugiyama | RPLP2 D11S2243E RPP2 | IGKLAsVPAGGAVAVsAAPGsAAPAAGsAPAAAEEKKDEKK |
| P05387 | S86 | Sugiyama | RPLP2 D11S2243E RPP2 | PAGGAVAVsAAPGsAAPAAGsAPAAAEEKKDEKKEEsEEsD |
| P05412 | S63 | SIGNOR|PSP | JUN | ADPVGSLKPHLRAKNsDLLtsPDVGLLKLAsPELERLIIQS |
| P05412 | S73 | SIGNOR|PSP | JUN | LRAKNsDLLtsPDVGLLKLAsPELERLIIQSSNGHItttPt |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P05787 | S432 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | KRT8 CYK8 | HtKTTSGYAGGLSSAYGGLtsPGLSYSLGSSFGSGAGSSSF |
| P05787 | S74 | iPTMNet | KRT8 CYK8 | YGGASGMGGITAVtVNQSLLsPLVLEVDPNIQAVRTQEKEQ |
| P06239 | S42 | GPS6|ELM|iPTMNet|EPSD | LCK | NCHYPIVPLDGKGTLLIRNGsEVRDPLVTYEGsNPPAsPLQ |
| P06239 | S59 | SIGNOR|ELM|iPTMNet|EPSD|PSP | LCK | RNGsEVRDPLVTYEGsNPPAsPLQDNLVIALHsYEPSHDGD |
| P06401 | S294 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PGR NR3C3 | RFSAPRVALVEQDAPMAPGRsPLATTVMDFIHVPILPLNHA |
| P06733 | S272 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | FRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsI |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07101 | S62 | SIGNOR|EPSD|PSP | TH TYH | TGsPWPGTAAPAASYTPTPRsPRFIGRRQsLIEDARKEREA |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S320 | Sugiyama | LDHB | GLtsVINQKLKDDEVAQLKKsADtLWDIQKDLKDL______ |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07237 | T428 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | DKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFPA |
| P07355 | S22 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | stVHEILCKLsLEGDHstPPsAyGsVKAytNFDAERDALNI |
| P07437 | S168 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | GTLLISKIREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLS |
| P07437 | S172 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | ISKIREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLSVHQL |
| P07437 | T166 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | GMGTLLISKIREEYPDRIMNtFsVVPsPKVSDTVVEPYNAT |
| P07437 | T55 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPGtMDs |
| P07686 | T307 | Sugiyama | HEXB HCC7 | PEFDTPGHTLSWGKGQKDLLtPCySRQNKLDSFGPINPTLN |
| P07737 | S57 | Sugiyama | PFN1 | GKtFVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDs |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07741 | S30 | Sugiyama | APRT | EQRIRsFPDFPTPGVVFRDIsPVLKDPASFRAAIGLLARHL |
| P07814 | S1350 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | YRRRLLsVNIRVRADLRDNysPGWKFNHWELKGVPIRLEVG |
| P07814 | S688 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | DIIQLQRRGFFICDQPyEPVsPysCKEAPCVLIyIPDGHtK |
| P07814 | S886 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EKTGKEyIPGQPPLsQssDssPtRNsEPAGLEtPEAKVLFD |
| P07814 | T737 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EKTKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRV |
| P07858 | S216 | Sugiyama | CTSB CPSB | PPCTGEGDTPKCSKICEPGysPtyKQDKHYGYNSYSVSNSE |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S505 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KENQKHIyyItGETKDQVANsAFVERLRKHGLEVIyMIEPI |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08047 | S59 | SIGNOR|EPSD|PSP | SP1 TSFP1 | RssstGsssstGGGGQEsQPsPLALLAATCSRIESPNENSN |
| P08047 | T453 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SP1 TSFP1 | ETLQNLQLQAVPNSGPIIIRtPTVGPNGQVSWQTLQLQNLQ |
| P08047 | T739 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SP1 TSFP1 | LsVGtLPLDsGAGsEGSGtAtPSALITTNMVAMEAICPEGI |
| P08195 | S296 | Sugiyama | SLC3A2 MDU1 | DLLQIDPNFGsKEDFDsLLQsAKKKSIRVILDLTPNYRGEN |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08195 | T401 | Sugiyama | SLC3A2 MDU1 | NSSDLQQILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQ |
| P08235 | S196 | SIGNOR|PSP | NR3C2 MCR MLR | VMRAVVKSPIMCHEKSPSVCsPLNMTSSVCSPAGINSVSST |
| P08235 | S227 | SIGNOR|PSP | NR3C2 MCR MLR | PAGINSVSSTTASFGSFPVHsPITQGTPLTCsPNVENRGSR |
| P08235 | S238 | SIGNOR|PSP | NR3C2 MCR MLR | ASFGSFPVHsPITQGTPLTCsPNVENRGSRSHSPAHASNVG |
| P08235 | S263 | SIGNOR|PSP | NR3C2 MCR MLR | NRGSRSHSPAHASNVGsPLssPLSSMKSSISSPPSHCSVKs |
| P08235 | S287 | SIGNOR|PSP | NR3C2 MCR MLR | SMKSSISSPPSHCSVKsPVSsPNNVTLRSSVssPANINNSR |
| P08235 | S361 | SIGNOR|PSP | NR3C2 MCR MLR | FSYTASGTSAGSSTLRDVVPsPDTQEKGAQEVPFPKTEEVE |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | T83 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sKLDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLG |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08651 | S323 | Sugiyama | NFIC NFI | PssPtsSSRNWTEDMEGGIssPVKKtEMDKsPFNsPsPQDs |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P08865 | S75 | Sugiyama | RPSA LAMBR LAMR1 | WEKLLLAARAIVAIENPADVsVIssRNtGQRAVLKFAAAtG |
| P08865 | S78 | Sugiyama | RPSA LAMBR LAMR1 | LLLAARAIVAIENPADVsVIssRNtGQRAVLKFAAAtGAtP |
| P08865 | T82 | Sugiyama | RPSA LAMBR LAMR1 | ARAIVAIENPADVsVIssRNtGQRAVLKFAAAtGAtPIAGR |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09651 | S368 | Sugiyama | HNRNPA1 HNRPA1 | FAKPRNQGGyGGssssssyGsGRRF________________ |
| P09874 | S372 | SIGNOR | PARP1 ADPRT PPOL | KQDRIFPPEtsAsVAAtPPPstAsAPAAVNSsAsADKPLSN |
| P09874 | T373 | SIGNOR | PARP1 ADPRT PPOL | QDRIFPPEtsAsVAAtPPPstAsAPAAVNSsAsADKPLSNM |
| P09917 | S272 | SIGNOR | ALOX5 LOG5 | LPEKLPVtTEMVECSLERQLsLEQEVQQGNIFIVDFELLDG |
| P09917 | S664 | SIGNOR | ALOX5 LOG5 | AIVSVIAERNKKKQLPYYYLsPDRIPNsVAI__________ |
| P09923 | S174 | Sugiyama | ALPI | RAKQAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADMP |
| P0DJD0 | T1459 | Sugiyama | RGPD1 RANBP2L6 RGP1 | DSFKKIFDEAKTAQEKDsLItPHVsRsstPREsPCGKIAVA |
| P10242 | S532 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MYB | VAEFQENGPPLLKKIKQEVEsPtDKSGNFFCSHHWEGDSLN |
| P10253 | T197 | Sugiyama | GAA | NRLHFTIKDPANRRyEVPLEtPHVHSRAPSPLYSVEFSEEP |
| P10275 | S516 | SIGNOR|EPSD|PSP | AR DHTR NR3C4 | DFTAPDVWYPGGMVSRVPYPsPTCVKSEMGPWMDSYSGPyG |
| P10275 | S651 | EPSD|PSP | AR DHTR NR3C4 | KLKKLGNLKLQEEGEAsSttsPTEETTQKLTVSHIEGYECQ |
| P10301 | S201 | SIGNOR|EPSD|PSP | RRAS | EAFEQLVRAVRKYQEQELPPsPPSAPRKKGGGCPCVLL___ |
| P10398 | S186 | Sugiyama | ARAF ARAF1 PKS PKS2 | RQHEAPsNRPLNELLtPQGPsPRTQHCDPEHFPFPAPANAP |
| P10398 | T181 | Sugiyama | ARAF ARAF1 PKS PKS2 | LsGGsRQHEAPsNRPLNELLtPQGPsPRTQHCDPEHFPFPA |
| P10415 | S70 | SIGNOR|ELM | BCL2 | SSQPGHtPHPAASRDPVARtsPLQtPAAPGAAAGPALsPVP |
| P10415 | S87 | SIGNOR|ELM|EPSD|PSP | BCL2 | ARtsPLQtPAAPGAAAGPALsPVPPVVHLTLRQAGDDFSRR |
| P10415 | T56 | SIGNOR|EPSD|PSP | BCL2 | GAAPPGAAPAPGIFSSQPGHtPHPAASRDPVARtsPLQtPA |
| P10415 | T69 | ELM | BCL2 | FSSQPGHtPHPAASRDPVARtsPLQtPAAPGAAAGPALsPV |
| P10415 | T74 | SIGNOR|EPSD|PSP | BCL2 | GHtPHPAASRDPVARtsPLQtPAAPGAAAGPALsPVPPVVH |
| P10636 | S46 | PSP | MAPT MAPTL MTBT1 TAU | QGGytMHQDQEGDtDAGLKEsPLQtPTEDGsEEPGsETSDA |
| P10636 | T50 | PSP | MAPT MAPTL MTBT1 TAU | tMHQDQEGDtDAGLKEsPLQtPTEDGsEEPGsETSDAKstP |
| P10809 | S225 | Sugiyama | HSPD1 HSP60 | KtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVL |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P10809 | T115 | Sugiyama | HSPD1 HSP60 | AKLVQDVANNtNEEAGDGtttAtVLARSIAKEGFEKISKGA |
| P10809 | T231 | Sugiyama | HSPD1 HSP60 | LEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLsEKKI |
| P10809 | T455 | Sugiyama | HSPD1 HSP60 | GIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLKIP |
| P10828 | S142 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | THRB ERBA2 NR1A2 THR1 | ITCEGCKGFFRRTIQKNLHPsYSCKYEGKCVIDKVTRNQCQ |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11274 | S382 | Sugiyama | BCR BCR1 D22S11 | MFRDKsRsPsQNsQQsFDSssPPtPQCHKRHRHCPVVVSEA |
| P11274 | T385 | Sugiyama | BCR BCR1 D22S11 | DKsRsPsQNsQQsFDSssPPtPQCHKRHRHCPVVVSEATIV |
| P11362 | S777 | SIGNOR|EPSD|PSP | FGFR1 BFGFR CEK FGFBR FLG FLT2 HBGFR | IVALTSNQEyLDLSMPLDQysPsFPDTRsstCsSGEDsVFS |
| P11388 | S1213 | GPS6|ELM|iPTMNet|EPSD|PSP | TOP2A TOP2 | LPGKGGKAKGKKTQMAEVLPsPRGQRVIPRITIEMKAEAEK |
| P11388 | S1247 | GPS6|ELM|iPTMNet|EPSD|PSP | TOP2A TOP2 | MKAEAEKKNKKKIKNENtEGsPQEDGVELEGLKQRLEKKQK |
| P11388 | S1354 | GPS6|ELM|iPTMNet|EPSD|PSP | TOP2A TOP2 | EDFsDFDEKtDDEDFVPsDAsPPKtKTsPKLsNKELKPQKs |
| P11388 | S1361 | GPS6|ELM|iPTMNet|EPSD|PSP | TOP2A TOP2 | EKtDDEDFVPsDAsPPKtKTsPKLsNKELKPQKsVVsDLEA |
| P11388 | S1393 | GPS6|ELM|iPTMNet|EPSD|PSP | TOP2A TOP2 | KsVVsDLEADDVKGsVPLsssPPAtHFPDEtEItNPVPKKN |
| P11940 | S315 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | NLyVKNLDDGIDDERLRKEFsPFGtItsAKVMMEGGRSKGF |
| P11940 | S322 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | DDGIDDERLRKEFsPFGtItsAKVMMEGGRSKGFGFVCFss |
| P12268 | S122 | Sugiyama | IMPDH2 IMPD2 | NEVRKVKKyEQGFITDPVVLsPKDRVRDVFEAKARHGFCGI |
| P12270 | S2155 | Sugiyama | TPR | PstPtLVVPHRtDGFAEAIHsPQVAGVPRFRFGPPEDMPQT |
| P12277 | S128 | Sugiyama | CKB CKBB | TDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPHCsR |
| P12277 | S129 | Sugiyama | CKB CKBB | DLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPHCsRG |
| P12277 | T35 | Sugiyama | CKB CKBB | PAEDEFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDD |
| P12980 | S36 | EPSD|PSP | LYL1 BHLHA18 | EKAEMVCAPsPAPAPPPKPAsPGPPQVEEVGHRGGssPPRL |
| P13489 | S84 | Sugiyama | RNH1 PRI RNH | RSNELGDVGVHCVLQGLQtPsCKIQKLSLQNCCLTGAGCGV |
| P13489 | T82 | Sugiyama | RNH1 PRI RNH | NLRSNELGDVGVHCVLQGLQtPsCKIQKLSLQNCCLTGAGC |
| P13631 | S79 | EPSD|PSP | RARG NR1B3 | ASLSVETQSTSSEEMVPSsPsPPPPPRVYKPCFVCNDKSSG |
| P13639 | S387 | Sugiyama | EEF2 EF2 | yRCELLyEGPPDDEAAMGIKsCDPKGPLMMYISKMVPTSDK |
| P13639 | S595 | Sugiyama | EEF2 EF2 | PVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGLAE |
| P13667 | S124 | Sugiyama | PDIA4 ERP70 ERP72 | IANILKDKDPPIPVAKIDAtsAsVLAsRFDVsGyPtIKILK |
| P13667 | S482 | Sugiyama | PDIA4 ERP70 ERP72 | VKDLGLsEsGEDVNAAILDEsGKKFAMEPEEFDsDtLREFV |
| P13798 | S304 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | YVDLIGGKCELLSDDsLAVssPRLSPDQCRIVYLQYPSLIP |
| P13807 | S723 | Sugiyama | GYS1 GYS | TSGSKRNsVDtAtsssLstPsEPLsPtssLGEERN______ |
| P13807 | S727 | Sugiyama | GYS1 GYS | KRNsVDtAtsssLstPsEPLsPtssLGEERN__________ |
| P13807 | T721 | Sugiyama | GYS1 GYS | sSTSGSKRNsVDtAtsssLstPsEPLsPtssLGEERN____ |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P14314 | S442 | Sugiyama | PRKCSH G19P1 | EYVYRLCPFKLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSA |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14598 | S345 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | RRNsVRFLQQRRRQARPGPQsPGsPLEEERQtQRsKPQPAV |
| P14598 | S348 | GPS6|ELM|iPTMNet|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | sVRFLQQRRRQARPGPQsPGsPLEEERQtQRsKPQPAVPPR |
| P14618 | S37 | PSP|Sugiyama | PKM OIP3 PK2 PK3 PKM2 | QLHAAMADTFLEHMCRLDIDsPPItARNtGIICtIGPAsRs |
| P14618 | T41 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | AMADTFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtL |
| P14625 | S552 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | KEKQDKIyFMAGsSRKEAEssPFVERLLKKGyEVIyLTEPV |
| P14635 | S126 | ELM | CCNB1 CCNB | EPEPVKEEKLsPEPILVDTAsPsPMETsGCAPAEEDLCQAF |
| P14635 | S128 | ELM | CCNB1 CCNB | EPVKEEKLsPEPILVDTAsPsPMETsGCAPAEEDLCQAFsD |
| P14784 | T476 | EPSD|PSP | IL2RB IL15RB | PPSLQERVPRDWDPQPLGPPtPGVPDLVDFQPPPELVLREA |
| P14866 | S101 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | GAAGGGGGGENyDDPHKtPAsPVVHIRGLIDGVVEADLVEA |
| P14868 | S369 | Sugiyama | DARS1 DARS PIG40 | CEALAMLREAGVEMGDEDDLstPNEKLLGHLVKEKyDTDFy |
| P14921 | T38 | SIGNOR|ELM|iPTMNet|EPSD | ETS1 EWSR2 | KVDLELFPsPDMECADVPLLtPSsKEMMSQALKATFSGFTK |
| P15056 | S151 | SIGNOR|PSP | BRAF BRAF1 RAFB1 | LPSSLSVFQNPTDVARsNPKsPQKPIVRVFLPNKQRTVVPA |
| P15056 | T401 | SIGNOR|EPSD|PSP | BRAF BRAF1 RAFB1 | DLIRDQGFRGDGGsttGLsAtPPAsLPGSLTNVKALQKsPG |
| P15056 | T753 | SIGNOR|EPSD|PSP | BRAF BRAF1 RAFB1 | LNRAGFQTEDFSLYACAsPKtPIQAGGYGAFPVH_______ |
| P15336 | T69 | SIGNOR|EPSD|PSP|Sugiyama | ATF2 CREB2 CREBP1 | HEMtLKFGPARNDsVIVADQtPtPtRFLKNCEEVGLFNELA |
| P15336 | T71 | GPS6|SIGNOR|EPSD|PSP|Sugiyama | ATF2 CREB2 CREBP1 | MtLKFGPARNDsVIVADQtPtPtRFLKNCEEVGLFNELAsP |
| P15408 | S320 | PSP | FOSL2 FRA2 | CSKAHRRssssGDQssDsLNsPtLLAL______________ |
| P15408 | T322 | PSP | FOSL2 FRA2 | KAHRRssssGDQssDsLNsPtLLAL________________ |
| P15531 | S125 | Sugiyama | NME1 NDPKA NM23 | RGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDyTsC |
| P15559 | S82 | Sugiyama | NQO1 DIA4 NMOR1 | DPANFQYPAESVLAYKEGHLsPDIVAEQKKLEAADLVIFQF |
| P15923 | T355 | SIGNOR|ELM|EPSD | TCF3 BHLHB21 E2A ITF1 | ALAsIysPDHssNNFsssPstPVGsPQGLAGTSQWPRAGAP |
| P15976 | S170 | GPS6 | GATA1 ERYF1 GF1 | PALPSSLPVPNsAYGGPDFSsTFFsPtGsPLNSAAYSsPKL |
| P15976 | S174 | GPS6 | GATA1 ERYF1 GF1 | SSLPVPNsAYGGPDFSsTFFsPtGsPLNSAAYSsPKLRGTL |
| P15976 | S26 | GPS6 | GATA1 ERYF1 GF1 | LGSLGTSEPLPQFVDPALVSsTPESGVFFPSGPEGLDAAAS |
| P15976 | T176 | GPS6 | GATA1 ERYF1 GF1 | LPVPNsAYGGPDFSsTFFsPtGsPLNSAAYSsPKLRGTLPL |
| P16144 | S1356 | EPSD|PSP | ITGB4 | DAQSGEDYDSFLMYSDDVLRsPSGsQRPsVSDDTGCGWKFE |
| P16152 | S56 | Sugiyama | CBR1 CBR CRN SDR21C1 | TARDVTRGQAAVQQLQAEGLsPRFHQLDIDDLQsIRALRDF |
| P16278 | S433 | Sugiyama | GLB1 ELNR1 | YGFVLYRTTLPQDCSNPAPLssPLNGVHDRAyVAVDGIPQG |
| P16949 | S25 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | STMN1 C1orf215 LAP18 OP18 | DIQVKELEKRAsGQAFELILsPRsKEsVPEFPLsPPKKKDL |
| P16949 | S38 | GPS6|SIGNOR|ELM|EPSD|PSP|Sugiyama | STMN1 C1orf215 LAP18 OP18 | QAFELILsPRsKEsVPEFPLsPPKKKDLsLEEIQKKLEAAE |
| P17174 | S93 | Sugiyama | GOT1 | PILGLAEFRsCAsRLALGDDsPALKEKRVGGVQsLGGtGAL |
| P17302 | S255 | SIGNOR|iPTMNet | GJA1 GJAL | GVKDRVKGKSDPyHATsGALsPAKDCGsQKyAyFNGCssPt |
| P17302 | S279 | SIGNOR|iPTMNet | GJA1 GJAL | DCGsQKyAyFNGCssPtAPLsPMsPPGyKLVTGDRNNssCR |
| P17302 | S282 | SIGNOR|iPTMNet | GJA1 GJAL | sQKyAyFNGCssPtAPLsPMsPPGyKLVTGDRNNssCRNYN |
| P17480 | T117 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | UBTF UBF UBF1 | KNPYKGKKLKKHPDFPKKPLtPYFRFFMEKRAKYAKLHPEM |
| P17480 | T201 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | UBTF UBF UBF1 | EDHPDLIQNAKKSDIPEKPKtPQQLWYtHEKKVYLKVRPDA |
| P17535 | S100 | SIGNOR | JUND | SAAPPDGLLAsPDLGLLKLAsPELERLIIQSNGLVtttPTS |
| P17542 | S122 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | TAL1 BHLHA17 SCL TCL5 | APAPASVTAELPGDGRMVQLsPPALAAPAAPGRALLYSLSQ |
| P17544 | T51 | Sugiyama | ATF7 ATFA | HEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEVGLFNELA |
| P17544 | T53 | Sugiyama | ATF7 ATFA | MTLKFGPARtDsVIIADQtPtPtRFLKNCEEVGLFNELASS |
| P17655 | S50 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CAPN2 CANPL2 | QDYEALRNECLEAGTLFQDPsFPAIPSALGFKELGPYSSKT |
| P17676 | T235 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CEBPB TCF5 PP9092 | AVPsGssGsLstsssssPPGtPsPADAKAPPTACyAGAAPA |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P17813 | S521 | Sugiyama | ENG END | GGTVELIQGRAAKGNCVSLLsPSPEGDPRFSFLLHFYTVPI |
| P17861 | S181 | SIGNOR|EPSD|PSP | XBP1 TREB5 XBP2 | SAESAALRLRAPLQQVQAQLsPLQNISPWILAVLTLQIQSL |
| P17861 | S68 | SIGNOR|EPSD|PSP | XBP1 TREB5 XBP2 | PEAASGGLPQARKRQRLTHLsPEEKALRRKLKNRVAAQTAR |
| P17980 | S376 | Sugiyama | PSMC3 TBP1 | MPNEEARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQC |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P18545 | T22 | iPTMNet | PDE6G PDEG | NLEPPKAEFRSATRVAGGPVtPRKGPPKFKQRQTRQFKSKP |
| P18669 | S14 | Sugiyama | PGAM1 PGAMA CDABP0006 | _______MAAYKLVLIRHGEsAWNLENRFsGWyDADLsPAG |
| P18669 | S31 | Sugiyama | PGAM1 PGAMA CDABP0006 | HGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALRDAGyE |
| P19404 | T51 | Sugiyama | NDUFV2 | QNGAGGALFVHRDTPENNPDtPFDFTPENyKRIEAIVKNYP |
| P19419 | S324 | SIGNOR | ELK1 | sPEISQPQKGRKPRDLELPLsPsLLGGPGPERtPGSGSGSG |
| P19419 | S383 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ELK1 | tPVLLtPSSLPPSIHFWSTLsPIAPRsPAKLSFQFPSSGSA |
| P19419 | S389 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ELK1 | PSSLPPSIHFWSTLsPIAPRsPAKLSFQFPSSGSAQVHIPS |
| P19419 | S422 | SIGNOR | ELK1 | SAQVHIPSISVDGLStPVVLsPGPQKP______________ |
| P19419 | T336 | SIGNOR | ELK1 | PRDLELPLsPsLLGGPGPERtPGSGSGSGLQAPGPALtPSL |
| P19793 | S260 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RXRA NR2B1 | LAVEPKTETyVEANMGLNPssPNDPVtNICQAADKQLFTLV |
| P19793 | T82 | SIGNOR|ELM | RXRA NR2B1 | GPPFsVISSPMGPHSMsVPTtPTLGFSTGSPQLSSPMNPVS |
| P20339 | S123 | EPSD|PSP | RAB5A RAB5 | TNEESFARAKNWVKELQRQAsPNIVIALSGNKADLANKRAV |
| P21333 | S1084 | Sugiyama | FLNA FLN FLN1 | PTKPSKVKAFGPGLQGGsAGsPARFtIDTKGAGTGGLGLTV |
| P21333 | S1533 | Sugiyama | FLNA FLN FLN1 | PSREGPysIsVLyGDEEVPRsPFKVKVLPTHDASKVKAsGP |
| P21333 | S1630 | Sugiyama | FLNA FLN FLN1 | PDVTGRYTILIKYGGDEIPFsPyRVRAVPTGDASKCTVTVS |
| P21333 | S2319 | Sugiyama | FLNA FLN FLN1 | VQEPGDyEVsVKFNEEHIPDsPFVVPVAsPsGDARRLtVss |
| P21333 | S2327 | Sugiyama | FLNA FLN FLN1 | VsVKFNEEHIPDsPFVVPVAsPsGDARRLtVssLQEsGLKV |
| P21333 | S2329 | Sugiyama | FLNA FLN FLN1 | VKFNEEHIPDsPFVVPVAsPsGDARRLtVssLQEsGLKVNQ |
| P21802 | S780 | PSP | FGFR2 BEK KGFR KSAM | ILTLTTNEEyLDLSQPLEQYsPsYPDTRSSCSSGDDSVFSP |
| P22102 | S88 | Sugiyama | GART PGFT PRGS | EFVVVGPEAPLAAGIVGNLRsAGVQCFGPTAEAAQLEssKR |
| P22234 | S27 | Sugiyama | PAICS ADE2 AIRC PAIS | LNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAGNAARK |
| P22314 | T233 | Sugiyama | UBA1 A1S9T UBE1 | GEQPLSAMVSMVTKDNPGVVtCLDEARHGFESGDFVSFSEV |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P22681 | S900 | Sugiyama | CBL CBL2 RNF55 | IAQNNIEMAKNILREFVSIssPAHVAT______________ |
| P23284 | T81 | Sugiyama | PPIB CYPB | IFGLFGKTVPKTVDNFVALAtGEKGFGYKNSKFHRVIKDFM |
| P23396 | T221 | Sugiyama | RPS3 OK/SW-cl.26 | KKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPVP |
| P23396 | T42 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RPS3 OK/SW-cl.26 | NEFLtRELAEDGysGVEVRVtPTRTEIIILATRTQNVLGEK |
| P23415 | S408 | PSP | GLRA1 | ISVKGANNSNTTNPPPAPSKsPEEMRKLFIQRAKKIDKISR |
| P23443 | S441 | SIGNOR | RPS6KB1 STK14A | SVKEKFsFEPKIRsPRRFIGsPRtPVsPVKFsPGDFWGRGA |
| P23443 | T444 | SIGNOR | RPS6KB1 STK14A | EKFsFEPKIRsPRRFIGsPRtPVsPVKFsPGDFWGRGASAS |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P23921 | S559 | Sugiyama | RRM1 RR1 | ALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTPTDLW |
| P24534 | S8 | Sugiyama | EEF1B2 EEF1B EF1B | _____________MGFGDLKsPAGLQVLNDyLADKSYIEGY |
| P24928 | S1619 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | POLR2A POLR2 | AYEPRSPGGYTPQSPSysPtsPsYsPTsPSYSPTSPNYSPT |
| P24928 | S1626 | SIGNOR | POLR2A POLR2 | GGYTPQSPSysPtsPsYsPTsPSYSPTSPNYSPTSPSYsPT |
| P24928 | S1647 | SIGNOR | POLR2A POLR2 | PSYSPTSPNYSPTSPSYsPTsPSYsPTsPSYSPTSPSYsPT |
| P24928 | S1654 | SIGNOR | POLR2A POLR2 | PNYSPTSPSYsPTsPSYsPTsPSYSPTSPSYsPTsPSYsPT |
| P24928 | S1668 | SIGNOR | POLR2A POLR2 | PSYsPTsPSYSPTSPSYsPTsPSYsPTsPSYSPTSPSYSPT |
| P24928 | S1675 | SIGNOR | POLR2A POLR2 | PSYSPTSPSYsPTsPSYsPTsPSYSPTSPSYSPTSPSYsPT |
| P24928 | S1696 | SIGNOR | POLR2A POLR2 | PSYSPTSPSYSPTSPSYsPTsPSYSPTSPSYSPTSPSYsPT |
| P24928 | S1717 | SIGNOR | POLR2A POLR2 | PSYSPTSPSYSPTSPSYsPTsPSYsPTsPSYSPTSPSYsPT |
| P24928 | S1724 | SIGNOR | POLR2A POLR2 | PSYSPTSPSYsPTsPSYsPTsPSYSPTSPSYsPTsPSYSPT |
| P24928 | S1738 | SIGNOR | POLR2A POLR2 | PSYsPTsPSYSPTSPSYsPTsPSYSPTSPNYSPTSPNYTPT |
| P24928 | S1766 | SIGNOR | POLR2A POLR2 | PNYSPTSPNYTPTSPSYsPTsPSYSPTSPNYTPTSPNYsPT |
| P24928 | S1787 | SIGNOR | POLR2A POLR2 | PSYSPTSPNYTPTSPNYsPTsPSYSPTSPSYSPTSPSYSPS |
| P24928 | S1864 | SIGNOR | POLR2A POLR2 | PsysPssPEytPtsPKysPtsPKysPtsPKysPtsPtysPt |
| P24928 | S1871 | SIGNOR | POLR2A POLR2 | PEytPtsPKysPtsPKysPtsPKysPtsPtysPttPKysPt |
| P24928 | S1882 | SIGNOR | POLR2A POLR2 | PtsPKysPtsPKysPtsPtysPttPKysPtsPtysPtsPVy |
| P24928 | S1892 | SIGNOR | POLR2A POLR2 | PKysPtsPtysPttPKysPtsPtysPtsPVytPtsPKysPt |
| P24928 | S1899 | SIGNOR | POLR2A POLR2 | PtysPttPKysPtsPtysPtsPVytPtsPKysPtsPtysPt |
| P24928 | S1913 | SIGNOR | POLR2A POLR2 | PtysPtsPVytPtsPKysPtsPtysPtsPKysPtsPtysPt |
| P24928 | S1920 | SIGNOR | POLR2A POLR2 | PVytPtsPKysPtsPtysPtsPKysPtsPtysPtsPKGstY |
| P24928 | S1927 | SIGNOR | POLR2A POLR2 | PKysPtsPtysPtsPKysPtsPtysPtsPKGstYsPtsPGY |
| P24928 | S1934 | SIGNOR | POLR2A POLR2 | PtysPtsPKysPtsPtysPtsPKGstYsPtsPGYsPtsPTY |
| P24928 | S1944 | SIGNOR | POLR2A POLR2 | sPtsPtysPtsPKGstYsPtsPGYsPtsPTYSLTsPAIsPD |
| P24928 | S1951 | SIGNOR | POLR2A POLR2 | sPtsPKGstYsPtsPGYsPtsPTYSLTsPAIsPDDsDEEN_ |
| P24941 | T160 | SIGNOR|EPSD|PSP | CDK2 CDKN2 | AIKLADFGLARAFGVPVRtytHEVVtLWyRAPEILLGCKYY |
| P25098 | S670 | SIGNOR|ELM|iPTMNet | GRK2 ADRBK1 BARK BARK1 | AYREAQQLVQRVPKMKNKPRsPVVELsKVPLVQRGsANGL_ |
| P25205 | T722 | Sugiyama | MCM3 | GDsyDPyDFsDtEEEMPQVHtPKTADsQEtKEsQKVELsES |
| P25786 | S230 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | VsIGIVGKDLEFTIyDDDDVsPFLEGLEERPQRKAQPAQPA |
| P26640 | S301 | Sugiyama | VARS1 G7A VARS VARS2 | DLPtPPGEKKDVSGPMPDsysPRYVEAAWYPWWEQQGFFKP |
| P27361 | T17 | Sugiyama | MAPK3 ERK1 PRKM3 | ____MAAAAAQGGGGGEPRRtEGVGPGVPGEVEMVKGQPFD |
| P27361 | T198 | Sugiyama | MAPK3 ERK1 PRKM3 | CDLKICDFGLARIADPEHDHtGFLtEyVAtRWyRAPEIMLN |
| P27361 | T202 | SIGNOR|iPTMNet|EPSD|Sugiyama | MAPK3 ERK1 PRKM3 | ICDFGLARIADPEHDHtGFLtEyVAtRWyRAPEIMLNSKGY |
| P27361 | T207 | GPS6|SIGNOR|EPSD|PSP | MAPK3 ERK1 PRKM3 | LARIADPEHDHtGFLtEyVAtRWyRAPEIMLNSKGYTKSID |
| P27361 | T368 | Sugiyama | MAPK3 ERK1 PRKM3 | FAMELDDLPKERLKELIFQEtARFQPGVLEAP_________ |
| P27361 | Y204 | SIGNOR|iPTMNet|EPSD|PSP|Sugiyama | MAPK3 ERK1 PRKM3 | DFGLARIADPEHDHtGFLtEyVAtRWyRAPEIMLNSKGYTK |
| P27708 | S1038 | Sugiyama | CAD | QLPNNMAMALHRQQCRVLGtsPEAIDSAENRFKFSRLLDTI |
| P27708 | T456 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CAD | NIATVQTSQGLADKVYFLPItPHYVTQVIRNERPDGVLLTF |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27824 | S362 | Sugiyama | CANX | WDEDMDGEWEAPQIANPRCEsAPGCGVWQRPVIDNPNyKGK |
| P27824 | S564 | GPS6 | CANX | GEEKLEEKQKsDAEEDGGtVsQEEEDRKPKAEEDEILNRsP |
| P27824 | S583 | EPSD|PSP|Sugiyama | CANX | VsQEEEDRKPKAEEDEILNRsPRNRKPRRE___________ |
| P28066 | S172 | Sugiyama | PSMA5 | QLFHMDPsGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLK |
| P28066 | S179 | Sugiyama | PSMA5 | sGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSL |
| P28324 | S381 | PSP | ELK4 SAP1 | tPIILtPSPLLSSIHFWSTLsPVAPLsPARLQGANTLFQFP |
| P28324 | S387 | PSP | ELK4 SAP1 | PSPLLSSIHFWSTLsPVAPLsPARLQGANTLFQFPSVLNSH |
| P28562 | S296 | SIGNOR | DUSP1 CL100 MKP1 PTPN10 VH1 | TNRVKLDEAFEFVKQRRSIIsPNFSFMGQLLQFESQVLAPH |
| P28562 | S323 | SIGNOR | DUSP1 CL100 MKP1 PTPN10 VH1 | GQLLQFESQVLAPHCSAEAGsPAMAVLDRGTsTTTVFNFPV |
| P28562 | S359 | SIGNOR|PSP | DUSP1 CL100 MKP1 PTPN10 VH1 | FNFPVSIPVHSTNSALSYLQsPITTsPSC____________ |
| P28562 | S364 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | DUSP1 CL100 MKP1 PTPN10 VH1 | SIPVHSTNSALSYLQsPITTsPSC_________________ |
| P28715 | S384 | Sugiyama | ERCC5 ERCM2 XPG XPGC | ENRRQARGRNAPAAVDEGsIsPRtLSAIKRALDDDEDVKVC |
| P29401 | S295 | Sugiyama | TKT | ysQIQsKKKILAtPPQEDAPsVDIANIRMPsLPsyKVGDKI |
| P29401 | S439 | Sugiyama | TKT | VSIGEDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVE |
| P29401 | T287 | Sugiyama | TKT | AEQIIQEIysQIQsKKKILAtPPQEDAPsVDIANIRMPsLP |
| P29590 | S36 | PSP | PML MYL PP8675 RNF71 TRIM19 | ARPQEPtMPPPEtPsEGRQPsPsPsPtERAPAsEEEFQFLR |
| P29590 | S38 | PSP | PML MYL PP8675 RNF71 TRIM19 | PQEPtMPPPEtPsEGRQPsPsPsPtERAPAsEEEFQFLRCQ |
| P29590 | S40 | PSP | PML MYL PP8675 RNF71 TRIM19 | EPtMPPPEtPsEGRQPsPsPsPtERAPAsEEEFQFLRCQQC |
| P29590 | S527 | EPSD|PSP | PML MYL PP8675 RNF71 TRIM19 | EQPRPstsKAVsPPHLDGPPsPRsPVIGsEVFLPNSNHVAs |
| P29590 | S530 | SIGNOR|EPSD|PSP | PML MYL PP8675 RNF71 TRIM19 | RPstsKAVsPPHLDGPPsPRsPVIGsEVFLPNSNHVAsGAG |
| P29590 | T28 | PSP | PML MYL PP8675 RNF71 TRIM19 | sPRPQQDPARPQEPtMPPPEtPsEGRQPsPsPsPtERAPAs |
| P29692 | S133 | Sugiyama | EEF1D EF1D | NVLEKssPGHRAtAPQtQHVsPMRQVEPPAKKPAtPAEDDE |
| P29692 | S70 | Sugiyama | EEF1D EF1D | IARARENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVE |
| P29966 | S101 | Sugiyama | MARCKS MACS PRKCSL | sPsAAEKGEPAAAAAPEAGAsPVEKEAPAEGEAAEPGsPtA |
| P29966 | S27 | Sugiyama | MARCKS MACS PRKCSL | KTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAsP |
| P29966 | S46 | EPSD|PSP | MARCKS MACS PRKCSL | ssPsKANGQENGHVKVNGDAsPAAAEsGAKEELQANGsAPA |
| P30041 | T44 | Sugiyama | PRDX6 AOP2 KIAA0106 | RFHDFLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKR |
| P30041 | T48 | Sugiyama | PRDX6 AOP2 KIAA0106 | FLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKL |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30050 | S165 | Sugiyama | RPL12 | GRHPHDIIDDINsGAVECPAs____________________ |
| P30050 | S26 | Sugiyama | RPL12 | DPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDDI |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30086 | S60 | Sugiyama | PEBP1 PBP PEBP | VLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPK |
| P30086 | T42 | Sugiyama | PEBP1 PBP PEBP | QHPLHVTYAGAAVDELGKVLtPtQVKNRPtsIsWDGLDsGK |
| P30086 | T51 | Sugiyama | PEBP1 PBP PEBP | GAAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDP |
| P30101 | S443 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LsKDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLN |
| P30101 | T120 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPASVPLR |
| P31327 | T45 | Sugiyama | CPS1 | AHQKWKFSRPGIRLLSVKAQtAHIVLEDGtKMKGYSFGHPS |
| P31645 | T616 | EPSD|PSP | SLC6A4 HTT SERT | RLIITPGtFKERIIKsItPEtPTEIPCGDIRLNAV______ |
| P31937 | S88 | Sugiyama | HIBADH | YDVFPDACKEFQDAGEQVVSsPADVAEKADRIITMLPTSIN |
| P31939 | S300 | Sugiyama | ATIC PURH OK/SW-cl.86 | sEDEAKVCMVyDLyKTLtPIsAAyARARGADRMssFGDFVA |
| P31939 | T297 | Sugiyama | ATIC PURH OK/SW-cl.86 | IPLsEDEAKVCMVyDLyKTLtPIsAAyARARGADRMssFGD |
| P31943 | S104 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | EVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P32121 | S14 | SIGNOR|EPSD|PSP | ARRB2 ARB2 ARR2 | _______MGEKPGTRVFKKSsPNCKLTVYLGKRDFVDHLDK |
| P32121 | T276 | SIGNOR|EPSD|PSP | ARRB2 ARB2 ARR2 | QLEQDDQVSPSSTFCKVYTItPLLSDNREKRGLALDGKLKH |
| P33076 | S280 | SIGNOR|EPSD|PSP | CIITA MHC2TA | VPQASQVPPPSGFTVHGLPTsPDRPGsTsPFAPsATDLPSM |
| P33076 | S288 | SIGNOR|EPSD|PSP | CIITA MHC2TA | PPSGFTVHGLPTsPDRPGsTsPFAPsATDLPSMPEPALTSR |
| P33981 | S821 | EPSD|PSP | TTK MPS1 MPS1L1 | MAKGttEEMKyVLGQLVGLNsPNsILKAAKTLyEHYsGGES |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P35228 | S745 | SIGNOR|EPSD|PSP | NOS2 NOS2A | SSMHAKNVFTMRLKSRQNLQsPTSSRATILVELSCEDGQGL |
| P35236 | S93 | SIGNOR | PTPN7 | HFLRTAGHPLTRWALQRQPPsPKQLEEEFLKIPsNFVsPED |
| P35236 | T66 | SIGNOR | PTPN7 | VALMLDVRSLGAVEPICsVNtPREVtLHFLRTAGHPLTRWA |
| P35250 | S30 | Sugiyama | RFC2 | AGEVEAQDSDPAPAFSKAPGsAGHyELPWVEKYRPVKLNEI |
| P35269 | T389 | Sugiyama | GTF2F1 RAP74 | PPKRERKPsGGSSRGNsRPGtPsAEGGstsstLRAAASKLE |
| P35568 | S616 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | IRS1 | GGHHRPDsstLHtDDGyMPMsPGVAPVPSGRKGsGDyMPMs |
| P35568 | S636 | SIGNOR | IRS1 | sPGVAPVPSGRKGsGDyMPMsPKsVSAPQQIINPIRRHPQR |
| P35606 | T828 | Sugiyama | COPB2 | EEWVKETHADLWPAKQyPLVtPNEERNVMEEGKDFQPSRst |
| P35611 | S12 | Sugiyama | ADD1 ADDA | _________MNGDsRAAVVtsPPPttAPHKERyFDRVDENN |
| P35611 | S358 | Sugiyama | ADD1 ADDA | PDNLVLLNPEKYKAKsRsPGsPVGEGtGsPPKWQIGEQEFE |
| P35613 | S278 | Sugiyama | BSG UNQ6505/PRO21383 | ITDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQ |
| P35637 | S346 | Sugiyama | FUS TLS | TDRETGKLKGEAtVsFDDPPsAKAAIDWFDGKEFsGNPIKV |
| P35658 | S1710 | EPSD|PSP | NUP214 CAIN CAN KIAA0023 | TGSTASTAAATPQVSSSGFSsPAFGTTAPGVFGQTTFGQAS |
| P35658 | S1809 | EPSD|PSP | NUP214 CAIN CAN KIAA0023 | SSPNTGGGLFGQSNAPAFGQsPGFGQGGSVFGGTSAATTTA |
| P35998 | T193 | Sugiyama | PSMC2 MSS1 | TYSDVGGCKEQIEKLREVVEtPLLHPERFVNLGIEPPKGVL |
| P36578 | S63 | Sugiyama | RPL4 RPL1 | NLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGG |
| P36578 | T69 | Sugiyama | RPL4 RPL1 | RQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHRsGQ |
| P36956 | S117 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SREBF1 BHLHD1 SREBP1 | LSPPQPAPTPLKMYPSMPAFsPGPGIKEESVPLSILQTPTP |
| P37231 | S112 | SIGNOR | PPARG NR1C3 | DYKYDLKLQEyQSAIKVEPAsPPYYSEKTQLYNKPHEEPSN |
| P37802 | S145 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | VQRTLMNLGGLAVARDDGLFsGDPNWFPKKSKENPRNFsDN |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P38646 | S212 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | tVPAyFNDsQRQAtKDAGQIsGLNVLRVINEPTAAALAyGL |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T87 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKR |
| P38936 | S130 | SIGNOR|ELM|EPSD|PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | HVDLsLSCTLVPRsGEQAEGsPGGPGDSQGRKRRQtsMTDF |
| P38936 | S98 | EPSD|PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | LPtGPRRGRDELGGGRRPGtsPALLQGTAEEDHVDLsLSCT |
| P38936 | T57 | SIGNOR|ELM | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | LMAGCIQEARERWNFDFVtEtPLEGDFAWERVRGLGLPKLy |
| P40763 | S701 | Sugiyama | STAT3 APRF | EAFGKyCRPEsQEHPEADPGsAAPyLKTKFICVtPttCsNt |
| P40763 | S727 | SIGNOR|PSP | STAT3 APRF | KTKFICVtPttCsNtIDLPMsPRTLDSLMQFGNNGEGAEPS |
| P40763 | Y705 | SIGNOR | STAT3 APRF | KyCRPEsQEHPEADPGsAAPyLKTKFICVtPttCsNtIDLP |
| P41091 | T109 | Sugiyama | EIF2S3 EIF2G | YKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLVRH |
| P41182 | S333 | SIGNOR|EPSD|PSP | BCL6 BCL5 LAZ3 ZBTB27 ZNF51 | ALHFEPPNAPLNRKGLVsPQsPQKsDCQPNsPtESCSSKNA |
| P41182 | S343 | SIGNOR|EPSD|PSP | BCL6 BCL5 LAZ3 ZBTB27 ZNF51 | LNRKGLVsPQsPQKsDCQPNsPtESCSSKNACILQAsGsPP |
| P41212 | S213 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ETV6 TEL TEL1 | sPDPEQRPLRsPLDNMIRRLsPAERAQGPRPHQENNHQESY |
| P41212 | S257 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ETV6 TEL TEL1 | VSPMENNHCPASSESHPKPSsPRQESTRVIQLMPsPIMHPL |
| P41235 | S138 | PSP | HNF4A HNF4 NR2A1 TCF14 | KKCFRAGMKKEAVQNERDRIstRRssYEDssLPsINALLQA |
| P41235 | S142 | PSP | HNF4A HNF4 NR2A1 TCF14 | RAGMKKEAVQNERDRIstRRssYEDssLPsINALLQAEVLS |
| P41235 | S143 | PSP | HNF4A HNF4 NR2A1 TCF14 | AGMKKEAVQNERDRIstRRssYEDssLPsINALLQAEVLSR |
| P41235 | S147 | PSP | HNF4A HNF4 NR2A1 TCF14 | KEAVQNERDRIstRRssYEDssLPsINALLQAEVLSRQIts |
| P41235 | S148 | PSP | HNF4A HNF4 NR2A1 TCF14 | EAVQNERDRIstRRssYEDssLPsINALLQAEVLSRQItsP |
| P41235 | S151 | PSP | HNF4A HNF4 NR2A1 TCF14 | QNERDRIstRRssYEDssLPsINALLQAEVLSRQItsPVSG |
| P41235 | S167 | PSP | HNF4A HNF4 NR2A1 TCF14 | ssLPsINALLQAEVLSRQItsPVSGINGDIRAKKIASIADV |
| P41235 | S262 | PSP | HNF4A HNF4 NR2A1 TCF14 | VLLLGNDYIVPRHCPELAEMsRVsIRILDELVLPFQELQID |
| P41235 | S265 | PSP | HNF4A HNF4 NR2A1 TCF14 | LGNDYIVPRHCPELAEMsRVsIRILDELVLPFQELQIDDNE |
| P41235 | S313 | PSP | HNF4A HNF4 NR2A1 TCF14 | IFFDPDAKGLsDPGKIKRLRsQVQVsLEDYINDRQYDSRGR |
| P41235 | S461 | PSP | HNF4A HNF4 NR2A1 TCF14 | SGsEPYKLLPGAVAtIVKPLsAIPQPtItKQEVI_______ |
| P41235 | S95 | PSP | HNF4A HNF4 NR2A1 TCF14 | SSCDGCKGFFRRSVRKNHMYsCRFSRQCVVDKDKRNQCRYC |
| P41235 | T139 | PSP | HNF4A HNF4 NR2A1 TCF14 | KCFRAGMKKEAVQNERDRIstRRssYEDssLPsINALLQAE |
| P41235 | T166 | PSP | HNF4A HNF4 NR2A1 TCF14 | DssLPsINALLQAEVLSRQItsPVSGINGDIRAKKIASIAD |
| P41235 | T467 | PSP | HNF4A HNF4 NR2A1 TCF14 | KLLPGAVAtIVKPLsAIPQPtItKQEVI_____________ |
| P41235 | T469 | PSP | HNF4A HNF4 NR2A1 TCF14 | LPGAVAtIVKPLsAIPQPtItKQEVI_______________ |
| P41236 | T73 | GPS6 | PPP1R2 IPP2 | LAtyHPADKDyGLMKIDEPstPYHsMMGDDEDACsDtEAtE |
| P41252 | S1047 | Sugiyama | IARS1 IARS | ESHTEFIFTTIKAPLKPYPVsPsDKVLIQEKTQLKGSELEI |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P42224 | S727 | EPSD|PSP | STAT1 | IsVsEVHPSRLQttDNLLPMsPEEFDEVSRIVGsVEFDSMM |
| P42229 | S780 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | STAT5A STAT5 | VARHVEELLRRPMDsLDsRLsPPAGLFTSARGSLS______ |
| P42677 | T74 | Sugiyama | RPS27 MPS1 | VLCVGCSTVLCQPTGGKARLtEGCsFRRKQH__________ |
| P42702 | S1044 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | LIFR | KTAGYRPQANVNTWNLVsPDsPRSIDsNSEIVSFGsPCSIN |
| P42892 | S733 | Sugiyama | ECE1 | VWCSVRTPESSHEGLITDPHsPsRFRVIGSLSNSKEFSEHF |
| P43364 | S174 | SIGNOR|EPSD|PSP | MAGEA11 MAGE11 | TLNVGTLEELPAAEsPsPPQsPQEESFsPTAMDAIFGSLSD |
| P46527 | S10 | SIGNOR | CDKN1B KIP1 p27 | ___________MSNVRVSNGsPsLERMDARQAEHPKPSACR |
| P46527 | S178 | SIGNOR | CDKN1B KIP1 p27 | DDSSTQNKRANRTEENVsDGsPNAGSVEQtPKKPGLRRRQt |
| P46527 | T187 | SIGNOR|EPSD|PSP | CDKN1B KIP1 p27 | ANRTEENVsDGsPNAGSVEQtPKKPGLRRRQt_________ |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46937 | T119 | Sugiyama | YAP1 YAP65 | PEPKsHsRQAstDAGtAGALtPQHVRAHssPAsLQLGAVsP |
| P47712 | S505 | SIGNOR|ELM | PLA2G4A CPLA2 PLA2G4 | RAGKVHNFMLGLNLNTSYPLsPLSDFATQDsFDDDELDAAV |
| P47756 | S207 | Sugiyama | CAPZB | MNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMENKIRst |
| P47914 | S142 | Sugiyama | RPL29 | KAKAKAKAKDQTKAQAAAPAsVPAQAPKRtQAPtKAsE___ |
| P48637 | S415 | Sugiyama | GSS | yILMEKIEPEPFENCLLRPGsPARVVQCISELGIFGVYVRQ |
| P49023 | S106 | Sugiyama | PXN | PVyGssAKtssVsNPQDsVGsPCsRVGEEEHVysFPNKQKs |
| P49023 | S126 | PSP | PXN | sPCsRVGEEEHVysFPNKQKsAEPsPtVMstsLGsNLsELD |
| P49023 | S130 | PSP | PXN | RVGEEEHVysFPNKQKsAEPsPtVMstsLGsNLsELDRLLL |
| P49023 | S83 | PSP | PXN | LDPLDQWQPSSSRFIHQQPQsssPVyGssAKtssVsNPQDs |
| P49137 | S272 | ELM | MAPKAPK2 | IMYILLCGYPPFYSNHGLAIsPGMKTRIRMGQYEFPNPEWS |
| P49137 | T222 | ELM | MAPKAPK2 | ILKLtDFGFAKEttsHNsLttPCytPyyVAPEVLGPEKYDK |
| P49137 | T25 | ELM | MAPKAPK2 | SQGQsPPVPFPAPAPPPQPPtPALPHPPAQPPPPPPQQFPQ |
| P49137 | T334 | ELM | MAPKAPK2 | MTItEFMNHPWIMQSTKVPQtPLHtsRVLKEDKERWEDVKE |
| P49327 | S831 | Sugiyama | FASN FAS | NPNALFPPVEFPAPRGtPLIsPLIKWDHSLAWDVPAAEDFP |
| P49327 | T2204 | Sugiyama | FASN FAS | LRKLQELSSKADEAsELACPtPKEDGLAQQQtQLNLRSLLV |
| P49327 | T827 | Sugiyama | FASN FAS | GIDANPNALFPPVEFPAPRGtPLIsPLIKWDHSLAWDVPAA |
| P49366 | S233 | GPS6|SIGNOR|PSP | DHPS DS | EINNPESVyyWAQKNHIPVFsPALTDGSLGDMIFFHSYKNP |
| P49407 | S412 | SIGNOR|iPTMNet|EPSD|PSP | ARRB1 ARR1 | ARQRLKGMKDDKEEEEDGtGsPQLNNR______________ |
| P49418 | S293 | SIGNOR | AMPH AMPH1 | PtAsPNHTLAPAsPAPARPRsPsQTRKGPPVPPLPKVtPtK |
| P49418 | S295 | SIGNOR | AMPH AMPH1 | AsPNHTLAPAsPAPARPRsPsQTRKGPPVPPLPKVtPtKEL |
| P49448 | T409 | Sugiyama | GLUD2 GLUDP1 | TKSNAPRVKAKIIAEGANGPttPEADKIFLERNILVIPDLY |
| P49585 | S315 | SIGNOR | PCYT1A CTPCT PCYT1 | PEGALKHMLKEGKGRMLQAIsPKQsPsssPtRERsPsPSFR |
| P49585 | S347 | Sugiyama | PCYT1A CTPCT PCYT1 | ERsPsPSFRWPFsGKtsPPCsPANLsRHKAAAyDIsEDEED |
| P49715 | S21 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CEBPA CEBP | MESADFYEAEPRPPMssHLQsPPHAPSSAAFGFPRGAGPAQ |
| P49790 | S257 | EPSD|PSP | NUP153 | GtLsPsLGNssILKTsQLGDsPFyPGKTTYGGAAAAVRQSK |
| P49790 | S320 | EPSD|PSP | NUP153 | SYGVTSstARRILQsLEKMSsPLADAKRIPsIVssPLNsPL |
| P49790 | S334 | EPSD|PSP | NUP153 | sLEKMSsPLADAKRIPsIVssPLNsPLDRsGIDItDFQAKR |
| P49790 | S338 | EPSD|PSP | NUP153 | MSsPLADAKRIPsIVssPLNsPLDRsGIDItDFQAKREKVD |
| P49790 | S516 | EPSD|PSP | NUP153 | TSSPSPINSSQALTNKVQMtsPsstGsPMFKFSsPIVKSTE |
| P49790 | S522 | EPSD|PSP | NUP153 | INSSQALTNKVQMtsPsstGsPMFKFSsPIVKSTEANVLPP |
| P49790 | S529 | SIGNOR|EPSD|PSP | NUP153 | TNKVQMtsPsstGsPMFKFSsPIVKSTEANVLPPSSIGFTF |
| P49790 | T369 | EPSD|PSP | NUP153 | DFQAKREKVDSQYPPVQRLMtPKPVSIATNRSVYFKPsLtP |
| P49790 | T388 | SIGNOR|EPSD|PSP | NUP153 | MtPKPVSIATNRSVYFKPsLtPsGEFRKTNQRIDNKCSTGY |
| P49790 | T413 | EPSD|PSP | NUP153 | FRKTNQRIDNKCSTGYEKNMtPGQNREQRESGFSYPNFSLP |
| P49792 | T1144 | Sugiyama | RANBP2 NUP358 | GFRRsDDMFTFHGPGKsVFGtPtLETANKNHEtDGGsAHGD |
| P49792 | T2450 | Sugiyama | RANBP2 NUP358 | DSFKKIFDEAKTAQEKDsLItPHVsRsstPREsPCGKIAVA |
| P49795 | S151 | GPS6 | RGS19 GAIP GNAI3IP | NQHVVDEKARLIyEDyVSILsPKEVSLDSRVREGINKKMQE |
| P49815 | S540 | SIGNOR | TSC2 TSC4 | HTHHFNSLLDIIEKVMARSLsPPPELEERDVAAYSASLEDV |
| P49815 | S664 | SIGNOR|EPSD|PSP | TSC2 TSC4 | CVCDYMEPERGSEKKtsGPLsPPtGPPGPAPAGPAVRLGSV |
| P49841 | S9 | SIGNOR | GSK3B | ____________MSGRPRttsFAEsCKPVQQPsAFGsMKVS |
| P49841 | T43 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | GSK3B | FGsMKVSRDKDGSKVTTVVAtPGQGPDRPQEVSyTDTKVIG |
| P49903 | T387 | Sugiyama | SEPHS1 SELD SPS SPS1 | IDKPRIIEVAPQVATQNVNPtPGAts_______________ |
| P50502 | S181 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | LQKPNAAIRDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| P50616 | S152 | SIGNOR|EPSD|PSP | TOB1 TOB TROB1 | FNPEAQVFMPISDPASsVsssPsPPFGHsAAVsPTFMPRSt |
| P50616 | S154 | SIGNOR|EPSD|PSP | TOB1 TOB TROB1 | PEAQVFMPISDPASsVsssPsPPFGHsAAVsPTFMPRStQP |
| P50616 | S164 | SIGNOR|EPSD|PSP | TOB1 TOB TROB1 | DPASsVsssPsPPFGHsAAVsPTFMPRStQPLTFTTATFAA |
| P50991 | T50 | Sugiyama | CCT4 CCTD SRB | PAQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtI |
| P51003 | S537 | SIGNOR | PAPOLA PAP | ALNDSSLDLsMDsDNsMsVPsPtSATKtsPLNSSGsSQGRN |
| P51003 | S545 | SIGNOR | PAPOLA PAP | LsMDsDNsMsVPsPtSATKtsPLNSSGsSQGRNsPAPAVTA |
| P51003 | S558 | SIGNOR | PAPOLA PAP | PtSATKtsPLNSSGsSQGRNsPAPAVTAASVTNIQATEVSV |
| P51168 | T615 | SIGNOR | SCNN1B | APRSPNTGPYPSEQALPIPGtPPPNYDSLRLQPLDVIESDS |
| P51170 | T622 | SIGNOR | SCNN1G | LPTFNSALHLPPALGTQVPGtPPPKYNTLRLERAFSNQLTD |
| P51784 | S948 | PSP | USP11 UHX1 | QRQDVARRLLsPAGssGAPAsPACssPPssEFMDVN_____ |
| P51812 | S227 | SIGNOR | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | IKLTDFGLSKESIDHEKKAysFCGtVEYMAPEVVNRRGHTQ |
| P51812 | T577 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | IRICDFGFAKQLRAENGLLMtPCytANFVAPEVLKRQGYDA |
| P51812 | Y529 | EPSD | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | KFFSEREASAVLFTITKTVEyLHAQGVVHRDLKPSNILYVD |
| P51858 | S40 | Sugiyama | HDGF HMG1L2 | MKGyPHWPARIDEMPEAAVKstANKYQVFFFGTHETAFLGP |
| P51858 | T41 | Sugiyama | HDGF HMG1L2 | KGyPHWPARIDEMPEAAVKstANKYQVFFFGTHETAFLGPK |
| P51991 | S358 | Sugiyama | HNRNPA3 HNRPA3 | QQQSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsRRF |
| P52565 | T160 | Sugiyama | ARHGDIA GDIA1 | DKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYsIKSR |
| P52597 | S107 | Sugiyama | HNRNPF HNRPF | KSHRTEMDWVLKHsGPNsADsANDGFVRLRGLPFGCTKEEI |
| P52948 | S623 | Sugiyama | NUP98 ADAR2 | KNLNNsNLFsPVNRDsENLAsPsEyPENGERFsFLSKPVDE |
| P53004 | S230 | EPSD|PSP | BLVRA BLVR BVR | KsPLSWIEEKGPGLKRNRyLsFHFKsGsLENVPNVGVNKNI |
| P53355 | S734 | EPSD|PSP | DAPK1 DAPK | SFFRRRRPRLSSTNSSRFPPsPLASKPTVSVSINNLYPGCE |
| P53396 | S481 | Sugiyama | ACLY | ADEVAPAKKAKPAMPQDsVPsPRSLQGKSTTLFSRHTKAIV |
| P53621 | S173 | Sugiyama | COPA | ASLDQTVRVWDISGLRKKNLsPGAVEsDVRGITGVDLFGTT |
| P53634 | T458 | Sugiyama | CTSC CPPI | yFRIRRGtDECAIEsIAVAAtPIPKL_______________ |
| P53805 | S167 | SIGNOR|iPTMNet | RCAN1 ADAPT78 CSP1 DSC1 DSCR1 | GSSHLAPPNPDKQFLIsPPAsPPVGWKQVEDAtPVINYDLL |
| P53992 | S328 | Sugiyama | SEC24C KIAA0079 | sQPGPPQPLPPKRLDPDAIPsPIQVIEDDRNNRGTEPFVTG |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P54819 | T89 | Sugiyama | AK2 ADK2 | DAGKLVSDEMVVELIEKNLEtPLCKNGFLLDGFPRTVRQAE |
| P55209 | T62 | Sugiyama | NAP1L1 NRP | MMQNPQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALK |
| P55211 | T125 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CASP9 MCH6 | NLtPVVLRPEIRKPEVLRPEtPRPVDIGSGGFGDVGALEsL |
| P55327 | S40 | PSP | TPD52 | AGVNKSYLYLSPSGNSSPPGsPTLQKFGLLRTDPVPEEGED |
| P55795 | S104 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | EVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P55809 | S509 | Sugiyama | OXCT1 OXCT SCOT | LWEGLTVDDVQKSTGCDFAVsPKLMPMQQIAN_________ |
| P56192 | S209 | SIGNOR|PSP | MARS1 MARS | VLKQQGVLALRPYLQKQPQPsPAEGRAVTNEPEEEELATLs |
| P56192 | S825 | SIGNOR|PSP | MARS1 MARS | LENDQIEsLRQRFGGGQAKtsPKPAVVEtVtTAKPQQIQAL |
| P56270 | T72 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MAZ ZNF801 | FFASQGCAQSPFQAAPAPPPtPQAPAAEPLQVDLLPVLAAA |
| P56693 | T240 | SIGNOR | SOX10 | GSPMsDGNPEHPsGQSHGPPtPPTtPKTELQSGKADPKRDG |
| P56693 | T244 | SIGNOR | SOX10 | sDGNPEHPsGQSHGPPtPPTtPKTELQSGKADPKRDGRSMG |
| P57740 | S11 | Sugiyama | NUP107 | __________MDRsGFGEIssPVIREAEVTRTARKQSAQKR |
| P60174 | S80 | Sugiyama | TPI1 TPI | IAVAAQNCyKVTNGAFtGEIsPGMIKDCGAtWVVLGHsERR |
| P60174 | T46 | Sugiyama | TPI1 TPI | IGtLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQN |
| P60174 | Y48 | Sugiyama | TPI1 TPI | tLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQNCy |
| P60709 | S300 | Sugiyama | ACTB | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | T201 | Sugiyama | ACTB | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y294 | Sugiyama | ACTB | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P60866 | T6 | Sugiyama | RPS20 | _______________MAFKDtGKtPVEPEVAIHRIRITLTS |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61586 | S88 | SIGNOR|EPSD|PSP | RHOA ARH12 ARHA RHO12 | RLRPLSYPDTDVILMCFSIDsPDSLENIPEKWtPEVKHFCP |
| P61586 | T100 | SIGNOR|EPSD|PSP | RHOA ARH12 ARHA RHO12 | ILMCFSIDsPDSLENIPEKWtPEVKHFCPNVPIILVGNKKD |
| P61604 | S64 | Sugiyama | HSPE1 | AtVVAVGsGsKGKGGEIQPVsVKVGDKVLLPEyGGtKVVLD |
| P61604 | T79 | Sugiyama | HSPE1 | EIQPVsVKVGDKVLLPEyGGtKVVLDDKDyFLFRDGDILGK |
| P61916 | S40 | Sugiyama | NPC2 HE1 | EPVQFKDCGsVDGVIKEVNVsPCPtQPCQLSKGQSYSVNVT |
| P61978 | S284 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | HNRNPK HNRPK | MPPGRGGRPMPPSRRDyDDMsPRRGPPPPPPGRGGRGGsRA |
| P61978 | S353 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | HNRNPK HNRPK | YDGMVGFSADETWDSAIDtWsPSEWQMAYEPQGGSGYDYSY |
| P61978 | S81 | Sugiyama | HNRNPK HNRPK | GGKNIKALRtDyNAsVsVPDssGPERILsISADIETIGEIL |
| P61981 | S38 | Sugiyama | YWHAG | ERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKNVVGARRS |
| P62070 | S186 | EPSD|PSP | RRAS2 TC21 | QAFHELVRVIRKFQEQECPPsPEPtRKEKDKKGCHCVIF__ |
| P62081 | S174 | Sugiyama | RPS7 | IKVHLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL |
| P62081 | T172 | Sugiyama | RPS7 | RLIKVHLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEF |
| P62195 | T109 | Sugiyama | PSMC5 SUG1 | VHPEGKFVVDVDKNIDINDVtPNCRVALRNDsytLHKILPN |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62714 | S212 | Sugiyama | PPP2CB | EGPMCDLLWSDPDDRGGWGIsPRGAGYTFGQDISETFNHAN |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62826 | S150 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARKLIG |
| P62826 | T21 | Sugiyama | RAN ARA24 OK/SW-cl.81 | MAAQGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVA |
| P62942 | S9 | Sugiyama | FKBP1A FKBP1 FKBP12 | ____________MGVQVEtIsPGDGRtFPKRGQtCVVHytG |
| P63000 | T108 | EPSD|PSP | RAC1 TC25 MIG5 | ASFENVRAKWYPEVRHHCPNtPIILVGTKLDLRDDKDTIEK |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63261 | S300 | Sugiyama | ACTG1 ACTG | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | T201 | Sugiyama | ACTG1 ACTG | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y294 | Sugiyama | ACTG1 ACTG | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P67775 | S212 | Sugiyama | PPP2CA | EGPMCDLLWSDPDDRGGWGIsPRGAGYTFGQDISETFNHAN |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P68400 | S362 | SIGNOR | CSNK2A1 CK2A1 | GStPVSSANMMSGISSVPtPsPLGPLAGsPVIAAANPLGMP |
| P68400 | T360 | SIGNOR | CSNK2A1 CK2A1 | PGGStPVSSANMMSGISSVPtPsPLGPLAGsPVIAAANPLG |
| P68431 | S29 | ELM | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | RKstGGKAPRKQLATKAARKsAPATGGVKKPHRyRPGtVAL |
| P78347 | S210 | Sugiyama | GTF2I BAP135 WBSCR6 | EPKKHVGGRVMVtDADRsILsPGGsCGPIKVKTEPTEDSGI |
| P78347 | S668 | SIGNOR | GTF2I BAP135 WBSCR6 | LVISyLPPGMASKINTKALQsPKRPRsPGsNsKVPEIEVtV |
| P78347 | S674 | SIGNOR | GTF2I BAP135 WBSCR6 | PPGMASKINTKALQsPKRPRsPGsNsKVPEIEVtVEGPNNN |
| P78371 | T475 | Sugiyama | CCT2 99D8.1 CCTB | GYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAILGITE |
| P78536 | T735 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ADAM17 CSVP TACE | MLSSMDSASVRIIKPFPAPQtPGRLQPAPVIPSAPAAPKLD |
| P78543 | S147 | GPS6 | BTG2 PC3 | PLAASCGLLTCKNQVLLGRssPsKNYVMAVSS_________ |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P84243 | S29 | SIGNOR | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | RKstGGKAPRKQLATKAARKsAPsTGGVKKPHRyRPGtVAL |
| P85037 | S420 | Sugiyama | FOXK1 MNF | RGVSCFRtPFGPLssRsAPAsPtHPGLMsPRsGGLQtPECL |
| P85037 | S428 | Sugiyama | FOXK1 MNF | PFGPLssRsAPAsPtHPGLMsPRsGGLQtPECLsREGsPIP |
| Q00613 | S303 | GPS6 | HSF1 HSTF1 | SIDERPLSSsPLVRVKEEPPsPPQsPRVEEAsPGRPssVDt |
| Q00613 | S307 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | HSF1 HSTF1 | RPLSSsPLVRVKEEPPsPPQsPRVEEAsPGRPssVDtLLsP |
| Q00613 | S326 | PSP | HSF1 HSTF1 | QsPRVEEAsPGRPssVDtLLsPtALIDsILREsEPAPAsVT |
| Q00975 | S446 | SIGNOR | CACNA1B CACH5 CACNL1A5 | NDLIHAEEGEDRFADLCAVGsPFARASLKSGKTESSSYFRR |
| Q01105 | S133 | Sugiyama | SET | DEEALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLS |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01196 | S249 | SIGNOR | RUNX1 AML1 CBFA2 | stAFNPQPQSQMQDTRQIQPsPPWsyDQsyQyLGSIAsPsV |
| Q01196 | S266 | SIGNOR | RUNX1 AML1 CBFA2 | IQPsPPWsyDQsyQyLGSIAsPsVHPAtPIsPGRASGMTTL |
| Q01196 | S276 | SIGNOR | RUNX1 AML1 CBFA2 | QsyQyLGSIAsPsVHPAtPIsPGRASGMTTLSAELSSRLsT |
| Q01196 | T273 | SIGNOR | RUNX1 AML1 CBFA2 | syDQsyQyLGSIAsPsVHPAtPIsPGRASGMTTLSAELSSR |
| Q01518 | S431 | Sugiyama | CAP1 CAP | NKTDGCHAYLSKNSLDCEIVsAKSSEMNVLIPTEGGDFNEF |
| Q01844 | T422 | Sugiyama | EWSR1 EWS | LDKETGKPKGDATVSyEDPPtAKAAVEWFDGKDFQGSKLKV |
| Q01844 | T79 | SIGNOR|EPSD|PSP | EWSR1 EWS | ATYGQTAYATSYGQPPTGYttPtAPQAYSQPVQGYGTGAYD |
| Q01860 | S111 | SIGNOR|EPSD|PSP | POU5F1 OCT3 OCT4 OTF3 | ETsQPEGEAGVGVESNSDGAsPEPCTVtPGAVKLEKEKLEQ |
| Q01892 | T56 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | SPIB | DsEGAPDSLWDWTVAPPVPAtPYEAFDPAAAAFSHPQAAQL |
| Q02447 | S73 | SIGNOR|EPSD|PSP | SP3 | DTQPSPLALLAATCSKIGPPsPGDDEEEAAAAAGAPAAAGA |
| Q02548 | S189 | SIGNOR | PAX5 | SVSTDSAGSSYSISGILGITsPSADTNKRKRDEGIQESPVP |
| Q02641 | S161 | SIGNOR | CACNB1 CACNLB1 | NNDWWIGRLVKEGCEVGFIPsPVKLDSLRLLQEQKLRQNRL |
| Q02641 | S348 | SIGNOR | CACNB1 CACNLB1 | HPAQLSKTSLAPIIVYIKITsPKVLQRLIKSRGKSQSKHLN |
| Q02750 | T286 | EPSD|PSP | MAP2K1 MEK1 PRKMK1 | PDAKELELMFGCQVEGDAAEtPPRPRtPGRPLssyGMDsRP |
| Q02750 | T292 | SIGNOR|EPSD|PSP | MAP2K1 MEK1 PRKMK1 | ELMFGCQVEGDAAEtPPRPRtPGRPLssyGMDsRPPMAIFE |
| Q02750 | T386 | SIGNOR | MAP2K1 MEK1 PRKMK1 | AEEVDFAGWLCstIGLNQPstPtHAAGV_____________ |
| Q02790 | S15 | Sugiyama | FKBP4 FKBP52 | ______MTAEEMKAtEsGAQsAPLPMEGVDIsPKQDEGVLK |
| Q02952 | S283 | Sugiyama | AKAP12 AKAP250 | EECKEEGEEKQEKEPSKsAEsPtsPVtsETGstFKKFFTQG |
| Q02952 | S286 | Sugiyama | AKAP12 AKAP250 | KEEGEEKQEKEPSKsAEsPtsPVtsETGstFKKFFTQGWAG |
| Q03060 | S277 | SIGNOR|PSP | CREM | APTAALPQGVVMAAsPGSLHsPQQLAEEATRKRELRLMKNR |
| Q04637 | S1231 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | tEDRDRGRDAVKREAALPPVsPLKAALsEEELEKKsKAIIE |
| Q04637 | S198 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | KTIRIRDPNQGGKDITEEIMsGARtAstPtPPQtGGGLEPQ |
| Q05209 | S571 | EPSD|PSP | PTPN12 | sEGNssDINYQTRKtVsLtPsPttQVEtPDLVDHDNtsPLF |
| Q05469 | T891 | SIGNOR|iPTMNet | LIPE | LKNLTLRDLSLRGNSETSSDtPEMSLSAETLSPSTPSDVNF |
| Q05682 | S759 | SIGNOR|EPSD|PSP | CALD1 CAD CDM | KVGVSsRINEWLTKtPDGNKsPAPKPSDLRPGDVssKRNLW |
| Q05682 | S789 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CALD1 CAD CDM | PGDVssKRNLWEKQsVDKVtsPTKV________________ |
| Q06210 | S103 | Sugiyama | GFPT1 GFAT GFPT | IEFDVHLGIAHTRWATHGEPsPVNSHPQRSDKNNEFIVIHN |
| Q06413 | S387 | ELM | MEF2C | GACTSTHLSQSSNLSLPSTQsLNIKSEPVsPPRDRTTtPSR |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q07021 | T165 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | GEEEPSQGQKVEEQEPELtstPNFVVEVIKNDDGKKALVLD |
| Q07157 | S1180 | Sugiyama | TJP1 ZO1 | QPAPGyDtHGRLRPEAQPHPsAGPKPAEsKQyFEQysRsyE |
| Q07157 | S1617 | Sugiyama | TJP1 ZO1 | AEKPKyQINNISTVPKAIPVsPsAVEEDEDEDGHTVVATAR |
| Q07820 | T163 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MCL1 BCL2L3 | LLELVGEsGNNtstDGsLPstPPPAEEEEDELYRQSLEIIS |
| Q07820 | T92 | EPSD|PSP | MCL1 BCL2L3 | DSRRVARPPPIGAEVPDVTAtPARLLFFAPTRRAAPLEEME |
| Q07866 | S460 | SIGNOR|Sugiyama | KLC1 KLC KNS2 | QKDGTsFGEyGGWyKACKVDsPtVTTtLKNLGALyRRQGKF |
| Q07869 | S12 | SIGNOR|ELM|iPTMNet|EPSD | PPARA NR1C1 PPAR | _________MVDTEsPLCPLsPLEAGDLEsPLSEEFLQEMG |
| Q07869 | S21 | SIGNOR|ELM|iPTMNet | PPARA NR1C1 PPAR | MVDTEsPLCPLsPLEAGDLEsPLSEEFLQEMGNIQEISQSI |
| Q07889 | S1132 | SIGNOR | SOS1 | PFHSSNDTVFIQVTLPHGPRsAsVSSISLTKGTDEVPVPPP |
| Q07889 | S1167 | SIGNOR | SOS1 | VPVPPPVPPRRRPEsAPAEssPSKIMSKHLDsPPAIPPRQP |
| Q07889 | S1178 | SIGNOR | SOS1 | RPEsAPAEssPSKIMSKHLDsPPAIPPRQPTSKAYsPRYsI |
| Q07889 | S1193 | SIGNOR | SOS1 | SKHLDsPPAIPPRQPTSKAYsPRYsISDRTsIsDPPEsPPL |
| Q07889 | S1197 | SIGNOR | SOS1 | DsPPAIPPRQPTSKAYsPRYsISDRTsIsDPPEsPPLLPPR |
| Q07960 | S51 | Sugiyama | ARHGAP1 CDC42GAP RHOGAP1 | KNWPsDEMPDFPKsDDsKsssPELVtHLKWDDPyyDIARHQ |
| Q08499 | S715 | SIGNOR | PDE4D DPDE3 | QDILDTLEDNREWYQstIPQsPsPAPDDPEEGRQGQTEKFQ |
| Q08AD1 | S673 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | DASKFLQDyDIRTGNTREALsPCPsTVsTKSQPGSSAssss |
| Q08J23 | S743 | Sugiyama | NSUN2 SAKI TRM4 | AstGQPDNDVtEGQRAGEPNsPDAEEANsPDVtAGCDPAGV |
| Q09472 | S1038 | SIGNOR|PSP | EP300 P300 | ELKTEIKEEEDQPstsAtQssPAPGQSKKKIFKPEELRQAL |
| Q09472 | S2039 | SIGNOR|PSP | EP300 P300 | AQHGQPLNMAPQPGLGQVGIsPLKPGTVSQQALQNLLRTLR |
| Q09472 | S2279 | SIGNOR | EP300 P300 | AYQQRLLQQQMGSPVQPNPMsPQQHMLPNQAQSPHLQGQQI |
| Q09472 | S2315 | SIGNOR | EP300 P300 | QGQQIPNSLSNQVRsPQPVPsPRPQsQPPHssPsPRMQPQP |
| Q09472 | S2366 | SIGNOR | EP300 P300 | SPHPGLVAAQANPMEQGHFAsPDQNSMLSQLASNPGMANLH |
| Q09666 | S93 | Sugiyama | AHNAK PM227 | LLNTMGHHTVGLKLHRKGDRsPEPGQtWtREVFssCssEVV |
| Q09666 | T4100 | Sugiyama | AHNAK PM227 | VDVNLPKADIDVsGPKVDIDtPDIDIHGPEGKLKGPKFKMP |
| Q09666 | T4564 | Sugiyama | AHNAK PM227 | LEGDLKGPKVDVKGPKVGIDtPDIDIHGPEGKLKGPKFKMP |
| Q12772 | S432 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SREBF2 BHLHD2 SREBP2 | LVDNEVDLKIEDFNQNVLLMsPPASDSGSQAGFSPYSIDSE |
| Q12772 | S455 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SREBF2 BHLHD2 SREBP2 | ASDSGSQAGFSPYSIDSEPGsPLLDDAKVKDEPDsPPVALG |
| Q12774 | S445 | Sugiyama | ARHGEF5 TIM | ASYLMTQIPGTQTESRAEELsPAALsPsLEPIRCSHQPISL |
| Q12774 | S450 | Sugiyama | ARHGEF5 TIM | TQIPGTQTESRAEELsPAALsPsLEPIRCSHQPISLLGsFL |
| Q12792 | S143 | Sugiyama | TWF1 PTK9 | GTVKEDVSLHGYKKyLLsQssPAPLtAAEEELRQIKINEVQ |
| Q12800 | S291 | SIGNOR | TFCP2 LSF SEF | TTILTECSPWPEITYVNNsPsPGFNSSHSSFSLGEGNGsPN |
| Q12800 | S309 | SIGNOR | TFCP2 LSF SEF | sPsPGFNSSHSSFSLGEGNGsPNHQPEPPPPVTDNLLPTTT |
| Q12929 | S625 | SIGNOR | EPS8 | tIQKQRMEYGPRPADtPPAPsPPPtPAPVPVPLPPstPAPV |
| Q12931 | S511 | EPSD|PSP|Sugiyama | TRAP1 HSP75 HSPC5 | RAGtRNIyyLCAPNRHLAEHsPyyEAMKKKDTEVLFCFEQF |
| Q12931 | S568 | Sugiyama | TRAP1 HSP75 HSPC5 | ISVETDIVVDHYKEEKFEDRsPAAECLSEKETEELMAWMRN |
| Q13033 | S229 | Sugiyama | STRN3 GS2NA SG2NA | SEPNGsVETKNLEQILNGGEsPKQKGQEIKRSSGDVLETFN |
| Q13115 | S386 | PSP | DUSP4 MKP2 VH2 | FSFPVSVGVHSAPSSLPYLHsPITTsPSC____________ |
| Q13115 | S391 | PSP | DUSP4 MKP2 VH2 | SVGVHSAPSSLPYLHsPITTsPSC_________________ |
| Q13127 | S861 | PSP | REST NRSF XBR | GLVPVKDSWLLKESVstEDLsPPsPPLPKENLREEASGDQK |
| Q13127 | S864 | PSP | REST NRSF XBR | PVKDSWLLKESVstEDLsPPsPPLPKENLREEASGDQKLLN |
| Q13153 | T292 | SIGNOR | PAK1 | RFEKIGQGASGTVyTAMDVAtGQEVAIKQMNLQQQPKKELI |
| Q13164 | T733 | EPSD|PSP | MAPK7 BMK1 ERK5 PRKM7 | VTQQLSKsQVEDPLPPVFsGtPKGSGAGYGVGFDLEEFLNQ |
| Q13200 | S16 | Sugiyama | PSMD2 TRAP2 | _____MEEGGRDKAPVQPQQsPAAAPGGtDEKPsGKERRDA |
| Q13228 | S53 | Sugiyama | SELENBP1 SBP | yRNtGtEAPDyLATVDVDPKsPQyCQVIHRLPMPNLKDELH |
| Q13263 | Y755 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | GGTLDLTLIRARLQEKLsPPyssPQEFAQDVGRMFKQFNKL |
| Q13283 | S230 | Sugiyama | G3BP1 G3BP | IQEEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFs |
| Q13283 | S231 | Sugiyama | G3BP1 G3BP | QEEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsW |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q13322 | S150 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | GRB10 GRBIR KIAA0207 | FRtssLPAIPNPFPELCGPGsPPVLtPGSLPPSQAAAKQDV |
| Q13322 | S418 | GPS6|SIGNOR | GRB10 GRBIR KIAA0207 | KYGMLLYQNYRIPQQRKALLsPFstPVRsVsENsLVAMDFS |
| Q13322 | S476 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | GRB10 GRBIR KIAA0207 | LEEGHAWRKRSTRMNILGsQsPLHPstLSTVIHRTQHWFHG |
| Q13362 | S337 | SIGNOR | PPP2R5C KIAA0044 | PSEFVKIMEPLFRQLAKCVssPHFQVAERALYYWNNEYIMS |
| Q13424 | S193 | ELM | SNTA1 SNT1 | SPYFKNStGGtsVGWDsPPAsPLQRQPssPGPTPRNFSEAK |
| Q13424 | S201 | ELM | SNTA1 SNT1 | GGtsVGWDsPPAsPLQRQPssPGPTPRNFSEAKHMSLKMAY |
| Q13428 | T1014 | Sugiyama | TCOF1 | ARssssEsEDEDVIPAtQCLtPGIRTNVVTMPTAHPRIAPK |
| Q13480 | S381 | GPS6|SIGNOR|iPTMNet | GAB1 | SIPRTAsDTDssyCIPtAGMsPSRSNtIstVDLNKLRKDAs |
| Q13480 | S454 | GPS6|SIGNOR|iPTMNet | GAB1 | TVGSVssEELDENyVPMNPNsPPRQHSSSFTEPIQEANyVP |
| Q13480 | S551 | SIGNOR | GAB1 | PAPLEIKPLPEWEELQAPVRsPITRSFARDSSRFPMsPRPD |
| Q13480 | S567 | SIGNOR | GAB1 | APVRsPITRSFARDSSRFPMsPRPDSVHSTTSSSDsHDSEE |
| Q13480 | S582 | GPS6 | GAB1 | SRFPMsPRPDSVHSTTSSSDsHDSEENyVPMNPNLsSEDPN |
| Q13480 | S597 | GPS6|SIGNOR|iPTMNet | GAB1 | TSSSDsHDSEENyVPMNPNLsSEDPNLFGSNSLDGGSSPMI |
| Q13480 | T312 | GPS6|SIGNOR|iPTMNet | GAB1 | GTSSVETQMRHVsIsyDIPPtPGNtyQIPRTFPEGTLGQTS |
| Q13480 | T476 | GPS6|SIGNOR|iPTMNet | GAB1 | PRQHSSSFTEPIQEANyVPMtPGTFDFSSFGMQVPPPAHMG |
| Q13485 | T277 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SMAD4 DPC4 MADH4 | PATYHHNStTTWtGSRtAPYtPNLPHHQNGHLQHHPPMPPH |
| Q13501 | S272 | Sugiyama | SQSTM1 ORCA OSIL | GIEVDIDVEHGGKRsRLtPVsPEssstEEKsssQPssCCsD |
| Q13501 | T269 | Sugiyama | SQSTM1 ORCA OSIL | sPLGIEVDIDVEHGGKRsRLtPVsPEssstEEKsssQPssC |
| Q13509 | S168 | Sugiyama | TUBB3 TUBB4 | GTLLISKVREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLS |
| Q13509 | S172 | Sugiyama | TUBB3 TUBB4 | ISKVREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLSIHQL |
| Q13509 | T166 | Sugiyama | TUBB3 TUBB4 | GMGTLLISKVREEYPDRIMNtFsVVPsPKVSDTVVEPYNAT |
| Q13526 | S115 | Sugiyama | PIN1 | KIKSGEEDFEsLAsQFSDCSsAKARGDLGAFsRGQMQKPFE |
| Q13541 | S65 | GPS6|EPSD|PSP | EIF4EBP1 | ttPGGtRIIyDRKFLMECRNsPVtKtPPRDLPtIPGVtsPs |
| Q13614 | S58 | EPSD|PSP | MTMR2 KIAA1073 | HTKSASVVssDSIStSADNFsPDLRVLRESNKLAEMEEPPL |
| Q13950 | S24 | EPSD|PSP | RUNX2 AML3 CBFA1 OSF2 PEBP2A | NSLFSTVTPCQQNFFWDPSTsRRFsPPSSSLQPGKMSDVsP |
| Q13950 | S275 | EPSD|PSP | RUNX2 AML3 CBFA1 OSF2 PEBP2A | PSMRVGVPPQNPRPsLNSAPsPFNPQGQSQITDPRQAQssP |
| Q13950 | S28 | EPSD|PSP | RUNX2 AML3 CBFA1 OSF2 PEBP2A | STVTPCQQNFFWDPSTsRRFsPPSSSLQPGKMSDVsPVVAA |
| Q13950 | S294 | SIGNOR|EPSD|PSP | RUNX2 AML3 CBFA1 OSF2 PEBP2A | PsPFNPQGQSQITDPRQAQssPPWsyDQSYPSYLSQMTsPs |
| Q13950 | S312 | SIGNOR|EPSD|PSP | RUNX2 AML3 CBFA1 OSF2 PEBP2A | QssPPWsyDQSYPSYLSQMTsPsIHSTTPLSSTRGTGLPAI |
| Q13950 | S314 | EPSD|PSP | RUNX2 AML3 CBFA1 OSF2 PEBP2A | sPPWsyDQSYPSYLSQMTsPsIHSTTPLSSTRGTGLPAITD |
| Q13950 | S340 | EPSD|PSP | RUNX2 AML3 CBFA1 OSF2 PEBP2A | PLSSTRGTGLPAITDVPRRIsDDDtAtsDFCLWPSTLSKKS |
| Q13950 | S43 | EPSD|PSP | RUNX2 AML3 CBFA1 OSF2 PEBP2A | TsRRFsPPSSSLQPGKMSDVsPVVAAQQQQQQQQQQQQQQQ |
| Q13950 | S503 | EPSD|PSP | RUNX2 AML3 CBFA1 OSF2 PEBP2A | LNPNLPNQNDGVDADGsHSSsPTVLNSSGRMDESVWRPY__ |
| Q14005 | S845 | GPS6|SIGNOR|EPSD | IL16 | HLGSHIRASSSSSSIRQRIssFETFGSSQLPDKGAQRLsLQ |
| Q14103 | T193 | Sugiyama | HNRNPD AUF1 HNRPD | KAMKTKEPVKKIFVGGLsPDtPEEKIREYFGGFGEVESIEL |
| Q14157 | S416 | Sugiyama | UBAP2L KIAA0144 NICE4 | tQsPsLVQYDLKNPsDsAVHsPFtKRQAFtPsstMMEVFLQ |
| Q14157 | S477 | Sugiyama | UBAP2L KIAA0144 NICE4 | PsKstsAPQMsPGssDNQsssPQPAQQKLKQQKKKAsLTSK |
| Q14157 | S859 | Sugiyama | UBAP2L KIAA0144 NICE4 | FPtPttPLtGRDGsLAsNPysGDLtKFGRGDASSPAPATTL |
| Q14160 | S1439 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | DGETLGEEEQEDEQPPWAsPsPtsRQsPAsPPPLGGGAPVR |
| Q14160 | S1448 | SIGNOR|Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | QEDEQPPWAsPsPtsRQsPAsPPPLGGGAPVRTAKAERRHQ |
| Q14160 | S504 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | MKRSIEGRRsEACPCQPDsGsPLPAEEEKRLsAESGLSEDS |
| Q14160 | S853 | SIGNOR | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | DysPRERRGGGLRLPLLPPEsPGPLRQRHVACLARSERGLG |
| Q14204 | S2410 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | GEDEAQRRRKGKEDEGEEAAsPMLQIQRDAATIMQPYFTSN |
| Q14204 | S3082 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | LHVVFTMNPSSEGLKDRAAtsPALFNRCVLNWFGDWSTEAL |
| Q14247 | S405 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | CTTN EMS1 | EEARRKLEEQARAKtQtPPVsPAPQPtEERLPssPVyEDAA |
| Q14247 | S418 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | CTTN EMS1 | KtQtPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVs |
| Q14247 | Y421 | Sugiyama | CTTN EMS1 | tPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVsGtE |
| Q14566 | S507 | Sugiyama | MCM6 | AGVKATLNARTsILAAANPIsGHyDRSKSLKQNINLSAPIM |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14684 | T708 | Sugiyama | RRP1B KIAA0179 | LNRNMtAEFKKTDKsILVsPtGPsRVAFDPEQKPLHGVLKt |
| Q14761 | S163 | PSP | PTPRCAP LPAP | VPVRAEEARDsDtEGDLVLGsPGPAsAGGsAEALLsDLHAF |
| Q14790 | S387 | SIGNOR|EPSD|PSP | CASP8 MCH5 | KGIPVETDSEEQPyLEMDLSsPQTRYIPDEADFLLGMATVN |
| Q14934 | S676 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NFATC4 NFAT3 | KRVSRPVQVYFYVSNGRRKRsPTQSFRFLPVICKEEPLPDS |
| Q14980 | S1757 | Sugiyama | NUMA1 NMP22 NUMA | ITSKLPRtQPDGtsVPGEPAsPIsQRLPPKVEsLEsLyFtP |
| Q15003 | S81 | Sugiyama | NCAPH BRRN BRRN1 CAPH KIAA0074 | EKERLQRRRsRVFDLQFstDsPRLLAsPsSRsIDIsATIPK |
| Q15007 | S306 | PSP | WTAP KIAA0105 | RtsGSGFHREGNtTEDDFPssPGNGNKSSNSSEERTGRGGS |
| Q15007 | S341 | PSP | WTAP KIAA0105 | TGRGGSGYVNQLSAGYESVDsPtGSENSLTHQSNDtDsSHD |
| Q15007 | T148 | PSP | WTAP KIAA0105 | LEQTKDKLEQAQNELSAWKFtPDSQTGKKLMAKCRMLIQEN |
| Q15046 | S207 | SIGNOR|EPSD|PSP | KARS1 KARS KIAA0070 | NPGKTKKGELSIIPYEITLLsPCLHMLPHLHFGLKDKETRY |
| Q15256 | T361 | SIGNOR | PTPRR ECPTP PTPRQ | VSLTLDMSSLGNIEPFVSIPtPREKVAMEYLQSASRILTRS |
| Q15293 | T76 | Sugiyama | RCN1 RCN | FQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGD |
| Q15303 | S1051 | SIGNOR|PSP | ERBB4 HER4 | PPPIyTSRARIDSNRsEIGHsPPPAyTPMSGNQFVyRDGGF |
| Q15303 | T699 | SIGNOR|PSP | ERBB4 HER4 | SIKKKRALRRFLETELVEPLtPSGTAPNQAQLRILKETELK |
| Q15366 | S173 | SIGNOR|PSP | PCBP2 | QSIIECVKQICVVMLEtLsQsPPKGVtIPyRPKPsssPVIF |
| Q15366 | S189 | SIGNOR|PSP | PCBP2 | tLsQsPPKGVtIPyRPKPsssPVIFAGGQDRYSTGSDSASF |
| Q15366 | S272 | SIGNOR|PSP | PCBP2 | QQSHFPMTHGNTGFsGIEsssPEVKGYWGLDASAQTTSHEL |
| Q15366 | T213 | SIGNOR|PSP | PCBP2 | FAGGQDRYSTGSDSASFPHTtPSMCLNPDLEGPPLEAYTIQ |
| Q15418 | S221 | SIGNOR | RPS6KA1 MAPKAPK1A RSK1 | IKLTDFGLSKEAIDHEKKAysFCGtVEYMAPEVVNRQGHSH |
| Q15418 | S363 | SIGNOR|ELM | RPS6KA1 MAPKAPK1A RSK1 | AQPDDTFYFDTEFTSRtPKDsPGIPPsAGAHQLFRGFsFVA |
| Q15418 | S380 | SIGNOR | RPS6KA1 MAPKAPK1A RSK1 | PKDsPGIPPsAGAHQLFRGFsFVAtGLMEDDGKPRAPQAPL |
| Q15418 | S732 | SIGNOR | RPS6KA1 MAPKAPK1A RSK1 | PQLKPIESSILAQRRVRKLPsTTL_________________ |
| Q15418 | T359 | SIGNOR|ELM | RPS6KA1 MAPKAPK1A RSK1 | KPAVAQPDDTFYFDTEFTSRtPKDsPGIPPsAGAHQLFRGF |
| Q15418 | T573 | SIGNOR | RPS6KA1 MAPKAPK1A RSK1 | LRICDFGFAKQLRAENGLLMtPCytANFVAPEVLKRQGYDE |
| Q15596 | S736 | EPSD|PSP | NCOA2 BHLHE75 SRC2 TIF2 | sQESSSTAPGsEVtIKQEPVsPKKKENALLRYLLDKDDTKD |
| Q15599 | S43 | Sugiyama | NHERF2 SLC9A3R2 | FHLHGEKGRRGQFIRRVEPGsPAEAAALRAGDRLVEVNGVN |
| Q15642 | S495 | Sugiyama | TRIP10 CIP4 STOT STP | VLsNRGDsLSRHARPPDPPAsAPPDsssNsAsQDtKESSEE |
| Q15648 | T1032 | SIGNOR|EPSD|PSP | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | RKKADtEGKsPsHssSNRPFtPPtSTGGSKsPGsAGRsQtP |
| Q15648 | T1457 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | sGstPKHERGsPsHsKsPAytPQNLDsEsEsGSSIAEKsyQ |
| Q15672 | S68 | SIGNOR|EPSD|PSP | TWIST1 BHLHA38 TWIST | GGAGPGGAAGGGVGGGDEPGsPAQGKRGKKSAGCGGGGGAG |
| Q15744 | T74 | ELM | CEBPE | LSDLFAVKPAPEARGLKGPGtPAFPHYLPPDPRPFAYPPHT |
| Q15746 | S16 | ELM | MYLK MLCK MLCK1 MYLK1 | _____MGDVKLVASSHIsKTsLsVDPSRVDSMPLTEAPAFI |
| Q15746 | S1779 | EPSD|PSP | MYLK MLCK MLCK1 MYLK1 | ssMAMISGLSGRKsstGsPtsPLNAEKLEsEEDVsQAFLEA |
| Q15746 | S947 | PSP | MYLK MLCK MLCK1 MYLK1 | ANLQRQVKPKTVSEEERKVHsPQQVDFRSVLAKKGTSKTPV |
| Q15746 | T978 | PSP | MYLK MLCK MLCK1 MYLK1 | AKKGTSKTPVPEKVPPPKPAtPDFRSVLGGKKKLPAENGSS |
| Q15750 | S438 | PSP | TAB1 MAP3K7IP1 | VNGAHsASTLDEAtPTLTNQsPTLTLQSTNTHTQssSSssD |
| Q15788 | S1185 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NCOA1 BHLHE74 SRC1 | QQFPYPPNYGTNPGtPPASTsPFSQLAANPEASLANRNSMV |
| Q15788 | T1179 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NCOA1 BHLHE74 SRC1 | LPQGAPQQFPYPPNYGTNPGtPPASTsPFSQLAANPEASLA |
| Q15796 | S245 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SMAD2 MADH2 MADR2 | YISEDGETSDQQLNQsMDtGsPAELsPTTLsPVNHsLDLQP |
| Q15796 | S250 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SMAD2 MADH2 MADR2 | GETSDQQLNQsMDtGsPAELsPTTLsPVNHsLDLQPVTYSE |
| Q15796 | S255 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SMAD2 MADH2 MADR2 | QQLNQsMDtGsPAELsPTTLsPVNHsLDLQPVTYSEPAFWC |
| Q15796 | T220 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SMAD2 MADH2 MADR2 | IPENTNFPAGIEPQSNYIPEtPPPGYISEDGETSDQQLNQs |
| Q15796 | T8 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SMAD2 MADH2 MADR2 | _____________MssILPFtPPVVKRLLGWKKsAGGSGGA |
| Q15831 | S428 | SIGNOR | STK11 LKB1 PJS | GRAPNPARKACSASSKIRRLsACKQQ_______________ |
| Q16204 | S240 | Sugiyama | CCDC6 D10S170 TST1 | RMDKLEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMR |
| Q16204 | S244 | SIGNOR|iPTMNet|Sugiyama | CCDC6 D10S170 TST1 | LEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMRHIRF |
| Q16254 | S244 | EPSD|PSP | E2F4 | TPPPLPKPALAQSQEASRPNsPQLTPTAVPGSAEVQGMAGP |
| Q16254 | S384 | EPSD|PSP | E2F4 | SSELLEELMSSEVFAPLLRLsPPPGDHDYIYNLDESEGVCD |
| Q16559 | S100 | EPSD|PSP | TAL2 BHLHA19 | QGPHLPGLEDRTLLENYQVPsPGPSHHIP____________ |
| Q16584 | S705 | EPSD|PSP | MAP3K11 MLK3 PTK1 SPRK | PCPTEPPPsPLICFSLKtPDsPPtPAPLLLDLGIPVGQRsA |
| Q16584 | S758 | EPSD|PSP | MAP3K11 MLK3 PTK1 SPRK | tVsPPPGTSRsAPGtPGTPRsPPLGLIsRPRPsPLRSRIDP |
| Q16630 | T157 | Sugiyama | CPSF6 CFIM68 | SKKLMDLLPKRELHGQNPVVtPCNKQFLsQFEMQSRKTTQS |
| Q16658 | S127 | Sugiyama | FSCN1 FAN1 HSN SNL | AHRRYFGGtEDRLsCFAQtVsPAEKWSVHIAMHPQVNIYSV |
| Q16659 | S189 | ELM | MAPK6 ERK3 PRKM6 | IGDFGLARIMDPHYSHKGHLsEGLVTKWYRSPRLLLSPNNY |
| Q16665 | S641 | SIGNOR | HIF1A BHLHE78 MOP1 PASD8 | TDELKTVTKDRMEDIKILIAsPsPTHIHKETTSATSsPYRD |
| Q16665 | S643 | SIGNOR | HIF1A BHLHE78 MOP1 PASD8 | ELKTVTKDRMEDIKILIAsPsPTHIHKETTSATSsPYRDTQ |
| Q16690 | S346 | EPSD|PSP | DUSP5 VH3 | PPSCQGEAAGSSLIGHLQTLsPDMQGAYCTFPASVLAPVPT |
| Q16690 | S376 | EPSD|PSP | DUSP5 VH3 | FPASVLAPVPTHSTVSELSRsPVATATSC____________ |
| Q16690 | T321 | EPSD|PSP | DUSP5 VH3 | SPNFGFMGQLLQYESEILPStPNPQPPSCQGEAAGSSLIGH |
| Q16828 | S159 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | DUSP6 MKP3 PYST1 | FQAEFSLHCETNLDGSCSSSsPPLPVLGLGGLRISsDSssD |
| Q16828 | S174 | EPSD|PSP | DUSP6 MKP3 PYST1 | SCSSSsPPLPVLGLGGLRISsDSssDIEsDLDRDPNSATDS |
| Q16828 | S197 | SIGNOR|EPSD|PSP | DUSP6 MKP3 PYST1 | ssDIEsDLDRDPNSATDSDGsPLSNSQPSFPVEILPFLYLG |
| Q16828 | S300 | EPSD|PSP | DUSP6 MKP3 PYST1 | DEARGKNCGVLVHCLAGISRsVTVTVAYLMQKLNLSMNDAY |
| Q16881 | T413 | Sugiyama | TXNRD1 GRIM12 KDRF | HGIKFIRQFVPIKVEQIEAGtPGRLRVVAQSTNSEEIIEGE |
| Q2M1V0 | S183 | PSP | ISX RAXLX | LDVAGPTWTSTALRRLAPPTsCCPSAQDQLASAWFPAWITL |
| Q2M1Z3 | T789 | SIGNOR | ARHGAP31 CDGAP KIAA1204 | VEVGGPGNLsPPLPPAPPPPtPLEESTPVLLSKGGPEREDS |
| Q53EL6 | S94 | Sugiyama | PDCD4 H731 | GDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLPK |
| Q53GS7 | S88 | PSP | GLE1 GLE1L | ETSPSSTSASALDQPSFVPKsPDAssAFsPAsPAtPNGTKG |
| Q53GS7 | S92 | PSP | GLE1 GLE1L | SSTSASALDQPSFVPKsPDAssAFsPAsPAtPNGTKGKDES |
| Q53GS7 | S93 | PSP | GLE1 GLE1L | STSASALDQPSFVPKsPDAssAFsPAsPAtPNGTKGKDESQ |
| Q53GS7 | S99 | PSP | GLE1 GLE1L | LDQPSFVPKsPDAssAFsPAsPAtPNGTKGKDESQHTESMV |
| Q53GS7 | T102 | PSP | GLE1 GLE1L | PSFVPKsPDAssAFsPAsPAtPNGTKGKDESQHTESMVLQS |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q5JSH3 | S96 | Sugiyama | WDR44 RPH11 | QLEDDsLDSKGKELsDQAtAsPIVARTDLSNIPGLLAIDQV |
| Q5SW79 | S223 | Sugiyama | CEP170 FAM68A KAB KIAA0470 | KNHEAGTSGCGIDAKQVEEQsAAANEEVLFPFCREPsYFEI |
| Q5T447 | T157 | SIGNOR | HECTD3 | EGWLLVCRPAEGGARLVPIDtPNHLQRQQQLFGVDYRPVLR |
| Q5T4S7 | S178 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | AKLPQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLT |
| Q5T4S7 | S181 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | PQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLTSVF |
| Q5T6F2 | S432 | Sugiyama | UBAP2 KIAA1491 | PPTSQSSVLSHLDFKsQPEPsPVLSQLsQRQQHQSQAVTVP |
| Q66K74 | S759 | Sugiyama | MAP1S BPY2IP1 C19orf5 MAP8 VCY2IP1 | LVsPCEFEHRKAVPMAPAPAsPGssNDssARsQERAGGLGA |
| Q68CZ2 | S840 | Sugiyama | TNS3 TEM6 TENS1 TPP | tPGyPQDLDIIDGRILSSKEsMCStPAFPVsPEtPyVKTAL |
| Q68CZ2 | T844 | Sugiyama | TNS3 TEM6 TENS1 TPP | PQDLDIIDGRILSSKEsMCStPAFPVsPEtPyVKTALRHPP |
| Q68CZ2 | T853 | Sugiyama | TNS3 TEM6 TENS1 TPP | RILSSKEsMCStPAFPVsPEtPyVKTALRHPPFsPPEPPLs |
| Q68CZ2 | Y855 | Sugiyama | TNS3 TEM6 TENS1 TPP | LSSKEsMCStPAFPVsPEtPyVKTALRHPPFsPPEPPLssP |
| Q69YN4 | S1579 | Sugiyama | VIRMA KIAA1429 MSTP054 | CCSDFDLHSELERsFLsEPssPGRtKTTKGFKLGKHKHETF |
| Q6FI81 | S272 | Sugiyama | CIAPIN1 CUA001 PRO0915 | GLAEELEKEKSREQMSSQPKsACGNCyLGDAFRCAsCPyLG |
| Q6FI81 | T136 | Sugiyama | CIAPIN1 CUA001 PRO0915 | CSALTLSGLVEVKELQREPLtPEEVQSVREHLGHESDNLLF |
| Q6P2E9 | S844 | Sugiyama | EDC4 HEDLS | sQVWPTAPDITREtCStLAEsPRNGLQEKHKsLAFHRPPYH |
| Q6PKG0 | S521 | Sugiyama | LARP1 KIAA0731 LARP | NCPEFVPRQHYQKEtEsAPGsPRAVtPVPtKTEEVSNLKTL |
| Q6PKG0 | S774 | Sugiyama | LARP1 KIAA0731 LARP | LFGAPEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDS |
| Q6PKG0 | T526 | Sugiyama | LARP1 KIAA0731 LARP | VPRQHYQKEtEsAPGsPRAVtPVPtKTEEVSNLKTLPKGLs |
| Q6S5L8 | T159 | SIGNOR | SHC4 SHCD UNQ6438/PRO21364 | RSGTAPPPQQDLVGHRAtALtPDSCPLPGPGEPTLRSRQDR |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6ULP2 | S151 | Sugiyama | AFTPH AFTH | PGNLNKVVEQRQNVGTLESFsPGDFRTNMNVVHQNKQLESC |
| Q6UUV7 | S391 | PSP | CRTC3 TORC3 | NPsLstTNLSGPSRRRQPPVsPLtLsPGPEAHQGFSRQLss |
| Q6VN20 | S365 | Sugiyama | RANBP10 KIAA1464 | DSEVRSLSSRsPKsQDsyPGsPsLsPRHGPsssHMHNTGAD |
| Q6VN20 | S369 | Sugiyama | RANBP10 KIAA1464 | RSLSSRsPKsQDsyPGsPsLsPRHGPsssHMHNTGADsPsC |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q71UM5 | T74 | Sugiyama | RPS27L | VLCVGCSTVLCQPTGGKARLtEGCsFRRKQH__________ |
| Q7L2J0 | S216 | Sugiyama | MEPCE BCDIN3 | NLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPKDIt |
| Q7L2J0 | S217 | Sugiyama | MEPCE BCDIN3 | LNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPKDItD |
| Q7L2J0 | T213 | Sugiyama | MEPCE BCDIN3 | DPLNLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPK |
| Q7Z2W4 | T273 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | FFQGsQEFLASASAsAERsCtPsPDQIsHRAsLEDAPVDDL |
| Q7Z3J3 | T1475 | Sugiyama | RGPD4 RGP4 | DSFKKIFDEAKTAQEKDsLItPHVsRsstPREsPCGKIAVA |
| Q7Z417 | S692 | Sugiyama | NUFIP2 KIAA1321 PIG1 | IWNLQKQDPKRIItyNEAMDsPDQ_________________ |
| Q7Z5K2 | S221 | Sugiyama | WAPL FOE KIAA0261 WAPAL | AsEIKETNDTWNSQFGKRPEsPsEIsPIKGsVRTGLFEWDN |
| Q7Z5K2 | S226 | Sugiyama | WAPL FOE KIAA0261 WAPAL | ETNDTWNSQFGKRPEsPsEIsPIKGsVRTGLFEWDNDFEDI |
| Q86U44 | S43 | SIGNOR|PSP | METTL3 MTA70 | QRRRKQDsGHLDLRNPEAALsPtFRsDsPVPtAPtsGGPKP |
| Q86U44 | S50 | SIGNOR|PSP | METTL3 MTA70 | sGHLDLRNPEAALsPtFRsDsPVPtAPtsGGPKPstAsAVP |
| Q86U44 | S525 | SIGNOR|PSP | METTL3 MTA70 | AEVRSTSHKPDEIyGMIERLsPGTRKIELFGRPHNVQPNWI |
| Q86UC2 | T286 | EPSD|PSP | RSPH3 RSHL2 RSP3 | DRIIEVDMECQTDAFLDRPPtPLFIPAKTGKDVATQILEGE |
| Q86UR1 | S282 | SIGNOR|EPSD|PSP | NOXA1 P51NOX | STAYQEQRPQVEQVGKQAPLsPGLPAMGGPGPGPCEDPAGA |
| Q86UY5 | S357 | Sugiyama | FAM83A TSGP | GRSAGSHPGTRsVsAssGPCsPAAPHPPPPPRFQPHQGPWG |
| Q86VP6 | S376 | Sugiyama | CAND1 KIAA0829 TIP120 TIP120A | CLDAVVSTRHEMLPEFyKTVsPALISRFKEREENVKADVFH |
| Q86W92 | S1001 | Sugiyama | PPFIBP1 KIAA1230 | NLTHMLKEDDMFKDFAARsPsAsItDEDsNV__________ |
| Q86YP4 | S114 | Sugiyama | GATAD2A | SERRPPsPDVIVLsDNEQPssPRVNGLttVALKETSTEALM |
| Q8IWA4 | T562 | SIGNOR | MFN1 | QRVLLGLSEPIFQLPRSLAStPTAPTTPATPDNASQEELMI |
| Q8IWX8 | S822 | Sugiyama | CHERP DAN26 SCAF6 | SKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDSRLGEE |
| Q8IWX8 | T819 | Sugiyama | CHERP DAN26 SCAF6 | RSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDSRL |
| Q8IX03 | S542 | EPSD|PSP | WWC1 KIAA0869 KIBRA | RsLSGtPKSMTSLsPRSsLSsPSPPCsPLMADPLLAGDAFL |
| Q8IX03 | S548 | SIGNOR|EPSD|PSP | WWC1 KIAA0869 KIBRA | PKSMTSLsPRSsLSsPSPPCsPLMADPLLAGDAFLNSLEFE |
| Q8IZP0 | S183 | EPSD|PSP | ABI1 SSH3BP1 | NQPARTGTLSRtNPPtQKPPsPPMsGRGtLGRNtPyKtLEP |
| Q8IZP0 | S216 | EPSD|PSP | ABI1 SSH3BP1 | tPyKtLEPVKPPTVPNDyMtsPARLGsQHsPGRtAsLNQRP |
| Q8IZP0 | S225 | SIGNOR|EPSD|PSP | ABI1 SSH3BP1 | KPPTVPNDyMtsPARLGsQHsPGRtAsLNQRPRTHsGSSGG |
| Q8IZP0 | S267 | EPSD|PSP | ABI1 SSH3BP1 | GSRENSGSSSIGIPIAVPtPsPPTIGPENISVPPPSGAPPA |
| Q8IZP0 | S392 | EPSD|PSP | ABI1 SSH3BP1 | LTPQIPLTGFVARVQENIADsPtPPPPPPPDDIPMFDDsPP |
| Q8IZP0 | S410 | EPSD|PSP | ABI1 SSH3BP1 | ADsPtPPPPPPPDDIPMFDDsPPPPPPPPVDyEDEEAAVVQ |
| Q8IZP0 | T265 | EPSD|PSP | ABI1 SSH3BP1 | GSGSRENSGSSSIGIPIAVPtPsPPTIGPENISVPPPSGAP |
| Q8IZP0 | T394 | EPSD|PSP | ABI1 SSH3BP1 | PQIPLTGFVARVQENIADsPtPPPPPPPDDIPMFDDsPPPP |
| Q8IZQ8 | S815 | GPS6 | MYOCD MYCD | PFDPYATDSDEHLEVLLNSQsPLGKMSDVTLLKIGSEEPHF |
| Q8IZQ8 | S862 | GPS6 | MYOCD MYCD | FSGKAAEDLFNAHEILPGPLsPMQTQFSPSSVDSNGLQLSF |
| Q8N122 | S696 | SIGNOR|EPSD|PSP | RPTOR KIAA1303 RAPTOR | SNFCTVALQFIEEEKNYALPsPATTEGGSLtPVRDsPCtPR |
| Q8N122 | S8 | SIGNOR|EPSD|PSP | RPTOR KIAA1303 RAPTOR | _____________MESEMLQsPLLGLGEEDEADLTDWNLPL |
| Q8N122 | S863 | SIGNOR|EPSD|PSP | RPTOR KIAA1303 RAPTOR | VNARPQRVLDtssLtQsAPAsPtNKGVHIHQAGGsPPAsst |
| Q8N1F7 | S112 | Sugiyama | NUP93 KIAA0095 | PVKDTDIQGFLKNEKDNALLsAIEESRKRtFGMAEEYHRES |
| Q8N556 | S265 | Sugiyama | AFAP1 AFAP | KEAYSGCSGPVDSECPPPPssPVHKAELEKKLssERPssDG |
| Q8N9N5 | T337 | SIGNOR|EPSD|PSP | BANP BEND1 SMAR1 | TAWRRKQRGQSLAVKSFSRRtPNSSSYCPSEPMMStPPPAS |
| Q8N9N5 | T352 | SIGNOR|EPSD|PSP | BANP BEND1 SMAR1 | SFSRRtPNSSSYCPSEPMMStPPPASELPQPQPQPQALHYA |
| Q8NBJ5 | S607 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | DRAKSQKMREQQALSREAKNsDVLQsPLDsAARDEL_____ |
| Q8NBJ5 | S612 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | QKMREQQALSREAKNsDVLQsPLDsAARDEL__________ |
| Q8NBJ5 | S616 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | EQQALSREAKNsDVLQsPLDsAARDEL______________ |
| Q8NBJ7 | S283 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | GsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPPGEL__ |
| Q8NBJ7 | S44 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | NGQATSMVQLQGGRFLMGtNsPDSRDGDGPVREATVKPFAI |
| Q8NDV7 | S1047 | Sugiyama | TNRC6A CAGH26 KIAA1460 TNRC6 | PNGNSRSDQQAQVHQLLtPAsAISNKEASSGSGWGEPWGEP |
| Q8NDV7 | T1044 | Sugiyama | TNRC6A CAGH26 KIAA1460 TNRC6 | KNVPNGNSRSDQQAQVHQLLtPAsAISNKEASSGSGWGEPW |
| Q8NET8 | T264 | SIGNOR|EPSD|PSP | TRPV3 | HAKGAFFNPKYQHEGFYFGEtPLALAACTNQPEIVQLLMEH |
| Q8NFI4 | S181 | Sugiyama | ST13P5 FAM10A5 | LQKPNAAIQDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| Q8TB45 | S235 | SIGNOR|PSP | DEPTOR DEPDC6 | YQFRMNFRRRRRLMELLNEKsPssQEtHDsPFCLRKQSHDN |
| Q8TB72 | S82 | Sugiyama | PUM2 KIAA0235 PUMH2 | MVQRRsGQGFHGNsEVNAILsPRsEsGGLGVsMVEYVLsss |
| Q8TC07 | S675 | Sugiyama | TBC1D15 | TSAFQSNALPTLSASGARNDsPtQIPVssDVCRLtPA____ |
| Q8WUI4 | S109 | Sugiyama | HDAC7 HDAC7A | LAEVILKKQQAALERtVHPNsPGIPYRTLEPLETEGATRSM |
| Q8WX93 | S484 | Sugiyama | PALLD KIAA0992 CGI-151 | VRGAPPLQVQWFRQGsEIQDsPDFRILQKKPRSTAEPEEIC |
| Q8WX93 | S688 | EPSD|PSP | PALLD KIAA0992 CGI-151 | RLEQEAGARQPPPAPRsAPPsPPFPPPPAFPELAACtPPAs |
| Q8WX93 | S808 | EPSD|PSP | PALLD KIAA0992 CGI-151 | PEAPWGSSSPSPPPPPPPVFsPTAAFPVPDVFPLPPPPPPL |
| Q8WXI9 | S122 | Sugiyama | GATAD2B KIAA1150 | DEPVDMSARRsEPERGRLtPsPDIIVLsDNEAssPRsSsRM |
| Q8WXI9 | S135 | Sugiyama | GATAD2B KIAA1150 | ERGRLtPsPDIIVLsDNEAssPRsSsRMEERLKAANLEMFK |
| Q8WYP5 | S1214 | Sugiyama | AHCTF1 ELYS TMBS62 MSTP108 | FSEFTPQSILRstLRstPLAsPsPsPGRsPQRLKEtRIsFV |
| Q8WYP5 | S1222 | Sugiyama | AHCTF1 ELYS TMBS62 MSTP108 | ILRstLRstPLAsPsPsPGRsPQRLKEtRIsFVEEDVHPKW |
| Q92530 | S153 | Sugiyama | PSMF1 | RIVSGIITPIHEQWEKANVssPHREFPPAtAREVDPLRIPP |
| Q92615 | S664 | Sugiyama | LARP4B KIAA0217 LARP5 | ELRKPSYAEICQRTSKEPPssPLQPQKEQKPNTVGCGKEEK |
| Q92734 | S183 | Sugiyama | TFG | AsMsAFDPLKNQDEINKNVMsAFGLtDDQVsGPPsAPAEDR |
| Q92734 | S197 | Sugiyama | TFG | INKNVMsAFGLtDDQVsGPPsAPAEDRSGTPDSIASSSSAA |
| Q92793 | S93 | EPSD|PSP | CREBBP CBP | LLRGGsGSSINPGIGNVsAssPVQQGLGGQAQGQPNSANMA |
| Q92797 | T1257 | EPSD|PSP | SYMPK SPK | tLKEERsPQtLAPVGEDAMKtPsPAAEDAREPEAKGNs___ |
| Q92804 | S295 | Sugiyama | TAF15 RBP56 TAF2N | TDKDTGKPKGEAtVsFDDPPsAKAAIDWFDGKEFHGNIIKV |
| Q92871 | S242 | Sugiyama | PMM1 PMMH22 | PGGNDFEIFADPRTVGHSVVsPQDtVQRCREIFFPETAHEA |
| Q92879 | S179 | Sugiyama | CELF1 BRUNOL2 CUGBP CUGBP1 NAB50 | AMAQTAIKAMHQAQtMEGCssPMVVKFADTQKDKEQKRMAQ |
| Q92908 | S266 | EPSD|PSP | GATA6 | AAGPGGAGSAAAHVSARFPYsPsPPMANGAAREPGGyAAAG |
| Q92922 | T335 | Sugiyama | SMARCC1 BAF155 | DRKASANARKRKHsPsPPPPtPtEsRKKSGKKGQASLYGKR |
| Q92934 | S75 | EPSD|PSP | BAD BBC6 BCL2L8 | PTSSSHHGGAGAVEIRsRHssyPAGtEDDEGMGEEPsPFRG |
| Q92974 | T679 | SIGNOR|EPSD|PSP | ARHGEF2 KIAA0651 LFP40 | IREVEGLKDLLVGPGVELLLtPREPALPLEPDsGGNtsPGV |
| Q93045 | S62 | SIGNOR|ELM|iPTMNet | STMN2 SCG10 SCGN10 | VKQINKRAsGQAFELILKPPsPISEAPRTLAsPKKKDLsLE |
| Q93045 | S73 | SIGNOR|ELM|iPTMNet | STMN2 SCG10 SCGN10 | AFELILKPPsPISEAPRTLAsPKKKDLsLEEIQKKLEAAEE |
| Q969H0 | S176 | PSP | FBXW7 FBW7 FBX30 SEL10 | QLSSPFYTKTTKMKRKLDHGsEVRSFSLGKKPCKVSEYTST |
| Q969H0 | T205 | EPSD|PSP | FBXW7 FBW7 FBX30 SEL10 | KKPCKVSEYTSTTGLVPCSAtPTTFGDLRAANGQGQQRRRI |
| Q969R2 | S762 | PSP | OSBP2 KIAA1664 ORP4 OSBPL4 | AHYVLSGSWDEQMECSKVMHssPssPsSDGKQKTVYQTLSA |
| Q969R2 | S763 | PSP | OSBP2 KIAA1664 ORP4 OSBPL4 | HYVLSGSWDEQMECSKVMHssPssPsSDGKQKTVYQTLSAK |
| Q969R2 | S766 | PSP | OSBP2 KIAA1664 ORP4 OSBPL4 | LSGSWDEQMECSKVMHssPssPsSDGKQKTVYQTLSAKLLW |
| Q969R2 | S768 | PSP | OSBP2 KIAA1664 ORP4 OSBPL4 | GSWDEQMECSKVMHssPssPsSDGKQKTVYQTLSAKLLWKK |
| Q969V6 | S454 | SIGNOR|EPSD|PSP | MRTFA KIAA1438 MAL MKL1 | ATVASSGVVKFGstGstPPVsPtPsERSLLSTGDENSTPGD |
| Q96B36 | S212 | Sugiyama | AKT1S1 PRAS40 | GFKEKRtEARssDEENGPPssPDLDRIAAsMRALVLREAED |
| Q96C19 | S74 | Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96D15 | T72 | Sugiyama | RCN3 UNQ239/PRO272 | FQYDHEAFLGREVAKEFDQLtPEEsQARLGRIVDRMDRAGD |
| Q96EK9 | S184 | Sugiyama | KTI12 SBBI81 | GSAQADVPKELEREEsGAAEsPALVtPDSEKSAKHGsGAFy |
| Q96EK9 | T189 | Sugiyama | KTI12 SBBI81 | DVPKELEREEsGAAEsPALVtPDSEKSAKHGsGAFysPELL |
| Q96FF9 | S209 | SIGNOR|EPSD|PSP | CDCA5 | TEVPRVCAKPWAPDMTLPGIsPPPEKQKRKKKKMPEILKTE |
| Q96FF9 | S79 | SIGNOR|EPSD|PSP | CDCA5 | VLKRIVAHAVEVPAVQsPRRsPRIsFFLEKENEPPGRELTK |
| Q96IR7 | S365 | Sugiyama | HPDL GLOXD1 | GATGFGQGNIRALWQsVQEQsARSQEA______________ |
| Q96K76 | S910 | Sugiyama | USP47 | DGDNGDssKstEtsDFENIEsPLNERDsSAsVDNRELEQHI |
| Q96MH2 | S76 | Sugiyama | HEXIM2 L3 | EDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRRPS |
| Q96MH2 | S81 | Sugiyama | HEXIM2 L3 | AVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRRPSKRKRH |
| Q96Q27 | S371 | SIGNOR|PSP | ASB2 | RIVQMLLPVTSRTRIRRSGVsPLHLAAERNHDEVLEALLSA |
| Q96RK0 | S1389 | EPSD | CIC KIAA0306 | TTDIDLKCKERVtDSESGDSsGEDPEGNKGFGRKVFSPVIR |
| Q96S38 | S560 | Sugiyama | RPS6KC1 RPK118 | NGVDTKAIKSFPAHLAADsDsPSTQLRAHELKFFPNDDPEA |
| Q96S59 | T163 | Sugiyama | RANBP9 RANBPM | QEKELQRRLKRLYPAVDEQEtPLPRSWsPKDKFsYIGLsQN |
| Q96ST3 | T161 | Sugiyama | SIN3A | PQVYNDFLDIMKEFKSQsIDtPGVISRVSQLFKGHPDLIMG |
| Q99459 | T385 | Sugiyama | CDC5L KIAA0432 PCDC5RP | EAQNLMALtNVDtPLKGGLNtPLHEsDFsGVtPQRQVVQtP |
| Q99666 | T1474 | Sugiyama | RGPD5 RANBP2L1 RGP5 RGP7 RGPD7; RGPD6 RANBP2L2 RGP6 | DSFKKIFDEAKTAQEKDsLItPHVsRsstPREsPCGKIAVA |
| Q99714 | T73 | Sugiyama | HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 | KLGNNCVFAPADVtsEKDVQtALALAKGKFGRVDVAVNCAG |
| Q99733 | S54 | Sugiyama | NAP1L4 NAP2 | NPRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALKQLQ |
| Q99733 | T51 | Sugiyama | NAP1L4 NAP2 | VMQNPRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALK |
| Q99814 | S484 | SIGNOR|PSP | EPAS1 BHLHE73 HIF2A MOP2 PASD2 | APGSTTPSATSSSSSCSTPNsPEDYYTSLDNDLKIEVIEKL |
| Q99814 | S672 | PSP | EPAS1 BHLHE73 HIF2A MOP2 PASD2 | WAVGDQRTEFLGAAPLGPPVsPPHVSTFKTRSAKGFGARGP |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BQG0 | S11 | Sugiyama | MYBBP1A P160 | __________MEsRDPAQPMsPGEAtQsGARPADRYGLLKH |
| Q9BQG0 | T1161 | Sugiyama | MYBBP1A P160 | TLGVQRPKLEKKDAKEIPsAtQsPIsKKRKKKGFLPETKKR |
| Q9BQQ3 | S274 | SIGNOR | GORASP1 GOLPH5 GRASP65 | MEALLQAPGSSMEDPLPGPGsPSHSAPDPDGLPHFMETPLQ |
| Q9BR01 | T11 | SIGNOR|EPSD|PSP | SULT4A1 SULTX3 | __________MAESEAEtPStPGEFESKYFEFHGVRLPPFC |
| Q9BTL3 | S36 | SIGNOR | RAMAC C15orf18 FAM103A1 RAMMET | ASRFTENDKEYQEYLKRPPEsPPIVEEWNSRAGGNQRNRGN |
| Q9BTU6 | S51 | Sugiyama | PI4K2A | VPGGAVRVAAAAGsGPsPPGsPGHDRERQPLLDRARGAAAQ |
| Q9BUB5 | T250 | SIGNOR | MKNK1 MNK1 | ICDFDLGSGMKLNNSCTPITtPELTtPCGSAEYMAPEVVEV |
| Q9BUB5 | T255 | SIGNOR | MKNK1 MNK1 | LGSGMKLNNSCTPITtPELTtPCGSAEYMAPEVVEVFTDQA |
| Q9BUB5 | T385 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MKNK1 MNK1 | AAQVLQHPWVQGQAPEKGLPtPQVLQRNSSTMDLTLFAAEA |
| Q9BXP5 | S493 | Sugiyama | SRRT ARS2 ASR2 | VNIKEICWNLQNIRLRECELsPGVNRDLTRRVRNINGITQH |
| Q9BYG3 | T238 | Sugiyama | NIFK MKI67IP NOPP34 | sGtLDtPEKtVDsQGPtPVCtPtFLERRKsQVAELNDDDKD |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BZI1 | S317 | SIGNOR | IRX2 IRXA2 | sPPPEAAPRGGRKTPQGSRtsPGAPPPAsKPKLWSLAEIAT |
| Q9BZI1 | S325 | SIGNOR | IRX2 IRXA2 | RGGRKTPQGSRtsPGAPPPAsKPKLWSLAEIATSDLKQPSL |
| Q9C0C2 | S1029 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | LGEGsRDAGRPGERGsGGLFsPstAHVPDGALGQRDQssWQ |
| Q9C0C2 | S1031 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | EGsRDAGRPGERGsGGLFsPstAHVPDGALGQRDQssWQNs |
| Q9C0C2 | S1103 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KRGWVGEFSLSVGPQREAAFsPGQQDWsRDFCIEASERsyQ |
| Q9C0C2 | S1297 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GQADWtPDLGLRNMAPGAVCsPGEsKELGVGQMDWGNNLGL |
| Q9C0C2 | S435 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | DAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAALPQGQG |
| Q9C0C2 | S601 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | LPLQQAEERyEsQEPLAGQEsPLPLATREAALPILEPVLGQ |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9C0C2 | S712 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | PPPsGGGARRGAGAELKDtQsPstCsEGLLGWsQKDLQSEF |
| Q9C0C2 | T715 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | sGGGARRGAGAELKDtQsPstCsEGLLGWsQKDLQSEFGIT |
| Q9H0B6 | S445 | Sugiyama | KLC2 | RRDsAPyGEyGsWYKACKVDsPtVNTTLRSLGALYRRQGKL |
| Q9H0F6 | S146 | PSP | SHARPIN SIPL1 PSEC0216 | GSKsNsPPALGPEACPVsLPsPPEASTLKGPPPEADLPRsP |
| Q9H0F6 | S165 | PSP | SHARPIN SIPL1 PSEC0216 | PsPPEASTLKGPPPEADLPRsPGNLtEREELAGSLARAIAG |
| Q9H0F6 | T309 | PSP | SHARPIN SIPL1 PSEC0216 | RQDGDPAFLYLLSAPREAPAtGPsPQHPQKMDGELGRLFPP |
| Q9H2U2 | S317 | Sugiyama | PPA2 HSPC124 | DSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLGK___ |
| Q9H3K6 | T76 | Sugiyama | BOLA2 BOLA2A My016; BOLA2B | VNACLAEELPHIHAFEQKTLtPDQWARERQK__________ |
| Q9H488 | S264 | Sugiyama | POFUT1 FUT12 KIAA0180 | DWKNACAMLKDGTAGSHFMAsPQCVGySRSTAAPLTMTMCL |
| Q9H4A3 | S1261 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GIPTSSLTQVVHSAGRRFIVsPVPEsRLRESKVFPSEITDT |
| Q9H4A3 | S2027 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | LNGPssDPEAAFLSRDVDDGsGsPHsPHQLssKSLPSQNLS |
| Q9H4A3 | S2032 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | sDPEAAFLSRDVDDGsGsPHsPHQLssKSLPSQNLSQSLSN |
| Q9H501 | S198 | Sugiyama | ESF1 ABTAP C20orf6 HDCMC28P | DssLEEKQRTLDsGtSEIVKsPRIECSKTRREMQSVVQLIM |
| Q9H773 | S26 | Sugiyama | DCTPP1 XTP3TPA CDA03 | GEIRGDTGGEDTAAPGRFsFsPEPTLEDIRRLHAEFAAERD |
| Q9H773 | S85 | Sugiyama | DCTPP1 XTP3TPA CDA03 | GELAELFQWKTDGEPGPQGWsPRERAALQEELSDVLIYLVA |
| Q9H8Y8 | T222 | EPSD|PSP | GORASP2 GOLPH6 | IPTRPFEEGKKIsLPGQMAGtPItPLKDGFTEVQLSSVNPP |
| Q9H8Y8 | T225 | EPSD|PSP | GORASP2 GOLPH6 | RPFEEGKKIsLPGQMAGtPItPLKDGFTEVQLSSVNPPSLS |
| Q9H9Z2 | S200 | SIGNOR|PSP | LIN28A CSDD1 LIN28 ZCCHC1 | QGPSAQGKPTYFREEEEEIHsPtLLPEAQN___________ |
| Q9HAV4 | S416 | SIGNOR | XPO5 KIAA1291 RANBP21 | KYLRASMTNLVKMGFPSKTDsPSCEYSRFDFDSDEDFNAFF |
| Q9HAV4 | S497 | SIGNOR | XPO5 KIAA1291 RANBP21 | GSVNSCSAVGTGEGSLCSVFsPSFVQWEAMTLFLESVITQM |
| Q9HAV4 | T345 | SIGNOR | XPO5 KIAA1291 RANBP21 | VLCALGNQLCALLGADSDVEtPSNFGKYLESFLAFTTHPSQ |
| Q9HCE7 | T223 | PSP | SMURF1 KIAA1625 | QDQRLQAQRLRNPDVRGSLQtPQNRPHGHQsPELPEGYEQR |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQ66 | S982 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PLCB1 KIAA0581 | RRAALEKSAKKDSKKKsEPssPDHGsstIEQDLAALDAEMT |
| Q9NQX3 | S268 | SIGNOR | GPHN GPH KIAA1385 | IISRGVQVLPRDTAsLsttPsEsPRAQAtsRLstAsCPtPK |
| Q9NR45 | S253 | Sugiyama | NANS SAS | KVLERHITLDKTWKGsDHsAsLEPGELAELVRSVRLVERAL |
| Q9NRA0 | S387 | SIGNOR|EPSD|PSP | SPHK2 SK2 | ATLHTYRGRLsyLPAtVEPAsPtPAHsLPRAKsELtLtPDP |
| Q9NRA0 | T614 | SIGNOR|EPSD|PSP | SPHK2 SK2 | SLGCPQLGYAAARAFRLEPLtPRGVLTVDGEQVEYGPLQAQ |
| Q9NRF2 | S96 | GPS6|EPSD|PSP | SH2B1 KIAA1299 SH2B | FEAEVARAsGsLsPPILAPLsPGAEIsPHDLSLESCRVGGP |
| Q9NTJ3 | S22 | Sugiyama | SMC4 CAPC SMC4L1 | PRKGTQPSTARRREEGPPPPsPDGAssDAEPEPPsGRtEsP |
| Q9NTJ3 | S28 | Sugiyama | SMC4 CAPC SMC4L1 | PSTARRREEGPPPPsPDGAssDAEPEPPsGRtEsPAtAAEt |
| Q9NUQ3 | S97 | Sugiyama | TXLNG CXorf15 ELRG LSR5 | KHSLEEDEGsDFItENRNLVsPAyCtQEsREEIPGGEARTD |
| Q9NUU7 | S85 | Sugiyama | DDX19A DDX19L | IRSNLVDNtNQVEVLQRDPNsPLysVKsFEELRLKPQLLQG |
| Q9NWS0 | T195 | Sugiyama | PIH1D1 NOP17 | sQQNIRSEQRPRIQELGDLytPAPGRAESGPEKPHLNLWLE |
| Q9NYA1 | S225 | SIGNOR|EPSD|PSP | SPHK1 SK1 SPHK SPK | TYRGRLAYLPVGRVGSKTPAsPVVVQQGPVDAHLVPLEEPV |
| Q9NYB0 | S203 | Sugiyama | TERF2IP DRIP5 RAP1 PP8000 | RYLKHLRGQEHKyLLGDAPVsPssQKLKRKAEEDPEAADsG |
| Q9NYD6 | S189 | Sugiyama | HOXC10 HOX3I | DFEAPFEQRASLNPRAEHLEsPQLGGKVSFPEtPKsDsQtP |
| Q9NYV6 | S633 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RRN3 TIFIA | VPQNDTVIGItPSsFDtHFRsPsssVGsPPVLyMQPsPL__ |
| Q9NYV6 | S649 | SIGNOR | RRN3 TIFIA | tHFRsPsssVGsPPVLyMQPsPL__________________ |
| Q9NZB2 | T991 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | PLQVVSVGGPARGRPRGVIstPVIRTFGRGGRYYGRGYKNQ |
| Q9NZI5 | S76 | PSP | GRHL1 LBP32 MGR TFCP2L2 | DSAAALGLLYDYYKVPRERRsstAKPEVEHPEPDHSKRNsI |
| Q9NZQ3 | T242 | PSP | NCKIPSD AF3P21 SPIN90 | SLDTLyTSSSPSEPGSSCSPtPPPVPRRGtHTTVsQVQPPP |
| Q9NZT2 | S378 | Sugiyama | OGFR | LERsQGDEAGGHGEDRPEPLsPKEsKKRKLELSRREQPPTE |
| Q9NZV1 | S184 | Sugiyama | CRIM1 S52 UNQ1886/PRO4330 | LKRIEEEKPDCSKARCEVQFsPRCPEDSVLIEGYAPPGECC |
| Q9UBN7 | S1035 | SIGNOR|EPSD|PSP | HDAC6 KIAA0901 JM21 | GTELIQTPLASSTDHQtPPTsPVQGTTPQISPSTLIGSLRT |
| Q9UBN7 | T1031 | SIGNOR|EPSD|PSP | HDAC6 KIAA0901 JM21 | EAPGGTELIQTPLASSTDHQtPPTsPVQGTTPQISPSTLIG |
| Q9UBS5 | S868 | SIGNOR | GABBR1 GPRC3A | TLVVLFVPKMRRLITRGEWQsEAQDtMKTGSstNNNEEEKS |
| Q9UBS5 | T873 | SIGNOR | GABBR1 GPRC3A | FVPKMRRLITRGEWQsEAQDtMKTGSstNNNEEEKSRLLEK |
| Q9UGV2 | S361 | Sugiyama | NDRG3 | sPFsRsVtsNQsDGtQESCEsPDVLDRHQTMEVsC______ |
| Q9UHB6 | S362 | SIGNOR|EPSD|PSP | LIMA1 EPLIN SREBP3 PP624 | DsRDsQVKSEVQQPVHPKPLsPDsRAssLsEssPPKAMKKF |
| Q9UHB6 | S374 | EPSD|PSP | LIMA1 EPLIN SREBP3 PP624 | QPVHPKPLsPDsRAssLsEssPPKAMKKFQAPARETCVECQ |
| Q9UHB6 | S490 | Sugiyama | LIMA1 EPLIN SREBP3 PP624 | ENEEILERPAQLANAREtPHsPGVEDAPIAKVGVLAAsMEA |
| Q9UHB6 | S604 | SIGNOR|EPSD|PSP | LIMA1 EPLIN SREBP3 PP624 | LKERSRPFTVAASFQstsVKsPKtVsPPIRKGWsMsEQSEE |
| Q9UHL4 | S213 | Sugiyama | DPP7 DPP2 QPP | AGLGDSNQFFRDVTADFEGQsPKCTQGVREAFRQIKDLFLQ |
| Q9UI10 | T86 | Sugiyama | EIF2B4 EIF2BD | AAQCQVGPTRELPESGIQLGtPREKVPAGRSKAELRAERRA |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UIG0 | S158 | SIGNOR|EPSD|PSP | BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF | HPLEKVDEEATEKKsDGACDsPssDKENssQIAQDHQKKET |
| Q9UJY1 | S24 | EPSD|PSP | HSPB8 CRYAC E2IG1 HSP22 PP1629 | GQMPFSCHYPsRLRRDPFRDsPLsSRLLDDGFGMDPFPDDL |
| Q9UJY1 | S27 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | HSPB8 CRYAC E2IG1 HSP22 PP1629 | PFSCHYPsRLRRDPFRDsPLsSRLLDDGFGMDPFPDDLTAS |
| Q9UJY1 | T87 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | HSPB8 CRYAC E2IG1 HSP22 PP1629 | GMVPRGPTATARFGVPAEGRtPPPFPGEPWKVCVNVHSFKP |
| Q9UKX7 | S221 | SIGNOR|EPSD|PSP|Sugiyama | NUP50 NPAP60L PRO1146 | HGNsGRNsESEsNKVAAEtQsPsLFGstKLQQEStFLFHGN |
| Q9UKX7 | S315 | SIGNOR|EPSD|PSP | NUP50 NPAP60L PRO1146 | FsPGNSSLFGKDttQsKPVssPFPtKPLEGQAEGDsGECKG |
| Q9ULC4 | T81 | GPS6|EPSD|PSP | MCTS1 MCT1 | ILTVNGELLFFRQREGPFYPtLRLLHKYPFILPHQQVDKGA |
| Q9ULD2 | S1264 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | RsPtssAIPLQsPRNsGsFPsPsIsPR______________ |
| Q9ULD2 | S1268 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | ssAIPLQsPRNsGsFPsPsIsPR__________________ |
| Q9ULV5 | S298 | PSP | HSF4 | SPSSDGRREKGLALLKEEPAsPGGDGEAGLALAPNECDFCV |
| Q9UMR2 | S86 | Sugiyama | DDX19B DBP5 DDX19 TDBP | IRSNLVDNtNQVEVLQRDPNsPLysVKsFEELRLKPQLLQG |
| Q9UNA1 | S685 | SIGNOR | ARHGAP26 GRAF KIAA0621 OPHN1L | PNPSPTSPLSPSWPMFSAPSsPMPTSSTSSDSSPVRSVAGF |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UPT5 | S250 | EPSD|PSP | EXOC7 EXO70 KIAA1067 | SIKGLKEHFHKsssssGVPysPAIPNKRKDTPTKKPVKRPG |
| Q9UQ13 | T507 | SIGNOR|PSP | SHOC2 KIAA0862 | PRGIGHLTNLTHLGLGENLLtHLPEEIGTLENLEELYLNDN |
| Q9UQ35 | S1320 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sMASSWGGPHFsPEHKELsNsPLRENsFGsPLEFRNsGPLG |
| Q9UQ35 | S1329 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | HFsPEHKELsNsPLRENsFGsPLEFRNsGPLGTEMNtGFss |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | S2272 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | tAVNLADsRtPAAAAAMNLAsPRtAVAPsAVNLADPRtPtA |
| Q9UQC2 | S623 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | GAB2 KIAA0571 | PAPKKSTGSVDyLALDFQPssPsPHRKPSTssVtSDEKVDy |
| Q9Y266 | S136 | Sugiyama | NUDC | QLEIDQKKDAENHEAQLKNGsLDsPGKQDtEEDEEEDEKDK |
| Q9Y266 | S139 | Sugiyama | NUDC | IDQKKDAENHEAQLKNGsLDsPGKQDtEEDEEEDEKDKGKL |
| Q9Y266 | S304 | Sugiyama | NUDC | RsMVEKMMYDQRQKsMGLPtsDEQKKQEILKKFMDQHPEMD |
| Q9Y266 | T303 | Sugiyama | NUDC | tRsMVEKMMYDQRQKsMGLPtsDEQKKQEILKKFMDQHPEM |
| Q9Y2R5 | S128 | Sugiyama | MRPS17 RPMS17 HSPC011 | SPLSSETTQLSKNLEELNIssAQ__________________ |
| Q9Y2V2 | S41 | Sugiyama | CARHSP1 | LDtPRsRERsPsPLRGNVVPsPLPtRRtRtFsAtVRASQGP |
| Q9Y2W2 | S237 | Sugiyama | WBP11 NPWBP SIPP1 SNP70 | RKVGFALDLPPRRRDEDMLysPELAQRGHDDDVSSTSEDDG |
| Q9Y3F4 | S228 | Sugiyama | STRAP MAWD UNRIP | FHSAVSLDPIKsFEAPAtINsAsLHPEKEFLVAGGEDFKLy |
| Q9Y3F4 | T117 | Sugiyama | STRAP MAWD UNRIP | LAHKHIVKtVDFtQDSNyLLtGGQDKLLRIYDLNKPEAEPK |
| Q9Y3F4 | T225 | Sugiyama | STRAP MAWD UNRIP | SIAFHSAVSLDPIKsFEAPAtINsAsLHPEKEFLVAGGEDF |
| Q9Y3R0 | S734 | SIGNOR | GRIP1 | IHIGDRILAINSSSLKGKPLsEAIHLLQMAGETVTLKIKKQ |
| Q9Y4E8 | S229 | Sugiyama | USP15 KIAA0529 | LVIEQKNEDGtWPRGPstPKsPGAsNFstLPKIsPssLsNN |
| Q9Y4E8 | T226 | Sugiyama | USP15 KIAA0529 | GQVLVIEQKNEDGtWPRGPstPKsPGAsNFstLPKIsPssL |
| Q9Y5A9 | S39 | PSP | YTHDF2 HGRG8 | QNGSVHQKDGLNDDDFEPyLsPQARPNNAYTAMSDSYLPSY |
| Q9Y5A9 | T381 | PSP | YTHDF2 HGRG8 | FGHNGVDGNGVGQSQAGSGStPSEPHPVLEKLRsINNYNPK |
| Q9Y5U2 | S146 | Sugiyama | TSSC4 | LAPsGRsPVEGLGRAHRsPAsPRVPPVPDYVAHPERWTKYS |
| Q9Y613 | S498 | PSP | FHOD1 FHOS FHOS1 | PDARQLWDsPEtAPAARtPQsPAPCVLLRAQRsLAPEPKEP |
| Q9Y6G9 | S207 | Sugiyama | DYNC1LI1 DNCLI1 | EQKLIRDFQEyVEPGEDFPAsPQRRNtAsQEDKDDsVVLPL |
| Q9Y6G9 | S516 | Sugiyama | DYNC1LI1 DNCLI1 | HAELDRITRKPVtVsPttPtsPtEGEAs_____________ |
| Q9Y6G9 | T515 | Sugiyama | DYNC1LI1 DNCLI1 | VHAELDRITRKPVtVsPttPtsPtEGEAs____________ |
| Q9Y6W5 | S343 | EPSD|PSP | WASF2 WAVE2 | PPPPPPMIGIPPPPPPVGFGsPGtPPPPsPPSFPPHPDFAA |
| Q9Y6W5 | S351 | EPSD|PSP | WASF2 WAVE2 | GIPPPPPPVGFGsPGtPPPPsPPSFPPHPDFAAPPPPPPPP |
| Q9Y6W5 | T346 | EPSD|PSP | WASF2 WAVE2 | PPPMIGIPPPPPPVGFGsPGtPPPPsPPSFPPHPDFAAPPP |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin organization | R-HSA-4839726 | 6.894622e-08 | 7.161 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.834638e-07 | 6.165 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.520733e-06 | 5.453 | 1 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.382897e-05 | 4.859 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.395256e-05 | 4.621 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.936098e-05 | 4.405 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.540216e-05 | 4.184 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.944622e-05 | 4.158 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.206816e-04 | 3.918 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.713810e-04 | 3.766 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.046703e-04 | 3.689 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.046703e-04 | 3.689 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.302035e-04 | 3.638 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.752521e-04 | 3.560 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.915091e-04 | 3.535 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.915091e-04 | 3.535 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.418757e-04 | 3.616 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.894643e-04 | 3.538 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.245418e-04 | 3.489 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.245418e-04 | 3.489 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.147931e-04 | 3.502 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.827712e-04 | 3.417 | 1 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.827712e-04 | 3.417 | 1 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.102681e-04 | 3.387 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.354888e-04 | 3.361 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.811625e-04 | 3.318 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.811625e-04 | 3.318 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.858148e-04 | 3.314 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.344614e-04 | 3.272 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.344614e-04 | 3.272 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.488759e-04 | 3.261 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.630287e-04 | 3.249 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.165042e-04 | 3.210 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.165042e-04 | 3.210 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.187714e-04 | 3.208 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 8.803504e-04 | 3.055 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 9.791894e-04 | 3.009 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.068394e-03 | 2.971 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.045112e-03 | 2.981 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.069306e-03 | 2.971 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.137585e-03 | 2.944 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.114274e-03 | 2.953 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.208392e-03 | 2.918 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.352748e-03 | 2.869 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.503642e-03 | 2.823 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.502821e-03 | 2.823 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.560432e-03 | 2.807 | 1 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.842076e-03 | 2.735 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.842076e-03 | 2.735 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.000106e-03 | 2.699 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.219981e-03 | 2.654 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.239470e-03 | 2.650 | 1 | 1 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.363163e-03 | 2.627 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.394880e-03 | 2.621 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.908039e-03 | 2.536 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.075874e-03 | 2.512 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.071884e-03 | 2.513 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.053712e-03 | 2.515 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.150856e-03 | 2.502 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.205380e-03 | 2.494 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.236693e-03 | 2.490 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.364742e-03 | 2.473 | 1 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.576347e-03 | 2.447 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.576347e-03 | 2.447 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.866797e-03 | 2.413 | 1 | 1 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.743909e-03 | 2.427 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.874537e-03 | 2.412 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.234186e-03 | 2.373 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 4.639270e-03 | 2.334 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.529575e-03 | 2.344 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.845444e-03 | 2.315 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.541969e-03 | 2.256 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.480010e-03 | 2.261 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.473030e-03 | 2.262 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.529687e-03 | 2.257 | 1 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.542141e-03 | 2.256 | 1 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.553430e-03 | 2.255 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.542141e-03 | 2.256 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.553430e-03 | 2.255 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 5.873622e-03 | 2.231 | 1 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.928085e-03 | 2.227 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.138728e-03 | 2.212 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 6.222615e-03 | 2.206 | 1 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.646521e-03 | 2.177 | 1 | 1 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 6.646521e-03 | 2.177 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 7.254339e-03 | 2.139 | 0 | 0 |
| M Phase | R-HSA-68886 | 6.979679e-03 | 2.156 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 7.339277e-03 | 2.134 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 7.528569e-03 | 2.123 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.532761e-03 | 2.123 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.532761e-03 | 2.123 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.111192e-03 | 2.091 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 8.111192e-03 | 2.091 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.969372e-03 | 2.099 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 8.683161e-03 | 2.061 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 8.958221e-03 | 2.048 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 9.268411e-03 | 2.033 | 1 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.473731e-03 | 2.023 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.017771e-02 | 1.992 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.064273e-02 | 1.973 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.080934e-02 | 1.966 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.083533e-02 | 1.965 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.083533e-02 | 1.965 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.103370e-02 | 1.957 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.118027e-02 | 1.952 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.235862e-02 | 1.908 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.245739e-02 | 1.905 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.268525e-02 | 1.897 | 1 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.416870e-02 | 1.849 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.333000e-02 | 1.875 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.335786e-02 | 1.874 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.428178e-02 | 1.845 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.347896e-02 | 1.870 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.428178e-02 | 1.845 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.442156e-02 | 1.841 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.562187e-02 | 1.806 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.617974e-02 | 1.791 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 1.620351e-02 | 1.790 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.647090e-02 | 1.783 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.817668e-02 | 1.740 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.853462e-02 | 1.732 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.853462e-02 | 1.732 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.817668e-02 | 1.740 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.828340e-02 | 1.738 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.881097e-02 | 1.726 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.121707e-02 | 1.673 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.160365e-02 | 1.665 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.214841e-02 | 1.655 | 1 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.292040e-02 | 1.640 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.319524e-02 | 1.635 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.254313e-02 | 1.647 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.419306e-02 | 1.616 | 1 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.447605e-02 | 1.611 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.447605e-02 | 1.611 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.441466e-02 | 1.612 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.345431e-02 | 1.630 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.606749e-02 | 1.584 | 1 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.669385e-02 | 1.574 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.669385e-02 | 1.574 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.687971e-02 | 1.571 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.913141e-02 | 1.536 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.913141e-02 | 1.536 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.913141e-02 | 1.536 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.913141e-02 | 1.536 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.913141e-02 | 1.536 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.845533e-02 | 1.546 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.753658e-02 | 1.560 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.007833e-02 | 1.522 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.879792e-02 | 1.541 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.013893e-02 | 1.521 | 1 | 1 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.029081e-02 | 1.519 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.033432e-02 | 1.518 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.300883e-02 | 1.481 | 1 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.447267e-02 | 1.463 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.483016e-02 | 1.458 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.483016e-02 | 1.458 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.483016e-02 | 1.458 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.678157e-02 | 1.434 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.075480e-02 | 1.390 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.122225e-02 | 1.385 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.899492e-02 | 1.409 | 1 | 1 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.960790e-02 | 1.402 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.960790e-02 | 1.402 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.960790e-02 | 1.402 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.960790e-02 | 1.402 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.960790e-02 | 1.402 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.201580e-02 | 1.377 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 4.201580e-02 | 1.377 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 4.201580e-02 | 1.377 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 4.208581e-02 | 1.376 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.233006e-02 | 1.373 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.355093e-02 | 1.361 | 1 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.595157e-02 | 1.338 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.595157e-02 | 1.338 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.470901e-02 | 1.350 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.470901e-02 | 1.350 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.025473e-02 | 1.299 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 5.025473e-02 | 1.299 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 5.025473e-02 | 1.299 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 5.025473e-02 | 1.299 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 5.025473e-02 | 1.299 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.802497e-02 | 1.319 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.802497e-02 | 1.319 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.527936e-02 | 1.344 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 4.527936e-02 | 1.344 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.819011e-02 | 1.317 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 5.025473e-02 | 1.299 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.880028e-02 | 1.312 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.032392e-02 | 1.298 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.137188e-02 | 1.289 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 5.139327e-02 | 1.289 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 5.139327e-02 | 1.289 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.139327e-02 | 1.289 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.220513e-02 | 1.282 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.220513e-02 | 1.282 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.220513e-02 | 1.282 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.225812e-02 | 1.282 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 6.019003e-02 | 1.220 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 6.019003e-02 | 1.220 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 6.019003e-02 | 1.220 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 5.924454e-02 | 1.227 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 5.924454e-02 | 1.227 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 6.267306e-02 | 1.203 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.267306e-02 | 1.203 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.978931e-02 | 1.223 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.267306e-02 | 1.203 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.875393e-02 | 1.231 | 1 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.507749e-02 | 1.259 | 1 | 1 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 6.019003e-02 | 1.220 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.594019e-02 | 1.252 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 6.124750e-02 | 1.213 | 1 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.697108e-02 | 1.244 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.697108e-02 | 1.244 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.594019e-02 | 1.252 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.195089e-02 | 1.208 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.384659e-02 | 1.195 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.556047e-02 | 1.183 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.641516e-02 | 1.178 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 6.641516e-02 | 1.178 | 0 | 0 |
| IRS activation | R-HSA-74713 | 6.641516e-02 | 1.178 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 6.641516e-02 | 1.178 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 6.641516e-02 | 1.178 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 6.641516e-02 | 1.178 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.804473e-02 | 1.167 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.804473e-02 | 1.167 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.809058e-02 | 1.167 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 6.926081e-02 | 1.160 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.941679e-02 | 1.159 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 7.057302e-02 | 1.151 | 1 | 1 |
| Kinesins | R-HSA-983189 | 7.105457e-02 | 1.148 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.657630e-02 | 1.116 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.657630e-02 | 1.116 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 8.325685e-02 | 1.080 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 8.156842e-02 | 1.088 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.719982e-02 | 1.112 | 1 | 1 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.860176e-02 | 1.105 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 8.042880e-02 | 1.095 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.377554e-02 | 1.132 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.657630e-02 | 1.116 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.697977e-02 | 1.114 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.697977e-02 | 1.114 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.976752e-02 | 1.098 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.236829e-02 | 1.140 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.915969e-02 | 1.101 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 7.413117e-02 | 1.130 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.697977e-02 | 1.114 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 8.378769e-02 | 1.077 | 1 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.659826e-02 | 1.062 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.659826e-02 | 1.062 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 9.030094e-02 | 1.044 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 9.030094e-02 | 1.044 | 1 | 1 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 9.030094e-02 | 1.044 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 9.030094e-02 | 1.044 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 9.200070e-02 | 1.036 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.239180e-02 | 1.034 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 9.483604e-02 | 1.023 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 9.483604e-02 | 1.023 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 9.483604e-02 | 1.023 | 1 | 1 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 9.483604e-02 | 1.023 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 9.483604e-02 | 1.023 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 9.689945e-02 | 1.014 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 9.689945e-02 | 1.014 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 9.689945e-02 | 1.014 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 9.836014e-02 | 1.007 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 9.943819e-02 | 1.002 | 1 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.052922e-01 | 0.978 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 1.052922e-01 | 0.978 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.052922e-01 | 0.978 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.052922e-01 | 0.978 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.060949e-01 | 0.974 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.078780e-01 | 0.967 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.078780e-01 | 0.967 | 1 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.083351e-01 | 0.965 | 1 | 1 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.233580e-01 | 0.909 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.233580e-01 | 0.909 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.233580e-01 | 0.909 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.233580e-01 | 0.909 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.233580e-01 | 0.909 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.172001e-01 | 0.931 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 1.172001e-01 | 0.931 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.172001e-01 | 0.931 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.191077e-01 | 0.924 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.294853e-01 | 0.888 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.299572e-01 | 0.886 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.271695e-01 | 0.896 | 1 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.285077e-01 | 0.891 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.181215e-01 | 0.928 | 1 | 1 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.309355e-01 | 0.883 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.309355e-01 | 0.883 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.197855e-01 | 0.922 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.111198e-01 | 0.954 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.271695e-01 | 0.896 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.315051e-01 | 0.635 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.315051e-01 | 0.635 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.315051e-01 | 0.635 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.315051e-01 | 0.635 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.315051e-01 | 0.635 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.315051e-01 | 0.635 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.315051e-01 | 0.635 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.414162e-01 | 0.850 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.875733e-01 | 0.727 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.875733e-01 | 0.727 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.875733e-01 | 0.727 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.263161e-01 | 0.486 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 3.263161e-01 | 0.486 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 3.263161e-01 | 0.486 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.263161e-01 | 0.486 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.263161e-01 | 0.486 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.263161e-01 | 0.486 | 0 | 0 |
| Defective SLC9A9 causes autism 16 (AUTS16) | R-HSA-5619052 | 3.263161e-01 | 0.486 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 3.263161e-01 | 0.486 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.263161e-01 | 0.486 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.263161e-01 | 0.486 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 1.466605e-01 | 0.834 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.466605e-01 | 0.834 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 1.466605e-01 | 0.834 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.466605e-01 | 0.834 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.466605e-01 | 0.834 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.354119e-01 | 0.628 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.354119e-01 | 0.628 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.782150e-01 | 0.749 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.782150e-01 | 0.749 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.782150e-01 | 0.749 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.382708e-01 | 0.859 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 1.382708e-01 | 0.859 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 1.382708e-01 | 0.859 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.382708e-01 | 0.859 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.382708e-01 | 0.859 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.624918e-01 | 0.789 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.624918e-01 | 0.789 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.114021e-01 | 0.675 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.114021e-01 | 0.675 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.114021e-01 | 0.675 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.838155e-01 | 0.547 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.838155e-01 | 0.547 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.838155e-01 | 0.547 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.838155e-01 | 0.547 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.838155e-01 | 0.547 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.838155e-01 | 0.547 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.094349e-01 | 0.388 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.094349e-01 | 0.388 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 4.094349e-01 | 0.388 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.094349e-01 | 0.388 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 4.094349e-01 | 0.388 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.094349e-01 | 0.388 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.094349e-01 | 0.388 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.094349e-01 | 0.388 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.094349e-01 | 0.388 | 0 | 0 |
| Defective F8 sulfation at Y1699 | R-HSA-9674519 | 4.094349e-01 | 0.388 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.094349e-01 | 0.388 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.094349e-01 | 0.388 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 4.094349e-01 | 0.388 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.094349e-01 | 0.388 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.094349e-01 | 0.388 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.467450e-01 | 0.833 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.467450e-01 | 0.833 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.881088e-01 | 0.726 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 1.322123e-01 | 0.879 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 2.457801e-01 | 0.609 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.149045e-01 | 0.668 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.319171e-01 | 0.479 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.319171e-01 | 0.479 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.809369e-01 | 0.551 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.809369e-01 | 0.551 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.809369e-01 | 0.551 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.809369e-01 | 0.551 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.426596e-01 | 0.615 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.121295e-01 | 0.673 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.318241e-01 | 0.880 | 1 | 1 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.828078e-01 | 0.738 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.164964e-01 | 0.500 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 3.164964e-01 | 0.500 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.164964e-01 | 0.500 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 3.790549e-01 | 0.421 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.790549e-01 | 0.421 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.790549e-01 | 0.421 | 1 | 1 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 3.790549e-01 | 0.421 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.790549e-01 | 0.421 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.790549e-01 | 0.421 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 3.790549e-01 | 0.421 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.823027e-01 | 0.317 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.823027e-01 | 0.317 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 4.823027e-01 | 0.317 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 4.823027e-01 | 0.317 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 4.823027e-01 | 0.317 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.823027e-01 | 0.317 | 0 | 0 |
| Defective DPM2 causes DPM2-CDG | R-HSA-4719377 | 4.823027e-01 | 0.317 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.823027e-01 | 0.317 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.823027e-01 | 0.317 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.823027e-01 | 0.317 | 0 | 0 |
| Defective DPM1 causes DPM1-CDG | R-HSA-4717374 | 4.823027e-01 | 0.317 | 0 | 0 |
| Defective DPM3 causes DPM3-CDG | R-HSA-4719360 | 4.823027e-01 | 0.317 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.600072e-01 | 0.585 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 1.724432e-01 | 0.763 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.001858e-01 | 0.523 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.001858e-01 | 0.523 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.001858e-01 | 0.523 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.521215e-01 | 0.453 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.521215e-01 | 0.453 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.521215e-01 | 0.453 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.521215e-01 | 0.453 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.521215e-01 | 0.453 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.521215e-01 | 0.453 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.521215e-01 | 0.453 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.521215e-01 | 0.453 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.804193e-01 | 0.744 | 1 | 1 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.804193e-01 | 0.744 | 1 | 1 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.804193e-01 | 0.744 | 1 | 1 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.023575e-01 | 0.694 | 1 | 1 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 2.023575e-01 | 0.694 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.023575e-01 | 0.694 | 1 | 1 |
| HIV Transcription Initiation | R-HSA-167161 | 2.023575e-01 | 0.694 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 2.023575e-01 | 0.694 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.738518e-01 | 0.760 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.247348e-01 | 0.372 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.247348e-01 | 0.372 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.247348e-01 | 0.372 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.247348e-01 | 0.372 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.247348e-01 | 0.372 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.868092e-01 | 0.729 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 3.100785e-01 | 0.509 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.919788e-01 | 0.717 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 2.342349e-01 | 0.630 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.590471e-01 | 0.445 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.590471e-01 | 0.445 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.356093e-01 | 0.474 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 2.677713e-01 | 0.572 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.024555e-01 | 0.694 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.939382e-01 | 0.712 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.783393e-01 | 0.749 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.885158e-01 | 0.411 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.885158e-01 | 0.411 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.224213e-01 | 0.374 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.685992e-01 | 0.329 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.685992e-01 | 0.329 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.461834e-01 | 0.263 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.461834e-01 | 0.263 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.461834e-01 | 0.263 | 1 | 1 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.461834e-01 | 0.263 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 5.461834e-01 | 0.263 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.461834e-01 | 0.263 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.393612e-01 | 0.469 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.740017e-01 | 0.562 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.566211e-01 | 0.340 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.566211e-01 | 0.340 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 4.566211e-01 | 0.340 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.127174e-01 | 0.384 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.357229e-01 | 0.474 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.357229e-01 | 0.474 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.467310e-01 | 0.350 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.467310e-01 | 0.350 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 5.104008e-01 | 0.292 | 1 | 1 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.104008e-01 | 0.292 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.104008e-01 | 0.292 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.382233e-01 | 0.358 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 2.752674e-01 | 0.560 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.933518e-01 | 0.405 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 4.899334e-01 | 0.310 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 4.899334e-01 | 0.310 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.175850e-01 | 0.379 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.175850e-01 | 0.379 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.752052e-01 | 0.323 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.752052e-01 | 0.323 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.117601e-01 | 0.385 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.634659e-01 | 0.334 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.634659e-01 | 0.334 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.634659e-01 | 0.334 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.634659e-01 | 0.334 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.341661e-01 | 0.362 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.883588e-01 | 0.311 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.222102e-01 | 0.282 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.499809e-01 | 0.260 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.499809e-01 | 0.260 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 6.021848e-01 | 0.220 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.021848e-01 | 0.220 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.021848e-01 | 0.220 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.021848e-01 | 0.220 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 6.021848e-01 | 0.220 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.021848e-01 | 0.220 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 6.021848e-01 | 0.220 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 6.021848e-01 | 0.220 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.021848e-01 | 0.220 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.435176e-01 | 0.353 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.128242e-01 | 0.290 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.303251e-01 | 0.275 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.303251e-01 | 0.275 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.029240e-01 | 0.298 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.533348e-01 | 0.257 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 5.533348e-01 | 0.257 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.996329e-01 | 0.301 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.316751e-01 | 0.274 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.471842e-01 | 0.262 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.471842e-01 | 0.262 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.602047e-01 | 0.252 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.830071e-01 | 0.234 | 1 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.842435e-01 | 0.233 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 5.842435e-01 | 0.233 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.221793e-01 | 0.206 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.221793e-01 | 0.206 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.512785e-01 | 0.186 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.512785e-01 | 0.186 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.512785e-01 | 0.186 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.512785e-01 | 0.186 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.512785e-01 | 0.186 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.512785e-01 | 0.186 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.512785e-01 | 0.186 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.512785e-01 | 0.186 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 6.512785e-01 | 0.186 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 6.512785e-01 | 0.186 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.512785e-01 | 0.186 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.236822e-01 | 0.205 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.507089e-01 | 0.187 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.310434e-01 | 0.200 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.310434e-01 | 0.200 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.310434e-01 | 0.200 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.310434e-01 | 0.200 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 6.547754e-01 | 0.184 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.547754e-01 | 0.184 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.547754e-01 | 0.184 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 6.547754e-01 | 0.184 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 6.547754e-01 | 0.184 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.489975e-01 | 0.604 | 1 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.035915e-01 | 0.518 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 2.291842e-01 | 0.640 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 6.071997e-01 | 0.217 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.305856e-01 | 0.637 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.305856e-01 | 0.637 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.305856e-01 | 0.637 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.393612e-01 | 0.469 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.339739e-01 | 0.476 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.467310e-01 | 0.350 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.467310e-01 | 0.350 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 3.001858e-01 | 0.523 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.295454e-01 | 0.482 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.295454e-01 | 0.482 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 1.447592e-01 | 0.839 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.842435e-01 | 0.233 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.383833e-01 | 0.471 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.207314e-01 | 0.283 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 6.117968e-01 | 0.213 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.848349e-01 | 0.545 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.504656e-01 | 0.823 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.533348e-01 | 0.257 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.533133e-01 | 0.185 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 2.354119e-01 | 0.628 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.624918e-01 | 0.789 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.521215e-01 | 0.453 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.380528e-01 | 0.623 | 1 | 1 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.662680e-01 | 0.779 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.237119e-01 | 0.490 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.100785e-01 | 0.509 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.597266e-01 | 0.797 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.053211e-01 | 0.218 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 5.602047e-01 | 0.252 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.121295e-01 | 0.673 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.224213e-01 | 0.374 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.382233e-01 | 0.358 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.303016e-01 | 0.638 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.919788e-01 | 0.717 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.881088e-01 | 0.726 | 1 | 1 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.272970e-01 | 0.278 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 5.207314e-01 | 0.283 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.933518e-01 | 0.405 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.180085e-01 | 0.662 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 5.104008e-01 | 0.292 | 1 | 1 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 4.658497e-01 | 0.332 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.872513e-01 | 0.231 | 1 | 0 |
| Nephron development | R-HSA-9831926 | 5.832184e-01 | 0.234 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 6.310434e-01 | 0.200 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.043045e-01 | 0.393 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.222102e-01 | 0.282 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.334169e-01 | 0.875 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 2.838155e-01 | 0.547 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.838155e-01 | 0.547 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.706534e-01 | 0.568 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.575707e-01 | 0.589 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.685992e-01 | 0.329 | 1 | 1 |
| Signaling by Activin | R-HSA-1502540 | 4.566211e-01 | 0.340 | 1 | 1 |
| Formation of apoptosome | R-HSA-111458 | 5.104008e-01 | 0.292 | 1 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.104008e-01 | 0.292 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.752052e-01 | 0.323 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.261338e-01 | 0.487 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.783694e-01 | 0.238 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.804193e-01 | 0.744 | 1 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.224213e-01 | 0.374 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.872513e-01 | 0.231 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.360252e-01 | 0.866 | 1 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.004760e-01 | 0.522 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.566211e-01 | 0.340 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.832184e-01 | 0.234 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.861379e-01 | 0.232 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.059929e-01 | 0.218 | 1 | 0 |
| MTOR signalling | R-HSA-165159 | 2.180691e-01 | 0.661 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.382708e-01 | 0.859 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.838155e-01 | 0.547 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.319171e-01 | 0.479 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.828078e-01 | 0.738 | 1 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.247348e-01 | 0.372 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 3.875154e-01 | 0.412 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.461834e-01 | 0.263 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.886845e-01 | 0.540 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.382233e-01 | 0.358 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.441938e-01 | 0.463 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.832184e-01 | 0.234 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.619252e-01 | 0.441 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.619252e-01 | 0.441 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 5.824351e-01 | 0.235 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 3.521215e-01 | 0.453 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.474423e-01 | 0.607 | 1 | 1 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.415702e-01 | 0.467 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 3.885158e-01 | 0.411 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.269714e-01 | 0.644 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.237119e-01 | 0.490 | 1 | 1 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.848349e-01 | 0.545 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 3.875154e-01 | 0.412 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.467310e-01 | 0.350 | 1 | 1 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.535670e-01 | 0.343 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.670637e-01 | 0.331 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.221793e-01 | 0.206 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.766055e-01 | 0.424 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.447592e-01 | 0.839 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 3.521215e-01 | 0.453 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.724432e-01 | 0.763 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.111172e-01 | 0.675 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.780551e-01 | 0.556 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.333972e-01 | 0.632 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.088265e-01 | 0.293 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.133500e-01 | 0.384 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.461030e-01 | 0.835 | 1 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.414162e-01 | 0.850 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.114021e-01 | 0.675 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.475375e-01 | 0.831 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 2.275491e-01 | 0.643 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.454692e-01 | 0.610 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.224213e-01 | 0.374 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.177918e-01 | 0.379 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 4.177918e-01 | 0.379 | 1 | 1 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.766055e-01 | 0.424 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.222102e-01 | 0.282 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 6.021848e-01 | 0.220 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.021848e-01 | 0.220 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.757659e-01 | 0.425 | 1 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 5.872513e-01 | 0.231 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.221987e-01 | 0.206 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.526005e-01 | 0.816 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.272970e-01 | 0.278 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.272970e-01 | 0.278 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.539353e-01 | 0.184 | 1 | 1 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.414145e-01 | 0.850 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.475375e-01 | 0.831 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.068878e-01 | 0.684 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.731413e-01 | 0.762 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.474416e-01 | 0.262 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.123316e-01 | 0.290 | 1 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.499809e-01 | 0.260 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.326676e-01 | 0.199 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 3.875154e-01 | 0.412 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.566211e-01 | 0.340 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.344161e-01 | 0.362 | 1 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.071997e-01 | 0.217 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.008808e-01 | 0.522 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.385477e-01 | 0.358 | 1 | 1 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.127174e-01 | 0.384 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.424286e-01 | 0.354 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.640735e-01 | 0.333 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.875733e-01 | 0.727 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.875733e-01 | 0.727 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 2.838155e-01 | 0.547 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.338081e-01 | 0.874 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.677922e-01 | 0.775 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 3.164964e-01 | 0.500 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.461834e-01 | 0.263 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.726909e-01 | 0.564 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.566211e-01 | 0.340 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 5.872513e-01 | 0.231 | 0 | 0 |
| S Phase | R-HSA-69242 | 6.020193e-01 | 0.220 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.853752e-01 | 0.414 | 1 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.048117e-01 | 0.689 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.402512e-01 | 0.267 | 1 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.914890e-01 | 0.228 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.358644e-01 | 0.197 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 5.031022e-01 | 0.298 | 1 | 1 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.222723e-01 | 0.653 | 1 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.319171e-01 | 0.479 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.944210e-01 | 0.711 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.341701e-01 | 0.630 | 1 | 0 |
| Myogenesis | R-HSA-525793 | 4.127174e-01 | 0.384 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.670637e-01 | 0.331 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 5.533348e-01 | 0.257 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.310434e-01 | 0.200 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.390279e-01 | 0.194 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.281554e-01 | 0.642 | 1 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.685992e-01 | 0.329 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.899334e-01 | 0.310 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.899334e-01 | 0.310 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.281554e-01 | 0.642 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.919788e-01 | 0.717 | 1 | 1 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.566211e-01 | 0.340 | 1 | 1 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.117968e-01 | 0.213 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.597913e-01 | 0.337 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.488044e-01 | 0.827 | 1 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.870431e-01 | 0.412 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.175850e-01 | 0.379 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.935720e-01 | 0.405 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.006069e-01 | 0.698 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 4.481902e-01 | 0.349 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.895267e-01 | 0.229 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.141495e-01 | 0.503 | 1 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.875733e-01 | 0.727 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.263161e-01 | 0.486 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.263161e-01 | 0.486 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.354119e-01 | 0.628 | 0 | 0 |
| TGFBR3 regulates activin signaling | R-HSA-9839406 | 4.094349e-01 | 0.388 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.094349e-01 | 0.388 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.893467e-01 | 0.723 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 1.893467e-01 | 0.723 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.711569e-01 | 0.567 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.164964e-01 | 0.500 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.823027e-01 | 0.317 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.823027e-01 | 0.317 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.521215e-01 | 0.453 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 4.247348e-01 | 0.372 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.247348e-01 | 0.372 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 3.875154e-01 | 0.412 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.356093e-01 | 0.474 | 1 | 1 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.685992e-01 | 0.329 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.685992e-01 | 0.329 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.461834e-01 | 0.263 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 3.037844e-01 | 0.517 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.874006e-01 | 0.727 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.076449e-01 | 0.390 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 5.104008e-01 | 0.292 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.104008e-01 | 0.292 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.968349e-01 | 0.401 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.222102e-01 | 0.282 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 5.499809e-01 | 0.260 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 6.021848e-01 | 0.220 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.021848e-01 | 0.220 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.475940e-01 | 0.349 | 1 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 5.533348e-01 | 0.257 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 5.367930e-01 | 0.270 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.872513e-01 | 0.231 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 5.832184e-01 | 0.234 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.051559e-01 | 0.218 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.512785e-01 | 0.186 | 0 | 0 |
| Sensory perception of salty taste | R-HSA-9730628 | 6.512785e-01 | 0.186 | 0 | 0 |
| Synthesis of dolichyl-phosphate mannose | R-HSA-162699 | 6.512785e-01 | 0.186 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.266147e-01 | 0.203 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.405541e-01 | 0.193 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.417474e-01 | 0.466 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 5.116927e-01 | 0.291 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.400063e-01 | 0.854 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.888173e-01 | 0.539 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.805731e-01 | 0.420 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.305856e-01 | 0.637 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.224213e-01 | 0.374 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.533348e-01 | 0.257 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.449220e-01 | 0.352 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.127174e-01 | 0.384 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 3.160892e-01 | 0.500 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.725021e-01 | 0.326 | 1 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.675100e-01 | 0.776 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.303251e-01 | 0.275 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.986152e-01 | 0.302 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.475375e-01 | 0.831 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 5.461834e-01 | 0.263 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.587296e-01 | 0.445 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.206572e-01 | 0.283 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.351688e-01 | 0.272 | 1 | 1 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.300728e-01 | 0.481 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.319171e-01 | 0.479 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 4.224213e-01 | 0.374 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 4.685992e-01 | 0.329 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.685992e-01 | 0.329 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.461834e-01 | 0.263 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 4.566211e-01 | 0.340 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.467310e-01 | 0.350 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 5.303251e-01 | 0.275 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.221793e-01 | 0.206 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.221793e-01 | 0.206 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.221793e-01 | 0.206 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.057724e-01 | 0.515 | 1 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.219879e-01 | 0.282 | 1 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.583075e-01 | 0.800 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.871761e-01 | 0.412 | 1 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.685992e-01 | 0.329 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.367930e-01 | 0.270 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.519468e-01 | 0.454 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.675100e-01 | 0.776 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.575707e-01 | 0.589 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.177918e-01 | 0.379 | 1 | 1 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.533348e-01 | 0.257 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 5.367930e-01 | 0.270 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.934578e-01 | 0.227 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.322123e-01 | 0.879 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.637287e-01 | 0.439 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.180691e-01 | 0.661 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.237119e-01 | 0.490 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.263161e-01 | 0.486 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.114021e-01 | 0.675 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.521215e-01 | 0.453 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.804193e-01 | 0.744 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.848349e-01 | 0.545 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.247348e-01 | 0.372 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 4.224213e-01 | 0.374 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.461834e-01 | 0.263 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 5.461834e-01 | 0.263 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.207224e-01 | 0.656 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.467310e-01 | 0.350 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.104008e-01 | 0.292 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.567920e-01 | 0.254 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.512785e-01 | 0.186 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.104008e-01 | 0.292 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.567131e-01 | 0.340 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.411751e-01 | 0.355 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.824351e-01 | 0.235 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.114021e-01 | 0.675 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.451728e-01 | 0.351 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.644927e-01 | 0.438 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.310434e-01 | 0.200 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.114021e-01 | 0.675 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.426596e-01 | 0.615 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.823027e-01 | 0.317 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 2.277889e-01 | 0.642 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.035915e-01 | 0.518 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.883588e-01 | 0.311 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.499809e-01 | 0.260 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.832184e-01 | 0.234 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.356093e-01 | 0.474 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.727448e-01 | 0.242 | 0 | 0 |
| Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells | R-HSA-210746 | 3.319171e-01 | 0.479 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.790549e-01 | 0.421 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 4.823027e-01 | 0.317 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 3.001858e-01 | 0.523 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.521215e-01 | 0.453 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.155193e-01 | 0.501 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.685992e-01 | 0.329 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.461834e-01 | 0.263 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.461834e-01 | 0.263 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.752052e-01 | 0.323 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.071997e-01 | 0.217 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 6.512785e-01 | 0.186 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.616595e-01 | 0.442 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.783051e-01 | 0.422 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.247348e-01 | 0.372 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.001200e-01 | 0.301 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 6.512785e-01 | 0.186 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.512785e-01 | 0.186 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 6.512785e-01 | 0.186 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.824351e-01 | 0.235 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.041374e-01 | 0.690 | 1 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.356093e-01 | 0.474 | 1 | 1 |
| tRNA processing | R-HSA-72306 | 5.979563e-01 | 0.223 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.922410e-01 | 0.406 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.021848e-01 | 0.220 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.272970e-01 | 0.278 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 5.954827e-01 | 0.225 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.372588e-01 | 0.472 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 6.021848e-01 | 0.220 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 2.978595e-01 | 0.526 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.513572e-01 | 0.186 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.616994e-01 | 0.179 | 1 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.648887e-01 | 0.177 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.648887e-01 | 0.177 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.652245e-01 | 0.177 | 1 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.664156e-01 | 0.176 | 1 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.673515e-01 | 0.176 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.750593e-01 | 0.171 | 1 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.758544e-01 | 0.170 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.758544e-01 | 0.170 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.758544e-01 | 0.170 | 1 | 1 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.758544e-01 | 0.170 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.758563e-01 | 0.170 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.758563e-01 | 0.170 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.758563e-01 | 0.170 | 1 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.769591e-01 | 0.169 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.784418e-01 | 0.168 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 6.850831e-01 | 0.164 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.850831e-01 | 0.164 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.863653e-01 | 0.163 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.893722e-01 | 0.162 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.893722e-01 | 0.162 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 6.893722e-01 | 0.162 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 6.895713e-01 | 0.161 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.908404e-01 | 0.161 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.908404e-01 | 0.161 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.915356e-01 | 0.160 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.940347e-01 | 0.159 | 1 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.943161e-01 | 0.158 | 1 | 1 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.943161e-01 | 0.158 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.943161e-01 | 0.158 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.943161e-01 | 0.158 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.943161e-01 | 0.158 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 6.943161e-01 | 0.158 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.943161e-01 | 0.158 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.943161e-01 | 0.158 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.943161e-01 | 0.158 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 6.943161e-01 | 0.158 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.943161e-01 | 0.158 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 6.943161e-01 | 0.158 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.943161e-01 | 0.158 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.943161e-01 | 0.158 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.943161e-01 | 0.158 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.943161e-01 | 0.158 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 6.943161e-01 | 0.158 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 6.943161e-01 | 0.158 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.944412e-01 | 0.158 | 1 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.967890e-01 | 0.157 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.968384e-01 | 0.157 | 1 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 7.029470e-01 | 0.153 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.029470e-01 | 0.153 | 1 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.029470e-01 | 0.153 | 1 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.038843e-01 | 0.152 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.065508e-01 | 0.151 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.080739e-01 | 0.150 | 1 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 7.091683e-01 | 0.149 | 1 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.124858e-01 | 0.147 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.124858e-01 | 0.147 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.124858e-01 | 0.147 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.124858e-01 | 0.147 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.124858e-01 | 0.147 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.124858e-01 | 0.147 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.124858e-01 | 0.147 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 7.131708e-01 | 0.147 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.131708e-01 | 0.147 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.131708e-01 | 0.147 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.131708e-01 | 0.147 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.131708e-01 | 0.147 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 7.131708e-01 | 0.147 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.131708e-01 | 0.147 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 7.188152e-01 | 0.143 | 1 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.217218e-01 | 0.142 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.217218e-01 | 0.142 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 7.227575e-01 | 0.141 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 7.227575e-01 | 0.141 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 7.244549e-01 | 0.140 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.258489e-01 | 0.139 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.294495e-01 | 0.137 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.294495e-01 | 0.137 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.297299e-01 | 0.137 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.314108e-01 | 0.136 | 1 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.314108e-01 | 0.136 | 1 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 7.320444e-01 | 0.135 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 7.320444e-01 | 0.135 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.320444e-01 | 0.135 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.320444e-01 | 0.135 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 7.320444e-01 | 0.135 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.320444e-01 | 0.135 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 7.320444e-01 | 0.135 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 7.320444e-01 | 0.135 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.320444e-01 | 0.135 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.320444e-01 | 0.135 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.320444e-01 | 0.135 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.320444e-01 | 0.135 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.320444e-01 | 0.135 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.320444e-01 | 0.135 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 7.320444e-01 | 0.135 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.342481e-01 | 0.134 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 7.342481e-01 | 0.134 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.356979e-01 | 0.133 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.363491e-01 | 0.133 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.374477e-01 | 0.132 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 7.391247e-01 | 0.131 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 7.391247e-01 | 0.131 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.391247e-01 | 0.131 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.396795e-01 | 0.131 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.396795e-01 | 0.131 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.396795e-01 | 0.131 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.432409e-01 | 0.129 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.432409e-01 | 0.129 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 7.442197e-01 | 0.128 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 7.500525e-01 | 0.125 | 1 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.507263e-01 | 0.125 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.536858e-01 | 0.123 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.536858e-01 | 0.123 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.536858e-01 | 0.123 | 1 | 1 |
| DNA Damage Bypass | R-HSA-73893 | 7.595066e-01 | 0.119 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.597025e-01 | 0.119 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 7.630436e-01 | 0.117 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 7.630436e-01 | 0.117 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.639691e-01 | 0.117 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.651180e-01 | 0.116 | 1 | 1 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.651180e-01 | 0.116 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.651180e-01 | 0.116 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.651180e-01 | 0.116 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.651180e-01 | 0.116 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.651180e-01 | 0.116 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.651180e-01 | 0.116 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.651180e-01 | 0.116 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.651180e-01 | 0.116 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.651180e-01 | 0.116 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.651180e-01 | 0.116 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.662208e-01 | 0.116 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.707148e-01 | 0.113 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.707148e-01 | 0.113 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.707148e-01 | 0.113 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.712194e-01 | 0.113 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.712194e-01 | 0.113 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.717176e-01 | 0.113 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.738404e-01 | 0.111 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.769650e-01 | 0.110 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 7.809216e-01 | 0.107 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 7.850344e-01 | 0.105 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.850344e-01 | 0.105 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.850344e-01 | 0.105 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.850344e-01 | 0.105 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.850344e-01 | 0.105 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 7.850344e-01 | 0.105 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.858560e-01 | 0.105 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.868049e-01 | 0.104 | 1 | 1 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.868049e-01 | 0.104 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.868049e-01 | 0.104 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.870324e-01 | 0.104 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 7.870324e-01 | 0.104 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.917488e-01 | 0.101 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 7.917488e-01 | 0.101 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 7.917488e-01 | 0.101 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.941111e-01 | 0.100 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.941111e-01 | 0.100 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.941111e-01 | 0.100 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.941111e-01 | 0.100 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.941111e-01 | 0.100 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.941111e-01 | 0.100 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.941111e-01 | 0.100 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.941111e-01 | 0.100 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.941111e-01 | 0.100 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.941111e-01 | 0.100 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.941111e-01 | 0.100 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.941111e-01 | 0.100 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 7.941894e-01 | 0.100 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.941894e-01 | 0.100 | 1 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.998644e-01 | 0.097 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.019800e-01 | 0.096 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.019800e-01 | 0.096 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.032025e-01 | 0.095 | 1 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.036886e-01 | 0.095 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.036886e-01 | 0.095 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 8.052085e-01 | 0.094 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.052085e-01 | 0.094 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.052085e-01 | 0.094 | 1 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 8.052085e-01 | 0.094 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.052085e-01 | 0.094 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.084597e-01 | 0.092 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.084597e-01 | 0.092 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 8.084597e-01 | 0.092 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.084597e-01 | 0.092 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.084597e-01 | 0.092 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.120898e-01 | 0.090 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.127574e-01 | 0.090 | 1 | 1 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.130558e-01 | 0.090 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.145783e-01 | 0.089 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.162670e-01 | 0.088 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.166248e-01 | 0.088 | 1 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.192793e-01 | 0.087 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 8.195269e-01 | 0.086 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 8.195269e-01 | 0.086 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.195269e-01 | 0.086 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 8.195269e-01 | 0.086 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 8.195269e-01 | 0.086 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.195269e-01 | 0.086 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.195269e-01 | 0.086 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.195269e-01 | 0.086 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 8.195269e-01 | 0.086 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.195269e-01 | 0.086 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.195269e-01 | 0.086 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.236792e-01 | 0.084 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.236792e-01 | 0.084 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 8.236792e-01 | 0.084 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.236792e-01 | 0.084 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.236792e-01 | 0.084 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.236792e-01 | 0.084 | 1 | 1 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.236792e-01 | 0.084 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.236792e-01 | 0.084 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.240236e-01 | 0.084 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.240236e-01 | 0.084 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.240236e-01 | 0.084 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.246202e-01 | 0.084 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.253046e-01 | 0.083 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 8.254053e-01 | 0.083 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.275595e-01 | 0.082 | 1 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.278467e-01 | 0.082 | 1 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.286785e-01 | 0.082 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.296954e-01 | 0.081 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 8.296954e-01 | 0.081 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.340381e-01 | 0.079 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.363853e-01 | 0.078 | 1 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.371964e-01 | 0.077 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.372083e-01 | 0.077 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.384932e-01 | 0.077 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.384932e-01 | 0.077 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.384932e-01 | 0.077 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.405596e-01 | 0.075 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.405596e-01 | 0.075 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.405596e-01 | 0.075 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 8.405596e-01 | 0.075 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 8.405596e-01 | 0.075 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.418065e-01 | 0.075 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.418065e-01 | 0.075 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.418065e-01 | 0.075 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.418065e-01 | 0.075 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 8.418065e-01 | 0.075 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 8.418065e-01 | 0.075 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.418065e-01 | 0.075 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.418065e-01 | 0.075 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.418065e-01 | 0.075 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.418065e-01 | 0.075 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.418065e-01 | 0.075 | 1 | 1 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.422968e-01 | 0.075 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.422968e-01 | 0.075 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.452601e-01 | 0.073 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.452601e-01 | 0.073 | 1 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.465656e-01 | 0.072 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.519227e-01 | 0.070 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.519227e-01 | 0.070 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.524184e-01 | 0.069 | 1 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.527140e-01 | 0.069 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.541040e-01 | 0.068 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.559608e-01 | 0.068 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.588181e-01 | 0.066 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 8.613368e-01 | 0.065 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.613368e-01 | 0.065 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.613368e-01 | 0.065 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.613368e-01 | 0.065 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 8.613368e-01 | 0.065 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.613368e-01 | 0.065 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.613368e-01 | 0.065 | 1 | 1 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 8.613368e-01 | 0.065 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.613368e-01 | 0.065 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.613368e-01 | 0.065 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 8.614124e-01 | 0.065 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.623059e-01 | 0.064 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.636306e-01 | 0.064 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.643671e-01 | 0.063 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.643671e-01 | 0.063 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.643671e-01 | 0.063 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.651511e-01 | 0.063 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.699907e-01 | 0.060 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 8.699907e-01 | 0.060 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.699907e-01 | 0.060 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.738356e-01 | 0.059 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.747559e-01 | 0.058 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.754725e-01 | 0.058 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.779822e-01 | 0.057 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.779822e-01 | 0.057 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.784570e-01 | 0.056 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.784570e-01 | 0.056 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.784570e-01 | 0.056 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.784570e-01 | 0.056 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.784570e-01 | 0.056 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.784570e-01 | 0.056 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.784570e-01 | 0.056 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.784570e-01 | 0.056 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.784570e-01 | 0.056 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.784570e-01 | 0.056 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.827530e-01 | 0.054 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.827530e-01 | 0.054 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.827530e-01 | 0.054 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 8.844271e-01 | 0.053 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.851029e-01 | 0.053 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.865076e-01 | 0.052 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 8.865076e-01 | 0.052 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.865193e-01 | 0.052 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.865193e-01 | 0.052 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 8.865193e-01 | 0.052 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.897567e-01 | 0.051 | 1 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.897567e-01 | 0.051 | 1 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.914052e-01 | 0.050 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 8.934642e-01 | 0.049 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.934642e-01 | 0.049 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.934642e-01 | 0.049 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.934642e-01 | 0.049 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.934642e-01 | 0.049 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.934642e-01 | 0.049 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.934642e-01 | 0.049 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.940772e-01 | 0.049 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.940772e-01 | 0.049 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.940772e-01 | 0.049 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.943467e-01 | 0.048 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.943467e-01 | 0.048 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.948838e-01 | 0.048 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.949987e-01 | 0.048 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.986940e-01 | 0.046 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.005761e-01 | 0.045 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.006929e-01 | 0.045 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.013137e-01 | 0.045 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.016361e-01 | 0.045 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.024297e-01 | 0.045 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.048659e-01 | 0.043 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.048659e-01 | 0.043 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 9.048659e-01 | 0.043 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.048659e-01 | 0.043 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 9.053793e-01 | 0.043 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.053793e-01 | 0.043 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.053793e-01 | 0.043 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.057192e-01 | 0.043 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.057192e-01 | 0.043 | 1 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.061286e-01 | 0.043 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.064091e-01 | 0.043 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 9.066193e-01 | 0.043 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 9.066193e-01 | 0.043 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 9.066193e-01 | 0.043 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 9.066193e-01 | 0.043 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 9.066193e-01 | 0.043 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 9.066193e-01 | 0.043 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 9.066193e-01 | 0.043 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 9.066193e-01 | 0.043 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.066193e-01 | 0.043 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 9.066193e-01 | 0.043 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.097213e-01 | 0.041 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.097213e-01 | 0.041 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.101943e-01 | 0.041 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.101943e-01 | 0.041 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.107853e-01 | 0.041 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.137035e-01 | 0.039 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.137035e-01 | 0.039 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.143991e-01 | 0.039 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.143991e-01 | 0.039 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.143991e-01 | 0.039 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.143991e-01 | 0.039 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.143991e-01 | 0.039 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.143991e-01 | 0.039 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.143991e-01 | 0.039 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 9.155891e-01 | 0.038 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.158854e-01 | 0.038 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.174042e-01 | 0.037 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.174944e-01 | 0.037 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 9.181506e-01 | 0.037 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 9.181506e-01 | 0.037 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.181506e-01 | 0.037 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.181506e-01 | 0.037 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.181506e-01 | 0.037 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 9.181506e-01 | 0.037 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 9.181506e-01 | 0.037 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 9.181506e-01 | 0.037 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 9.181506e-01 | 0.037 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.181506e-01 | 0.037 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 9.181506e-01 | 0.037 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 9.181506e-01 | 0.037 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 9.181506e-01 | 0.037 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.181506e-01 | 0.037 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.188819e-01 | 0.037 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.189497e-01 | 0.037 | 1 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.198369e-01 | 0.036 | 1 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.209646e-01 | 0.036 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.213557e-01 | 0.036 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.213557e-01 | 0.036 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.226902e-01 | 0.035 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.230293e-01 | 0.035 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.230293e-01 | 0.035 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 9.230293e-01 | 0.035 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.230293e-01 | 0.035 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.230293e-01 | 0.035 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.230293e-01 | 0.035 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.230293e-01 | 0.035 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 9.236319e-01 | 0.035 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.240916e-01 | 0.034 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.282585e-01 | 0.032 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 9.282585e-01 | 0.032 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 9.282585e-01 | 0.032 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 9.282585e-01 | 0.032 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 9.282585e-01 | 0.032 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.282585e-01 | 0.032 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.282585e-01 | 0.032 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 9.282585e-01 | 0.032 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 9.282585e-01 | 0.032 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.283822e-01 | 0.032 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.283822e-01 | 0.032 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.285632e-01 | 0.032 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.302896e-01 | 0.031 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.308341e-01 | 0.031 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.308341e-01 | 0.031 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.308341e-01 | 0.031 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.311297e-01 | 0.031 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.339799e-01 | 0.030 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.348273e-01 | 0.029 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.348273e-01 | 0.029 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.352311e-01 | 0.029 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.355184e-01 | 0.029 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.371187e-01 | 0.028 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.371187e-01 | 0.028 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.371187e-01 | 0.028 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.371187e-01 | 0.028 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.371187e-01 | 0.028 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 9.371187e-01 | 0.028 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.371187e-01 | 0.028 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 9.378858e-01 | 0.028 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.378858e-01 | 0.028 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.378858e-01 | 0.028 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.385252e-01 | 0.028 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.407332e-01 | 0.027 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.407332e-01 | 0.027 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.412657e-01 | 0.026 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 9.428488e-01 | 0.026 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.442512e-01 | 0.025 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.442512e-01 | 0.025 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.442512e-01 | 0.025 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.448851e-01 | 0.025 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.448851e-01 | 0.025 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.448851e-01 | 0.025 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.448851e-01 | 0.025 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.448851e-01 | 0.025 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.461397e-01 | 0.024 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.468413e-01 | 0.024 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.470385e-01 | 0.024 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.470385e-01 | 0.024 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.481563e-01 | 0.023 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.481563e-01 | 0.023 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.483937e-01 | 0.023 | 1 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.510844e-01 | 0.022 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.510844e-01 | 0.022 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.510844e-01 | 0.022 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.516553e-01 | 0.022 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.516927e-01 | 0.022 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.516927e-01 | 0.022 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.516927e-01 | 0.022 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 9.516927e-01 | 0.022 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.516927e-01 | 0.022 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.516927e-01 | 0.022 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.516927e-01 | 0.022 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 9.516927e-01 | 0.022 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.516927e-01 | 0.022 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.516927e-01 | 0.022 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.516927e-01 | 0.022 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.516927e-01 | 0.022 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.527980e-01 | 0.021 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.527980e-01 | 0.021 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.540846e-01 | 0.020 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.540846e-01 | 0.020 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.549184e-01 | 0.020 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.549184e-01 | 0.020 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.549184e-01 | 0.020 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.549184e-01 | 0.020 | 1 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.551660e-01 | 0.020 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.551660e-01 | 0.020 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.555079e-01 | 0.020 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.556026e-01 | 0.020 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.560100e-01 | 0.020 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.573740e-01 | 0.019 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.573983e-01 | 0.019 | 1 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.576597e-01 | 0.019 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.576597e-01 | 0.019 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.576597e-01 | 0.019 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.576597e-01 | 0.019 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 9.576597e-01 | 0.019 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.576597e-01 | 0.019 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.576597e-01 | 0.019 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.576597e-01 | 0.019 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.576597e-01 | 0.019 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.580017e-01 | 0.019 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.587606e-01 | 0.018 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.587606e-01 | 0.018 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.587606e-01 | 0.018 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.597277e-01 | 0.018 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.597277e-01 | 0.018 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.597277e-01 | 0.018 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.598251e-01 | 0.018 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.611706e-01 | 0.017 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.627621e-01 | 0.016 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.628900e-01 | 0.016 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.628900e-01 | 0.016 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.628900e-01 | 0.016 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.628900e-01 | 0.016 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.628900e-01 | 0.016 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.628900e-01 | 0.016 | 0 | 0 |
| Synthesis of Ketone Bodies | R-HSA-77111 | 9.628900e-01 | 0.016 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 9.628900e-01 | 0.016 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.640176e-01 | 0.016 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.655517e-01 | 0.015 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.656528e-01 | 0.015 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.674745e-01 | 0.014 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.674745e-01 | 0.014 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.674745e-01 | 0.014 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.674745e-01 | 0.014 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.674745e-01 | 0.014 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.674745e-01 | 0.014 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.677877e-01 | 0.014 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.677877e-01 | 0.014 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.677877e-01 | 0.014 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.677877e-01 | 0.014 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.684363e-01 | 0.014 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.685425e-01 | 0.014 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.711198e-01 | 0.013 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.711198e-01 | 0.013 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.711337e-01 | 0.013 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.711757e-01 | 0.013 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.711757e-01 | 0.013 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.714929e-01 | 0.013 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.714929e-01 | 0.013 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.714929e-01 | 0.013 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.714929e-01 | 0.013 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.714929e-01 | 0.013 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.714929e-01 | 0.013 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.718185e-01 | 0.012 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.739806e-01 | 0.011 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.740667e-01 | 0.011 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.742186e-01 | 0.011 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.743458e-01 | 0.011 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.750150e-01 | 0.011 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.750150e-01 | 0.011 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.750150e-01 | 0.011 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.750150e-01 | 0.011 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.750150e-01 | 0.011 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.754741e-01 | 0.011 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.754861e-01 | 0.011 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.769497e-01 | 0.010 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.769497e-01 | 0.010 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.769497e-01 | 0.010 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.772152e-01 | 0.010 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.777084e-01 | 0.010 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.778245e-01 | 0.010 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.781021e-01 | 0.010 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.781021e-01 | 0.010 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.781021e-01 | 0.010 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.781021e-01 | 0.010 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.781021e-01 | 0.010 | 0 | 0 |
| Ketone body metabolism | R-HSA-74182 | 9.781021e-01 | 0.010 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 9.781021e-01 | 0.010 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.782421e-01 | 0.010 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.782421e-01 | 0.010 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.782421e-01 | 0.010 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.785633e-01 | 0.009 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.789003e-01 | 0.009 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.793998e-01 | 0.009 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.793998e-01 | 0.009 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.793998e-01 | 0.009 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.797641e-01 | 0.009 | 1 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.799593e-01 | 0.009 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.799593e-01 | 0.009 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.799593e-01 | 0.009 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.801832e-01 | 0.009 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.801879e-01 | 0.009 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.808079e-01 | 0.008 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.808079e-01 | 0.008 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.808079e-01 | 0.008 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 9.808079e-01 | 0.008 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.808079e-01 | 0.008 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.808079e-01 | 0.008 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.808079e-01 | 0.008 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.810098e-01 | 0.008 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.812898e-01 | 0.008 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.815236e-01 | 0.008 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.815965e-01 | 0.008 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.815965e-01 | 0.008 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.819310e-01 | 0.008 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.819310e-01 | 0.008 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.819599e-01 | 0.008 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.830150e-01 | 0.007 | 1 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.831310e-01 | 0.007 | 1 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.831796e-01 | 0.007 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.831796e-01 | 0.007 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.831796e-01 | 0.007 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.831796e-01 | 0.007 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.835650e-01 | 0.007 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.835850e-01 | 0.007 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.836549e-01 | 0.007 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.844021e-01 | 0.007 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.852485e-01 | 0.006 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.852582e-01 | 0.006 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.852582e-01 | 0.006 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.853282e-01 | 0.006 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.853282e-01 | 0.006 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.856101e-01 | 0.006 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.856638e-01 | 0.006 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.866357e-01 | 0.006 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.866925e-01 | 0.006 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.869068e-01 | 0.006 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.869068e-01 | 0.006 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.870599e-01 | 0.006 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.870801e-01 | 0.006 | 1 | 1 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.870801e-01 | 0.006 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.870801e-01 | 0.006 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.870801e-01 | 0.006 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.870801e-01 | 0.006 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.870801e-01 | 0.006 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.872780e-01 | 0.006 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.876676e-01 | 0.005 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.877288e-01 | 0.005 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.880228e-01 | 0.005 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.880341e-01 | 0.005 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.883194e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.883194e-01 | 0.005 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.883194e-01 | 0.005 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.886316e-01 | 0.005 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.886770e-01 | 0.005 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.886770e-01 | 0.005 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.886770e-01 | 0.005 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.896673e-01 | 0.005 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.900765e-01 | 0.004 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.900765e-01 | 0.004 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.900765e-01 | 0.004 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.902372e-01 | 0.004 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.905244e-01 | 0.004 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.907126e-01 | 0.004 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.908834e-01 | 0.004 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.912061e-01 | 0.004 | 1 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.912225e-01 | 0.004 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.912225e-01 | 0.004 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.913032e-01 | 0.004 | 1 | 1 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.913032e-01 | 0.004 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.913032e-01 | 0.004 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.913032e-01 | 0.004 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.916278e-01 | 0.004 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.916831e-01 | 0.004 | 1 | 1 |
| Gap junction trafficking | R-HSA-190828 | 9.917223e-01 | 0.004 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.917223e-01 | 0.004 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.917223e-01 | 0.004 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.920409e-01 | 0.003 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.920974e-01 | 0.003 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.923782e-01 | 0.003 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.924082e-01 | 0.003 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.924082e-01 | 0.003 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.924082e-01 | 0.003 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.924648e-01 | 0.003 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.926243e-01 | 0.003 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.926243e-01 | 0.003 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.926243e-01 | 0.003 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.926243e-01 | 0.003 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.927099e-01 | 0.003 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.928877e-01 | 0.003 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.931185e-01 | 0.003 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.932220e-01 | 0.003 | 1 | 1 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.934299e-01 | 0.003 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.934299e-01 | 0.003 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.935311e-01 | 0.003 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.936012e-01 | 0.003 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.941463e-01 | 0.003 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.941463e-01 | 0.003 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.941491e-01 | 0.003 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.944109e-01 | 0.002 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.947910e-01 | 0.002 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.947910e-01 | 0.002 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.948700e-01 | 0.002 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.948700e-01 | 0.002 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.948865e-01 | 0.002 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.953046e-01 | 0.002 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.955043e-01 | 0.002 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.955043e-01 | 0.002 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.955043e-01 | 0.002 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.955043e-01 | 0.002 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.955043e-01 | 0.002 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.955043e-01 | 0.002 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.955043e-01 | 0.002 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.955043e-01 | 0.002 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.955043e-01 | 0.002 | 1 | 1 |
| Regulation of insulin secretion | R-HSA-422356 | 9.957293e-01 | 0.002 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.958743e-01 | 0.002 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.960602e-01 | 0.002 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.960602e-01 | 0.002 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.960602e-01 | 0.002 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.962124e-01 | 0.002 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.963296e-01 | 0.002 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.963296e-01 | 0.002 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.965474e-01 | 0.002 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.965474e-01 | 0.002 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 9.965474e-01 | 0.002 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 9.965474e-01 | 0.002 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.967437e-01 | 0.001 | 1 | 1 |
| Parasite infection | R-HSA-9664407 | 9.967437e-01 | 0.001 | 1 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.967437e-01 | 0.001 | 1 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.967470e-01 | 0.001 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.969744e-01 | 0.001 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.969744e-01 | 0.001 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.969744e-01 | 0.001 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.969744e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.969754e-01 | 0.001 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.969915e-01 | 0.001 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.970101e-01 | 0.001 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.970971e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.972858e-01 | 0.001 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.972915e-01 | 0.001 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.973486e-01 | 0.001 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.974192e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.976765e-01 | 0.001 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.977061e-01 | 0.001 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.979158e-01 | 0.001 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.979639e-01 | 0.001 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.979639e-01 | 0.001 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.979639e-01 | 0.001 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.982157e-01 | 0.001 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.982786e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.983073e-01 | 0.001 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.983484e-01 | 0.001 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.983484e-01 | 0.001 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.984365e-01 | 0.001 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.984365e-01 | 0.001 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.984365e-01 | 0.001 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.984365e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.984875e-01 | 0.001 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.985711e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.985908e-01 | 0.001 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.986299e-01 | 0.001 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.986590e-01 | 0.001 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.987147e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.987378e-01 | 0.001 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.987994e-01 | 0.001 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.987994e-01 | 0.001 | 1 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.988452e-01 | 0.001 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.988736e-01 | 0.000 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.988861e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.989364e-01 | 0.000 | 1 | 1 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.989430e-01 | 0.000 | 1 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.989479e-01 | 0.000 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.989881e-01 | 0.000 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.989913e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.990002e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.990018e-01 | 0.000 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.990781e-01 | 0.000 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.990781e-01 | 0.000 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.990781e-01 | 0.000 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.990781e-01 | 0.000 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.990781e-01 | 0.000 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.990781e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.990944e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.991127e-01 | 0.000 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.991922e-01 | 0.000 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.991922e-01 | 0.000 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.992126e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.992712e-01 | 0.000 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.992712e-01 | 0.000 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.992922e-01 | 0.000 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.992922e-01 | 0.000 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.992922e-01 | 0.000 | 1 | 0 |
| rRNA processing | R-HSA-72312 | 9.993099e-01 | 0.000 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.993440e-01 | 0.000 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.993810e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.994098e-01 | 0.000 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.994337e-01 | 0.000 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.994337e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.994565e-01 | 0.000 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.994690e-01 | 0.000 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.994816e-01 | 0.000 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.995225e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.995238e-01 | 0.000 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.995737e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.995827e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.995827e-01 | 0.000 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.996157e-01 | 0.000 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.996344e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.996605e-01 | 0.000 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.996791e-01 | 0.000 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.996791e-01 | 0.000 | 1 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.997540e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.997540e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.997845e-01 | 0.000 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.997845e-01 | 0.000 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.997899e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.997907e-01 | 0.000 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.998180e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.998203e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.998546e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.998546e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.998550e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.998673e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.998887e-01 | 0.000 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.998887e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999020e-01 | 0.000 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.999025e-01 | 0.000 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.999191e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999252e-01 | 0.000 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.999265e-01 | 0.000 | 1 | 1 |
| Neuronal System | R-HSA-112316 | 9.999314e-01 | 0.000 | 1 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999405e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.999470e-01 | 0.000 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.999497e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.999497e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.999497e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999516e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.999655e-01 | 0.000 | 1 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999704e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.999740e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999772e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999790e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999834e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.999845e-01 | 0.000 | 1 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.999845e-01 | 0.000 | 1 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999853e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999888e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999890e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999890e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999900e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.999914e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999914e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999918e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999921e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999927e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999947e-01 | 0.000 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.999959e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999969e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.999969e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999970e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.999972e-01 | 0.000 | 1 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999978e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.999980e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999991e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999992e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.999993e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999995e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999997e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999997e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999997e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999997e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999998e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.999999e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999999e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999999e-01 | 0.000 | 1 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999999e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 1.000000e+00 | 0.000 | 1 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 1.000000e+00 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.000000e+00 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 1.000000e+00 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 1.000000e+00 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.000000e+00 | 0.000 | 1 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 1 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 1 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 1 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 1 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 1 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | -0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin organization | R-HSA-4839726 | 7.297131e-08 | 7.137 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.644248e-06 | 5.438 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 7.550896e-06 | 5.122 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.435805e-05 | 4.843 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.326969e-05 | 4.877 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.774607e-05 | 4.751 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.774607e-05 | 4.751 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.783119e-05 | 4.555 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.763788e-05 | 4.558 | 1 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 9.059386e-05 | 4.043 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 6.712828e-05 | 4.173 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 6.712828e-05 | 4.173 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.521845e-05 | 4.069 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.521845e-05 | 4.069 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 9.243153e-05 | 4.034 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.985123e-05 | 4.098 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.700326e-05 | 4.113 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 7.650232e-05 | 4.116 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 7.737907e-05 | 4.111 | 1 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.521845e-05 | 4.069 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 7.087258e-05 | 4.150 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.136410e-04 | 3.944 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.341361e-04 | 3.872 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.341361e-04 | 3.872 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.341361e-04 | 3.872 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.388959e-04 | 3.857 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.381194e-04 | 3.860 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.177428e-04 | 3.929 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.529648e-04 | 3.815 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.689541e-04 | 3.772 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.664481e-04 | 3.779 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.688086e-04 | 3.773 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.688086e-04 | 3.773 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.664481e-04 | 3.779 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.688086e-04 | 3.773 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.852384e-04 | 3.732 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.852384e-04 | 3.732 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 2.079866e-04 | 3.682 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.051358e-04 | 3.688 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.430265e-04 | 3.614 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.511756e-04 | 3.600 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.998323e-04 | 3.523 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.201827e-04 | 3.495 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.416691e-04 | 3.466 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.703337e-04 | 3.431 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.337949e-04 | 3.363 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.179087e-04 | 3.379 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.536378e-04 | 3.343 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.554485e-04 | 3.342 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 4.993038e-04 | 3.302 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 5.321112e-04 | 3.274 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 5.428579e-04 | 3.265 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.639634e-04 | 3.249 | 1 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.296688e-04 | 3.137 | 1 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.296688e-04 | 3.137 | 1 | 0 |
| Signal Transduction | R-HSA-162582 | 7.116656e-04 | 3.148 | 1 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 7.983864e-04 | 3.098 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 7.983864e-04 | 3.098 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 8.102202e-04 | 3.091 | 1 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 7.501311e-04 | 3.125 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 8.208361e-04 | 3.086 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 8.396773e-04 | 3.076 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.076376e-04 | 3.042 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 8.958672e-04 | 3.048 | 1 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 9.424467e-04 | 3.026 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.006887e-03 | 2.997 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.150477e-03 | 2.939 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.315271e-03 | 2.881 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.361125e-03 | 2.866 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.408464e-03 | 2.851 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.463732e-03 | 2.835 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.590489e-03 | 2.798 | 1 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.620152e-03 | 2.790 | 1 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.634442e-03 | 2.787 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.727817e-03 | 2.763 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.945162e-03 | 2.711 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.927240e-03 | 2.715 | 1 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.945162e-03 | 2.711 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.886648e-03 | 2.724 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.029638e-03 | 2.693 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.035481e-03 | 2.691 | 1 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.097495e-03 | 2.678 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.250392e-03 | 2.648 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.252735e-03 | 2.647 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.381436e-03 | 2.623 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.408703e-03 | 2.618 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.469600e-03 | 2.607 | 1 | 1 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.539223e-03 | 2.595 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.686906e-03 | 2.571 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.768266e-03 | 2.558 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.839019e-03 | 2.547 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.006508e-03 | 2.522 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.047229e-03 | 2.516 | 1 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.099578e-03 | 2.509 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.099578e-03 | 2.509 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.123976e-03 | 2.505 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.462141e-03 | 2.461 | 1 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.602282e-03 | 2.443 | 1 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.799487e-03 | 2.420 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.361044e-03 | 2.360 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.361044e-03 | 2.360 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.266169e-03 | 2.370 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.288256e-03 | 2.368 | 1 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.531494e-03 | 2.344 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.556993e-03 | 2.341 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.556993e-03 | 2.341 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.134020e-03 | 2.290 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 5.575722e-03 | 2.254 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.704842e-03 | 2.244 | 1 | 1 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.704842e-03 | 2.244 | 1 | 1 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.704842e-03 | 2.244 | 1 | 1 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.239520e-03 | 2.281 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.704842e-03 | 2.244 | 1 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.704447e-03 | 2.244 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 5.835659e-03 | 2.234 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.945230e-03 | 2.226 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.966166e-03 | 2.224 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.966166e-03 | 2.224 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.966166e-03 | 2.224 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.051902e-03 | 2.218 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 6.312642e-03 | 2.200 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 7.180143e-03 | 2.144 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.261681e-03 | 2.139 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.011637e-03 | 2.154 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 7.344119e-03 | 2.134 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.582231e-03 | 2.120 | 1 | 1 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.606935e-03 | 2.119 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.606935e-03 | 2.119 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 7.606935e-03 | 2.119 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 7.606935e-03 | 2.119 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 8.053721e-03 | 2.094 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 8.089574e-03 | 2.092 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 8.089574e-03 | 2.092 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 9.012805e-03 | 2.045 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 9.012805e-03 | 2.045 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 9.012805e-03 | 2.045 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 9.012805e-03 | 2.045 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 9.012805e-03 | 2.045 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 9.012805e-03 | 2.045 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.281079e-03 | 2.082 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 8.910654e-03 | 2.050 | 1 | 1 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 8.809250e-03 | 2.055 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.931197e-03 | 2.049 | 1 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.158762e-03 | 2.088 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 9.062648e-03 | 2.043 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 9.062648e-03 | 2.043 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.062648e-03 | 2.043 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 9.150342e-03 | 2.039 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.228234e-03 | 2.035 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 9.566967e-03 | 2.019 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.084947e-02 | 1.965 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.084947e-02 | 1.965 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.094160e-02 | 1.961 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.109194e-02 | 1.955 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.184888e-02 | 1.926 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.171745e-02 | 1.931 | 1 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.273082e-02 | 1.895 | 1 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.296798e-02 | 1.887 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.307153e-02 | 1.884 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.380241e-02 | 1.860 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.380241e-02 | 1.860 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.397962e-02 | 1.855 | 1 | 1 |
| Signal attenuation | R-HSA-74749 | 1.415305e-02 | 1.849 | 1 | 1 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 1.446582e-02 | 1.840 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.580076e-02 | 1.801 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.616206e-02 | 1.792 | 1 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.645579e-02 | 1.784 | 1 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.645776e-02 | 1.784 | 1 | 1 |
| Signaling by EGFR | R-HSA-177929 | 1.695515e-02 | 1.771 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.746447e-02 | 1.758 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.755007e-02 | 1.756 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 1.796516e-02 | 1.746 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.796516e-02 | 1.746 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.957465e-02 | 1.708 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.957465e-02 | 1.708 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.925332e-02 | 1.715 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.998341e-02 | 1.699 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.116978e-02 | 1.674 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.210924e-02 | 1.655 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 2.354878e-02 | 1.628 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.389725e-02 | 1.622 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.439811e-02 | 1.613 | 1 | 1 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.439811e-02 | 1.613 | 1 | 1 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.457457e-02 | 1.610 | 1 | 1 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.457457e-02 | 1.610 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.460698e-02 | 1.609 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.460698e-02 | 1.609 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.604220e-02 | 1.584 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.648509e-02 | 1.577 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.722601e-02 | 1.565 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.730309e-02 | 1.564 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.761401e-02 | 1.559 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.761401e-02 | 1.559 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.761401e-02 | 1.559 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.761401e-02 | 1.559 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 2.761401e-02 | 1.559 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.761401e-02 | 1.559 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.841021e-02 | 1.547 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 3.335058e-02 | 1.477 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.339602e-02 | 1.476 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.335058e-02 | 1.477 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.223217e-02 | 1.492 | 1 | 1 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.110445e-02 | 1.507 | 1 | 1 |
| Signaling by WNT | R-HSA-195721 | 3.079761e-02 | 1.511 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.288277e-02 | 1.483 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.335058e-02 | 1.477 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.343781e-02 | 1.476 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.453118e-02 | 1.462 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.460297e-02 | 1.461 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.577357e-02 | 1.446 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.842046e-02 | 1.415 | 1 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.843541e-02 | 1.415 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.869897e-02 | 1.412 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.939083e-02 | 1.405 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 3.973051e-02 | 1.401 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.369337e-02 | 1.360 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 4.369337e-02 | 1.360 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.369337e-02 | 1.360 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.391464e-02 | 1.357 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.406761e-02 | 1.356 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.406761e-02 | 1.356 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.909032e-02 | 1.309 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.675671e-02 | 1.330 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.983824e-02 | 1.302 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.116161e-02 | 1.291 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.736581e-02 | 1.325 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.442200e-02 | 1.264 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.272133e-02 | 1.278 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.442310e-02 | 1.264 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.608594e-02 | 1.336 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.983824e-02 | 1.302 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.116161e-02 | 1.291 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.051791e-02 | 1.297 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.056292e-02 | 1.296 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.675671e-02 | 1.330 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.294086e-02 | 1.276 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.662803e-02 | 1.331 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.592179e-02 | 1.338 | 1 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.592179e-02 | 1.338 | 1 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 5.393827e-02 | 1.268 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.442310e-02 | 1.264 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.442703e-02 | 1.264 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.442703e-02 | 1.264 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.442703e-02 | 1.264 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.444875e-02 | 1.264 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.454009e-02 | 1.263 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.454009e-02 | 1.263 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.454009e-02 | 1.263 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.454009e-02 | 1.263 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.454009e-02 | 1.263 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.010769e-02 | 1.221 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.010769e-02 | 1.221 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.010769e-02 | 1.221 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.103647e-02 | 1.214 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.103647e-02 | 1.214 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.103647e-02 | 1.214 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.273464e-02 | 1.202 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 6.522132e-02 | 1.186 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 6.522132e-02 | 1.186 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 6.522132e-02 | 1.186 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.737011e-02 | 1.172 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 6.755993e-02 | 1.170 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 6.755993e-02 | 1.170 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 6.755993e-02 | 1.170 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 6.755993e-02 | 1.170 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 6.755993e-02 | 1.170 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 6.755993e-02 | 1.170 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.758986e-02 | 1.170 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 6.794341e-02 | 1.168 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 6.794341e-02 | 1.168 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 6.794341e-02 | 1.168 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 6.794341e-02 | 1.168 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 8.790999e-02 | 1.056 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 8.790999e-02 | 1.056 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 8.790999e-02 | 1.056 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 8.790999e-02 | 1.056 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 8.790999e-02 | 1.056 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 8.790999e-02 | 1.056 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 7.798768e-02 | 1.108 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.798768e-02 | 1.108 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.249591e-02 | 1.140 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 7.249591e-02 | 1.140 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.200021e-02 | 1.143 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.405644e-02 | 1.075 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 7.279460e-02 | 1.138 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 7.279460e-02 | 1.138 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.691661e-02 | 1.061 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.798768e-02 | 1.108 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.374211e-02 | 1.077 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.121334e-02 | 1.090 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 8.642447e-02 | 1.063 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.099511e-02 | 1.092 | 1 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.121334e-02 | 1.090 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 7.798768e-02 | 1.108 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 8.405644e-02 | 1.075 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 8.121334e-02 | 1.090 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 7.166842e-02 | 1.145 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 8.266194e-02 | 1.083 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 8.121334e-02 | 1.090 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 9.049204e-02 | 1.043 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 9.068201e-02 | 1.042 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 9.068201e-02 | 1.042 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 9.176384e-02 | 1.037 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.233174e-02 | 1.035 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.264250e-02 | 1.033 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 9.264250e-02 | 1.033 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.331830e-02 | 1.030 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 9.522456e-02 | 1.021 | 1 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.036611e-01 | 0.984 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.041674e-01 | 0.982 | 1 | 1 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.047347e-01 | 0.980 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.047347e-01 | 0.980 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.047347e-01 | 0.980 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.047347e-01 | 0.980 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.098002e-01 | 0.959 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.098002e-01 | 0.959 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.098002e-01 | 0.959 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 1.098002e-01 | 0.959 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.098002e-01 | 0.959 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.114007e-01 | 0.953 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.114021e-01 | 0.953 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.133146e-01 | 0.946 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 1.133146e-01 | 0.946 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.312743e-01 | 0.882 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.312743e-01 | 0.882 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.312743e-01 | 0.882 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 1.329277e-01 | 0.876 | 1 | 1 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 1.329277e-01 | 0.876 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.513599e-01 | 0.820 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 1.513599e-01 | 0.820 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.170196e-01 | 0.932 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.434806e-01 | 0.843 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.197027e-01 | 0.922 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.329675e-01 | 0.876 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.329675e-01 | 0.876 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.239126e-01 | 0.907 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.431570e-01 | 0.844 | 1 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.283626e-01 | 0.892 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.230014e-01 | 0.910 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.500850e-01 | 0.824 | 1 | 1 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.434806e-01 | 0.843 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.352359e-01 | 0.869 | 1 | 1 |
| Downstream signal transduction | R-HSA-186763 | 1.228164e-01 | 0.911 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.262965e-01 | 0.899 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.250900e-01 | 0.903 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.293548e-01 | 0.888 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.373568e-01 | 0.862 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.182008e-01 | 0.927 | 1 | 0 |
| Axon guidance | R-HSA-422475 | 1.413417e-01 | 0.850 | 1 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.513599e-01 | 0.820 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.428653e-01 | 0.845 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.342808e-01 | 0.872 | 1 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.289771e-01 | 0.889 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.309840e-01 | 0.883 | 1 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.397034e-01 | 0.855 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.543395e-01 | 0.812 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.543395e-01 | 0.812 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.549871e-01 | 0.810 | 1 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.570237e-01 | 0.804 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 1.570237e-01 | 0.804 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 1.570237e-01 | 0.804 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.570237e-01 | 0.804 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 1.570237e-01 | 0.804 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.570237e-01 | 0.804 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.600339e-01 | 0.796 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 1.903056e-01 | 0.721 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 1.903056e-01 | 0.721 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.903056e-01 | 0.721 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.453289e-01 | 0.610 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.453289e-01 | 0.610 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 2.453289e-01 | 0.610 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.453289e-01 | 0.610 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.453289e-01 | 0.610 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.453289e-01 | 0.610 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.453289e-01 | 0.610 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.453289e-01 | 0.610 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.453289e-01 | 0.610 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.453289e-01 | 0.610 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.453289e-01 | 0.610 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.453289e-01 | 0.610 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.453289e-01 | 0.610 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.453289e-01 | 0.610 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 2.966161e-01 | 0.528 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 2.966161e-01 | 0.528 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 2.966161e-01 | 0.528 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.966161e-01 | 0.528 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.966161e-01 | 0.528 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.966161e-01 | 0.528 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.071969e-01 | 0.684 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 3.444207e-01 | 0.463 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.444207e-01 | 0.463 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 3.444207e-01 | 0.463 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 3.444207e-01 | 0.463 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 3.444207e-01 | 0.463 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.681534e-01 | 0.774 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.681534e-01 | 0.774 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 2.587332e-01 | 0.587 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.587332e-01 | 0.587 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.587332e-01 | 0.587 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.587332e-01 | 0.587 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.587332e-01 | 0.587 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 3.889790e-01 | 0.410 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 3.889790e-01 | 0.410 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 3.889790e-01 | 0.410 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.031933e-01 | 0.692 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.846185e-01 | 0.546 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.846185e-01 | 0.546 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.213027e-01 | 0.655 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.397170e-01 | 0.620 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.397170e-01 | 0.620 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.104113e-01 | 0.508 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.104113e-01 | 0.508 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.104113e-01 | 0.508 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.104113e-01 | 0.508 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.104113e-01 | 0.508 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.104113e-01 | 0.508 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.104113e-01 | 0.508 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.104113e-01 | 0.508 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 4.305113e-01 | 0.366 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 4.305113e-01 | 0.366 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 4.305113e-01 | 0.366 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.195194e-01 | 0.659 | 1 | 1 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.888120e-01 | 0.724 | 1 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 2.772130e-01 | 0.557 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.772130e-01 | 0.557 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.343324e-01 | 0.630 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.343324e-01 | 0.630 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.493762e-01 | 0.603 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.493762e-01 | 0.603 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.613067e-01 | 0.442 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 3.613067e-01 | 0.442 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 4.692229e-01 | 0.329 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 4.692229e-01 | 0.329 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 4.692229e-01 | 0.329 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 4.692229e-01 | 0.329 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.862388e-01 | 0.413 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.862388e-01 | 0.413 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.386750e-01 | 0.622 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 4.347381e-01 | 0.362 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.347381e-01 | 0.362 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.302735e-01 | 0.638 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.319772e-01 | 0.479 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.098384e-01 | 0.387 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.098384e-01 | 0.387 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.582032e-01 | 0.339 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.283670e-01 | 0.368 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.283670e-01 | 0.368 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.283670e-01 | 0.368 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.283670e-01 | 0.368 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.283670e-01 | 0.368 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.585264e-01 | 0.445 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.810923e-01 | 0.318 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.810923e-01 | 0.318 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.466840e-01 | 0.350 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.144454e-01 | 0.383 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 3.905665e-01 | 0.408 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.281093e-01 | 0.368 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.281093e-01 | 0.368 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.598212e-01 | 0.337 | 1 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.071211e-01 | 0.684 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.358180e-01 | 0.361 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.882299e-01 | 0.725 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.583738e-01 | 0.588 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.461972e-01 | 0.461 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.104113e-01 | 0.508 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.637484e-01 | 0.786 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.637484e-01 | 0.786 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.049705e-01 | 0.688 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.617740e-01 | 0.582 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.647613e-01 | 0.333 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 3.742544e-01 | 0.427 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.071969e-01 | 0.684 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.647613e-01 | 0.333 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.961781e-01 | 0.528 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.183102e-01 | 0.497 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.049705e-01 | 0.688 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.961781e-01 | 0.528 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.552293e-01 | 0.342 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.339079e-01 | 0.476 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.152153e-01 | 0.501 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.647613e-01 | 0.333 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 2.338787e-01 | 0.631 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.269319e-01 | 0.486 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.302720e-01 | 0.481 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.862388e-01 | 0.413 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.785356e-01 | 0.748 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.444207e-01 | 0.463 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.397170e-01 | 0.620 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.104113e-01 | 0.508 | 0 | 0 |
| Ligand-receptor interactions | R-HSA-5632681 | 4.305113e-01 | 0.366 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.183716e-01 | 0.661 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.810923e-01 | 0.318 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.397170e-01 | 0.620 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.212844e-01 | 0.375 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.212844e-01 | 0.375 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.812985e-01 | 0.318 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 3.104113e-01 | 0.508 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.276537e-01 | 0.369 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 2.472025e-01 | 0.607 | 1 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.071969e-01 | 0.684 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 2.587332e-01 | 0.587 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 3.889790e-01 | 0.410 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 3.889790e-01 | 0.410 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.031933e-01 | 0.692 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.955670e-01 | 0.529 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 4.347381e-01 | 0.362 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.287579e-01 | 0.641 | 1 | 1 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 4.810923e-01 | 0.318 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.637484e-01 | 0.786 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.725412e-01 | 0.763 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.326298e-01 | 0.364 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.780842e-01 | 0.749 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.271655e-01 | 0.485 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.810923e-01 | 0.318 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.104113e-01 | 0.508 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.471789e-01 | 0.607 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.444207e-01 | 0.463 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 3.444207e-01 | 0.463 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.444207e-01 | 0.463 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 2.846185e-01 | 0.546 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.107346e-01 | 0.386 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.098384e-01 | 0.387 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 4.582032e-01 | 0.339 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.453726e-01 | 0.462 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.681534e-01 | 0.774 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.521712e-01 | 0.345 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.131840e-01 | 0.671 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.585264e-01 | 0.445 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.326298e-01 | 0.364 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.846185e-01 | 0.546 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.583738e-01 | 0.588 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 3.862388e-01 | 0.413 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 3.862388e-01 | 0.413 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.911291e-01 | 0.408 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.367882e-01 | 0.360 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.778117e-01 | 0.556 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.391222e-01 | 0.357 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.854544e-01 | 0.732 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 4.810923e-01 | 0.318 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.016976e-01 | 0.520 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.745801e-01 | 0.758 | 1 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.956246e-01 | 0.403 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.341558e-01 | 0.476 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.257277e-01 | 0.646 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.854900e-01 | 0.414 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 1.903056e-01 | 0.721 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.966161e-01 | 0.528 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.071969e-01 | 0.684 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.071969e-01 | 0.684 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 3.444207e-01 | 0.463 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.681534e-01 | 0.774 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.681534e-01 | 0.774 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.854544e-01 | 0.732 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 3.889790e-01 | 0.410 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.031933e-01 | 0.692 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.846185e-01 | 0.546 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.846185e-01 | 0.546 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.846185e-01 | 0.546 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.846185e-01 | 0.546 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.533083e-01 | 0.452 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.533083e-01 | 0.452 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.245247e-01 | 0.649 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.269319e-01 | 0.486 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.098384e-01 | 0.387 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.963838e-01 | 0.707 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.810923e-01 | 0.318 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.393851e-01 | 0.469 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.079858e-01 | 0.389 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.598212e-01 | 0.337 | 1 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.598212e-01 | 0.337 | 1 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 3.158816e-01 | 0.500 | 1 | 1 |
| Parasite infection | R-HSA-9664407 | 3.158816e-01 | 0.500 | 1 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 3.158816e-01 | 0.500 | 1 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.042825e-01 | 0.690 | 1 | 1 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.063120e-01 | 0.685 | 1 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.079858e-01 | 0.389 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.297035e-01 | 0.367 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.212844e-01 | 0.375 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.328786e-01 | 0.633 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.583738e-01 | 0.588 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.751914e-01 | 0.426 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.632431e-01 | 0.787 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.646178e-01 | 0.577 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.566321e-01 | 0.448 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.160200e-01 | 0.381 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 3.889790e-01 | 0.410 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 3.095029e-01 | 0.509 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.319772e-01 | 0.479 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.365570e-01 | 0.626 | 1 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.977073e-01 | 0.400 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.328786e-01 | 0.633 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.008721e-01 | 0.697 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.269319e-01 | 0.486 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.347381e-01 | 0.362 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.848097e-01 | 0.415 | 1 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.987691e-01 | 0.702 | 1 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.045042e-01 | 0.393 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.888120e-01 | 0.724 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.107346e-01 | 0.386 | 1 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.455279e-01 | 0.351 | 1 | 1 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.778647e-01 | 0.321 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.583738e-01 | 0.588 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.646178e-01 | 0.577 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.862388e-01 | 0.413 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.790174e-01 | 0.320 | 1 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.818502e-01 | 0.740 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.305113e-01 | 0.366 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.899957e-01 | 0.409 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.612271e-01 | 0.442 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.612271e-01 | 0.442 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.612271e-01 | 0.442 | 1 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.582032e-01 | 0.339 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.582032e-01 | 0.339 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.692931e-01 | 0.329 | 1 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.152153e-01 | 0.501 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.133879e-01 | 0.384 | 1 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.412876e-01 | 0.355 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.368382e-01 | 0.626 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.805525e-01 | 0.318 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.087747e-01 | 0.389 | 1 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.912079e-01 | 0.536 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.438267e-01 | 0.353 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.334101e-01 | 0.477 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.407486e-01 | 0.468 | 1 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.426968e-01 | 0.465 | 1 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.885890e-01 | 0.724 | 1 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 1.903056e-01 | 0.721 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 3.444207e-01 | 0.463 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.328786e-01 | 0.633 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.854544e-01 | 0.732 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 2.587332e-01 | 0.587 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.305113e-01 | 0.366 | 1 | 1 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.008721e-01 | 0.697 | 1 | 1 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.613067e-01 | 0.442 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 3.613067e-01 | 0.442 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 4.692229e-01 | 0.329 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.453726e-01 | 0.462 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.453587e-01 | 0.610 | 1 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.241904e-01 | 0.489 | 1 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.453587e-01 | 0.610 | 1 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.071211e-01 | 0.684 | 1 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.599693e-01 | 0.337 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.343324e-01 | 0.630 | 1 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.722734e-01 | 0.429 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.118912e-01 | 0.506 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.049705e-01 | 0.688 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 2.266209e-01 | 0.645 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.426968e-01 | 0.465 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.533083e-01 | 0.452 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.533083e-01 | 0.452 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.708826e-01 | 0.431 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.368382e-01 | 0.626 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.368382e-01 | 0.626 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.717348e-01 | 0.430 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.064289e-01 | 0.685 | 1 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.997966e-01 | 0.699 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.936110e-01 | 0.713 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.689528e-01 | 0.772 | 1 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.689528e-01 | 0.772 | 1 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 2.966161e-01 | 0.528 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.071969e-01 | 0.684 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 3.444207e-01 | 0.463 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 4.305113e-01 | 0.366 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 3.360047e-01 | 0.474 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 4.692229e-01 | 0.329 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.056798e-01 | 0.392 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.276750e-01 | 0.369 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.252950e-01 | 0.647 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.047140e-01 | 0.516 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.649884e-01 | 0.783 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.912079e-01 | 0.536 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.955670e-01 | 0.529 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.582032e-01 | 0.339 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.341558e-01 | 0.476 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.031933e-01 | 0.692 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 4.305113e-01 | 0.366 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 4.305113e-01 | 0.366 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 4.305113e-01 | 0.366 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 3.862388e-01 | 0.413 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.375089e-01 | 0.624 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.582032e-01 | 0.339 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 3.339079e-01 | 0.476 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 1.964746e-01 | 0.707 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.514598e-01 | 0.454 | 1 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.328786e-01 | 0.633 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.342744e-01 | 0.476 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 4.107346e-01 | 0.386 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.869834e-01 | 0.412 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 4.692229e-01 | 0.329 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.862388e-01 | 0.413 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.047140e-01 | 0.516 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.618933e-01 | 0.791 | 1 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.689528e-01 | 0.772 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 4.326298e-01 | 0.364 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.810923e-01 | 0.318 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.767988e-01 | 0.753 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.347381e-01 | 0.362 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.328786e-01 | 0.633 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.009930e-01 | 0.397 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 3.551659e-01 | 0.450 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.493762e-01 | 0.603 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.342744e-01 | 0.476 | 1 | 1 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.825736e-01 | 0.316 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 4.825736e-01 | 0.316 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.830690e-01 | 0.316 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.874266e-01 | 0.312 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.874266e-01 | 0.312 | 1 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.895475e-01 | 0.310 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.932780e-01 | 0.307 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.951894e-01 | 0.305 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.974168e-01 | 0.303 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.974168e-01 | 0.303 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.000984e-01 | 0.301 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.033752e-01 | 0.298 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.033752e-01 | 0.298 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.033752e-01 | 0.298 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.051640e-01 | 0.297 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 5.053051e-01 | 0.296 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 5.053051e-01 | 0.296 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 5.053051e-01 | 0.296 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 5.053051e-01 | 0.296 | 1 | 1 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 5.053051e-01 | 0.296 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.053051e-01 | 0.296 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.053051e-01 | 0.296 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 5.053051e-01 | 0.296 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.053051e-01 | 0.296 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.053051e-01 | 0.296 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 5.053051e-01 | 0.296 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.053051e-01 | 0.296 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.053051e-01 | 0.296 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 5.053051e-01 | 0.296 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.053051e-01 | 0.296 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 5.053051e-01 | 0.296 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.082689e-01 | 0.294 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.122235e-01 | 0.291 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.173157e-01 | 0.286 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.173157e-01 | 0.286 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.173157e-01 | 0.286 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.174561e-01 | 0.286 | 1 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.216330e-01 | 0.283 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.242630e-01 | 0.280 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 5.250286e-01 | 0.280 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 5.250286e-01 | 0.280 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 5.250286e-01 | 0.280 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 5.250286e-01 | 0.280 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 5.250286e-01 | 0.280 | 1 | 1 |
| Nephrin family interactions | R-HSA-373753 | 5.250286e-01 | 0.280 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.266705e-01 | 0.278 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 5.266705e-01 | 0.278 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.266705e-01 | 0.278 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.269268e-01 | 0.278 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.340029e-01 | 0.272 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.342081e-01 | 0.272 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.342081e-01 | 0.272 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.342081e-01 | 0.272 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 5.389366e-01 | 0.268 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 5.389366e-01 | 0.268 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 5.389366e-01 | 0.268 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 5.389366e-01 | 0.268 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.389366e-01 | 0.268 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 5.389366e-01 | 0.268 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 5.389366e-01 | 0.268 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 5.389366e-01 | 0.268 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 5.389366e-01 | 0.268 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 5.389366e-01 | 0.268 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 5.389366e-01 | 0.268 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 5.389366e-01 | 0.268 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.389366e-01 | 0.268 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.409836e-01 | 0.267 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.409836e-01 | 0.267 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 5.460351e-01 | 0.263 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 5.460351e-01 | 0.263 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.460351e-01 | 0.263 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.460351e-01 | 0.263 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 5.460351e-01 | 0.263 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 5.460351e-01 | 0.263 | 1 | 1 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 5.460351e-01 | 0.263 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.507604e-01 | 0.259 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.546301e-01 | 0.256 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.550724e-01 | 0.256 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 5.663826e-01 | 0.247 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.663826e-01 | 0.247 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.663826e-01 | 0.247 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.663826e-01 | 0.247 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.663826e-01 | 0.247 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.666010e-01 | 0.247 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.689267e-01 | 0.245 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 5.702834e-01 | 0.244 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 5.702834e-01 | 0.244 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 5.702834e-01 | 0.244 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 5.702834e-01 | 0.244 | 1 | 1 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 5.702834e-01 | 0.244 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 5.702834e-01 | 0.244 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.702834e-01 | 0.244 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 5.702834e-01 | 0.244 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 5.702834e-01 | 0.244 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 5.702834e-01 | 0.244 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 5.702834e-01 | 0.244 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.768107e-01 | 0.239 | 1 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.822481e-01 | 0.235 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.822481e-01 | 0.235 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 5.827946e-01 | 0.234 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 5.827946e-01 | 0.234 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.827946e-01 | 0.234 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.827946e-01 | 0.234 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.841040e-01 | 0.234 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.850977e-01 | 0.233 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 5.860636e-01 | 0.232 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 5.860636e-01 | 0.232 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 5.860636e-01 | 0.232 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 5.860636e-01 | 0.232 | 1 | 1 |
| Signaling by KIT in disease | R-HSA-9669938 | 5.860636e-01 | 0.232 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 5.860636e-01 | 0.232 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.869857e-01 | 0.231 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 5.958972e-01 | 0.225 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 5.982565e-01 | 0.223 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 5.995009e-01 | 0.222 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.995009e-01 | 0.222 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 5.995009e-01 | 0.222 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.995009e-01 | 0.222 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 5.995009e-01 | 0.222 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 5.995009e-01 | 0.222 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 5.995009e-01 | 0.222 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.995009e-01 | 0.222 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 5.995009e-01 | 0.222 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 5.995009e-01 | 0.222 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.995009e-01 | 0.222 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.995009e-01 | 0.222 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 5.995009e-01 | 0.222 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.995009e-01 | 0.222 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.000154e-01 | 0.222 | 1 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.050747e-01 | 0.218 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.050747e-01 | 0.218 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.050747e-01 | 0.218 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 6.050747e-01 | 0.218 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.089986e-01 | 0.215 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.089986e-01 | 0.215 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.089986e-01 | 0.215 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.089986e-01 | 0.215 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.089986e-01 | 0.215 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.168862e-01 | 0.210 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.218358e-01 | 0.206 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.218358e-01 | 0.206 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 6.234160e-01 | 0.205 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 6.234160e-01 | 0.205 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.234160e-01 | 0.205 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.234160e-01 | 0.205 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 6.267334e-01 | 0.203 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 6.267334e-01 | 0.203 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 6.267334e-01 | 0.203 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 6.267334e-01 | 0.203 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 6.267334e-01 | 0.203 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 6.267334e-01 | 0.203 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 6.267334e-01 | 0.203 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 6.267334e-01 | 0.203 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 6.267334e-01 | 0.203 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 6.267334e-01 | 0.203 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.276513e-01 | 0.202 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.280339e-01 | 0.202 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 6.280339e-01 | 0.202 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.344038e-01 | 0.198 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.359253e-01 | 0.197 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 6.410906e-01 | 0.193 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.410906e-01 | 0.193 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.410906e-01 | 0.193 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 6.410906e-01 | 0.193 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 6.411811e-01 | 0.193 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.411811e-01 | 0.193 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.423398e-01 | 0.192 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 6.423398e-01 | 0.192 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.423398e-01 | 0.192 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.423398e-01 | 0.192 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.423398e-01 | 0.192 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.423398e-01 | 0.192 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 6.423398e-01 | 0.192 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.423398e-01 | 0.192 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.466985e-01 | 0.189 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.479513e-01 | 0.188 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.520975e-01 | 0.186 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.520975e-01 | 0.186 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 6.521157e-01 | 0.186 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.521157e-01 | 0.186 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 6.521157e-01 | 0.186 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 6.521157e-01 | 0.186 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.521157e-01 | 0.186 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.521157e-01 | 0.186 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 6.521157e-01 | 0.186 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.562531e-01 | 0.183 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.581044e-01 | 0.182 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 6.581044e-01 | 0.182 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 6.581044e-01 | 0.182 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 6.581044e-01 | 0.182 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.581044e-01 | 0.182 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.587164e-01 | 0.181 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 6.587164e-01 | 0.181 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.628003e-01 | 0.179 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.675649e-01 | 0.176 | 1 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.697727e-01 | 0.174 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.744656e-01 | 0.171 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.744656e-01 | 0.171 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.744656e-01 | 0.171 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.744656e-01 | 0.171 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 6.744656e-01 | 0.171 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 6.757734e-01 | 0.170 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 6.757734e-01 | 0.170 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.757734e-01 | 0.170 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 6.757734e-01 | 0.170 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.757734e-01 | 0.170 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.757734e-01 | 0.170 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.757734e-01 | 0.170 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 6.757734e-01 | 0.170 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.757734e-01 | 0.170 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.771081e-01 | 0.169 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.788666e-01 | 0.168 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.814081e-01 | 0.167 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 6.828984e-01 | 0.166 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 6.828984e-01 | 0.166 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.833657e-01 | 0.165 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.905506e-01 | 0.161 | 1 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 6.978236e-01 | 0.156 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 6.978236e-01 | 0.156 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.978236e-01 | 0.156 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 6.978236e-01 | 0.156 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.978236e-01 | 0.156 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.978236e-01 | 0.156 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.978236e-01 | 0.156 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 6.978236e-01 | 0.156 | 1 | 1 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 6.978236e-01 | 0.156 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.035404e-01 | 0.153 | 1 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.052717e-01 | 0.152 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.052717e-01 | 0.152 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.052717e-01 | 0.152 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.052717e-01 | 0.152 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 7.107692e-01 | 0.148 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 7.145905e-01 | 0.146 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 7.145905e-01 | 0.146 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 7.145905e-01 | 0.146 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.183754e-01 | 0.144 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.183754e-01 | 0.144 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 7.183754e-01 | 0.144 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.183754e-01 | 0.144 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.183754e-01 | 0.144 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 7.183754e-01 | 0.144 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 7.183754e-01 | 0.144 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.183754e-01 | 0.144 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.197415e-01 | 0.143 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.197415e-01 | 0.143 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.199273e-01 | 0.143 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.201634e-01 | 0.143 | 1 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.231024e-01 | 0.141 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.249185e-01 | 0.140 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 7.249185e-01 | 0.140 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.303914e-01 | 0.136 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.336078e-01 | 0.135 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.336078e-01 | 0.135 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 7.361131e-01 | 0.133 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 7.375306e-01 | 0.132 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 7.375306e-01 | 0.132 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.375306e-01 | 0.132 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 7.375306e-01 | 0.132 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.375306e-01 | 0.132 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.375306e-01 | 0.132 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.375306e-01 | 0.132 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 7.375306e-01 | 0.132 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 7.375306e-01 | 0.132 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.375306e-01 | 0.132 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 7.375306e-01 | 0.132 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 7.375306e-01 | 0.132 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.388525e-01 | 0.131 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 7.388525e-01 | 0.131 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.426874e-01 | 0.129 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 7.426874e-01 | 0.129 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.466415e-01 | 0.127 | 1 | 1 |
| MHC class II antigen presentation | R-HSA-2132295 | 7.466415e-01 | 0.127 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.468856e-01 | 0.127 | 1 | 1 |
| SLC transporter disorders | R-HSA-5619102 | 7.512248e-01 | 0.124 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.528506e-01 | 0.123 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.535031e-01 | 0.123 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 7.553840e-01 | 0.122 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.553840e-01 | 0.122 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.553840e-01 | 0.122 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 7.553840e-01 | 0.122 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.553840e-01 | 0.122 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.553840e-01 | 0.122 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.553840e-01 | 0.122 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.553840e-01 | 0.122 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.577520e-01 | 0.120 | 1 | 1 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.595908e-01 | 0.119 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.595908e-01 | 0.119 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.595908e-01 | 0.119 | 1 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 7.595908e-01 | 0.119 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.617502e-01 | 0.118 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.701204e-01 | 0.113 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.717398e-01 | 0.113 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.717398e-01 | 0.113 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 7.720240e-01 | 0.112 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 7.720240e-01 | 0.112 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 7.720240e-01 | 0.112 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 7.720240e-01 | 0.112 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.720240e-01 | 0.112 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 7.720240e-01 | 0.112 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.720240e-01 | 0.112 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 7.720240e-01 | 0.112 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.720240e-01 | 0.112 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 7.723880e-01 | 0.112 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.740340e-01 | 0.111 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 7.741025e-01 | 0.111 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 7.779940e-01 | 0.109 | 1 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 7.823556e-01 | 0.107 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.833496e-01 | 0.106 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.833496e-01 | 0.106 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.833496e-01 | 0.106 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.833496e-01 | 0.106 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.833496e-01 | 0.106 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.833496e-01 | 0.106 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.875330e-01 | 0.104 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 7.875330e-01 | 0.104 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.875330e-01 | 0.104 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 7.875330e-01 | 0.104 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.875330e-01 | 0.104 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.875330e-01 | 0.104 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.875330e-01 | 0.104 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.894783e-01 | 0.103 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.931413e-01 | 0.101 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.944372e-01 | 0.100 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.944372e-01 | 0.100 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.944372e-01 | 0.100 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.976303e-01 | 0.098 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.976303e-01 | 0.098 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.985104e-01 | 0.098 | 1 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.019878e-01 | 0.096 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 8.019878e-01 | 0.096 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.019878e-01 | 0.096 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.019878e-01 | 0.096 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 8.019878e-01 | 0.096 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.019878e-01 | 0.096 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.019878e-01 | 0.096 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.021789e-01 | 0.096 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.042458e-01 | 0.095 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.050199e-01 | 0.094 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.050199e-01 | 0.094 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.050199e-01 | 0.094 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.051683e-01 | 0.094 | 1 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.055257e-01 | 0.094 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.055257e-01 | 0.094 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.055257e-01 | 0.094 | 1 | 1 |
| Degradation of AXIN | R-HSA-4641257 | 8.151151e-01 | 0.089 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.154600e-01 | 0.089 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.154600e-01 | 0.089 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.154600e-01 | 0.089 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.154600e-01 | 0.089 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.154600e-01 | 0.089 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.154600e-01 | 0.089 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.154600e-01 | 0.089 | 1 | 1 |
| Other interleukin signaling | R-HSA-449836 | 8.154600e-01 | 0.089 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.154600e-01 | 0.089 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.154600e-01 | 0.089 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.154600e-01 | 0.089 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.161215e-01 | 0.088 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 8.246925e-01 | 0.084 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.247401e-01 | 0.084 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.247401e-01 | 0.084 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.247401e-01 | 0.084 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 8.277163e-01 | 0.082 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.280163e-01 | 0.082 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.280163e-01 | 0.082 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.280163e-01 | 0.082 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.280163e-01 | 0.082 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.280163e-01 | 0.082 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.280163e-01 | 0.082 | 1 | 1 |
| SARS-CoV Infections | R-HSA-9679506 | 8.322714e-01 | 0.080 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.339121e-01 | 0.079 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.339121e-01 | 0.079 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.346302e-01 | 0.079 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.359132e-01 | 0.078 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.360640e-01 | 0.078 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.397190e-01 | 0.076 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.397190e-01 | 0.076 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.425176e-01 | 0.074 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.426482e-01 | 0.074 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.433759e-01 | 0.074 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.438017e-01 | 0.074 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.496727e-01 | 0.071 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.506261e-01 | 0.070 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.506261e-01 | 0.070 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.506261e-01 | 0.070 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 8.506261e-01 | 0.070 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 8.506261e-01 | 0.070 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.506261e-01 | 0.070 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.509652e-01 | 0.070 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.509652e-01 | 0.070 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.509652e-01 | 0.070 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.509652e-01 | 0.070 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.509652e-01 | 0.070 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.509652e-01 | 0.070 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.539924e-01 | 0.069 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 8.565429e-01 | 0.067 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.565429e-01 | 0.067 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.588797e-01 | 0.066 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.588797e-01 | 0.066 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.588797e-01 | 0.066 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.589427e-01 | 0.066 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.607915e-01 | 0.065 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 8.607915e-01 | 0.065 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.607915e-01 | 0.065 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.607915e-01 | 0.065 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.607915e-01 | 0.065 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 8.624565e-01 | 0.064 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.658026e-01 | 0.063 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.664079e-01 | 0.062 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.664079e-01 | 0.062 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.694628e-01 | 0.061 | 1 | 1 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.702657e-01 | 0.060 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.702657e-01 | 0.060 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.702657e-01 | 0.060 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 8.702657e-01 | 0.060 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.702657e-01 | 0.060 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.702657e-01 | 0.060 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.708455e-01 | 0.060 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.735657e-01 | 0.059 | 1 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.735657e-01 | 0.059 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.738841e-01 | 0.059 | 1 | 1 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.755291e-01 | 0.058 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.755291e-01 | 0.058 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.790956e-01 | 0.056 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.790956e-01 | 0.056 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.790956e-01 | 0.056 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.803687e-01 | 0.055 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 8.803687e-01 | 0.055 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.803687e-01 | 0.055 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.813442e-01 | 0.055 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.856409e-01 | 0.053 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.868319e-01 | 0.052 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.868319e-01 | 0.052 | 1 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.873251e-01 | 0.052 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.873251e-01 | 0.052 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.873251e-01 | 0.052 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 8.873251e-01 | 0.052 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.873251e-01 | 0.052 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.873251e-01 | 0.052 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.873251e-01 | 0.052 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.873251e-01 | 0.052 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 8.922529e-01 | 0.050 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.929701e-01 | 0.049 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.941256e-01 | 0.049 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.949949e-01 | 0.048 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 8.949949e-01 | 0.048 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.949949e-01 | 0.048 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.008874e-01 | 0.045 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.021430e-01 | 0.045 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.021430e-01 | 0.045 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.021430e-01 | 0.045 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.021430e-01 | 0.045 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.021430e-01 | 0.045 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.021430e-01 | 0.045 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.022535e-01 | 0.045 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.022535e-01 | 0.045 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.067894e-01 | 0.042 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.088049e-01 | 0.042 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.088049e-01 | 0.042 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.088049e-01 | 0.042 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.088049e-01 | 0.042 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.088049e-01 | 0.042 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.088049e-01 | 0.042 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 9.093000e-01 | 0.041 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.095751e-01 | 0.041 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.095751e-01 | 0.041 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.095751e-01 | 0.041 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.102080e-01 | 0.041 | 1 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 9.123131e-01 | 0.040 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.145516e-01 | 0.039 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.150137e-01 | 0.039 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.150137e-01 | 0.039 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.150137e-01 | 0.039 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.150137e-01 | 0.039 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.156874e-01 | 0.038 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.170720e-01 | 0.038 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.192701e-01 | 0.037 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.208001e-01 | 0.036 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.208001e-01 | 0.036 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 9.236854e-01 | 0.034 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.237425e-01 | 0.034 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.237425e-01 | 0.034 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.237425e-01 | 0.034 | 1 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.242430e-01 | 0.034 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.261928e-01 | 0.033 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.261928e-01 | 0.033 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.261928e-01 | 0.033 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.276153e-01 | 0.033 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.279806e-01 | 0.032 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 9.309829e-01 | 0.031 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.312187e-01 | 0.031 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.331437e-01 | 0.030 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.343857e-01 | 0.029 | 1 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.350937e-01 | 0.029 | 1 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.350937e-01 | 0.029 | 1 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.357979e-01 | 0.029 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.359026e-01 | 0.029 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.369346e-01 | 0.028 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.393981e-01 | 0.027 | 1 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.393981e-01 | 0.027 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.402678e-01 | 0.027 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.402678e-01 | 0.027 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.402678e-01 | 0.027 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.402762e-01 | 0.027 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.407315e-01 | 0.027 | 1 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.407315e-01 | 0.027 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.425276e-01 | 0.026 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.433341e-01 | 0.025 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.443359e-01 | 0.025 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.443359e-01 | 0.025 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.443359e-01 | 0.025 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.443359e-01 | 0.025 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.443359e-01 | 0.025 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.443359e-01 | 0.025 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.443359e-01 | 0.025 | 1 | 1 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.465047e-01 | 0.024 | 1 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.465047e-01 | 0.024 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.472644e-01 | 0.024 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.476644e-01 | 0.023 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.477816e-01 | 0.023 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.481273e-01 | 0.023 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.481273e-01 | 0.023 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.481273e-01 | 0.023 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.481273e-01 | 0.023 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.481273e-01 | 0.023 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.481273e-01 | 0.023 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.481273e-01 | 0.023 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.491910e-01 | 0.023 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.498856e-01 | 0.022 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.502363e-01 | 0.022 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.516606e-01 | 0.022 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.516606e-01 | 0.022 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.516606e-01 | 0.022 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.516606e-01 | 0.022 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.516606e-01 | 0.022 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.516606e-01 | 0.022 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.516606e-01 | 0.022 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.518491e-01 | 0.021 | 1 | 0 |
| Kinesins | R-HSA-983189 | 9.519689e-01 | 0.021 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.523774e-01 | 0.021 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.546985e-01 | 0.020 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.549534e-01 | 0.020 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.549534e-01 | 0.020 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.549534e-01 | 0.020 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.549534e-01 | 0.020 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.563840e-01 | 0.019 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.569581e-01 | 0.019 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.572794e-01 | 0.019 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.580221e-01 | 0.019 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.580221e-01 | 0.019 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.580221e-01 | 0.019 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.580221e-01 | 0.019 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.597191e-01 | 0.018 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.606525e-01 | 0.017 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.606525e-01 | 0.017 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.608341e-01 | 0.017 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.608820e-01 | 0.017 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.608820e-01 | 0.017 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.608820e-01 | 0.017 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.628188e-01 | 0.016 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.635471e-01 | 0.016 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.635471e-01 | 0.016 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.635471e-01 | 0.016 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.635471e-01 | 0.016 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.635471e-01 | 0.016 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.637875e-01 | 0.016 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.660308e-01 | 0.015 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.660308e-01 | 0.015 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.682061e-01 | 0.014 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.683455e-01 | 0.014 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.683455e-01 | 0.014 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.683455e-01 | 0.014 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.699348e-01 | 0.013 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.699348e-01 | 0.013 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.700422e-01 | 0.013 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.705025e-01 | 0.013 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.705025e-01 | 0.013 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.710791e-01 | 0.013 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.720074e-01 | 0.012 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.725127e-01 | 0.012 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.725127e-01 | 0.012 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.743860e-01 | 0.011 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.743860e-01 | 0.011 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.743860e-01 | 0.011 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.746384e-01 | 0.011 | 1 | 1 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.757347e-01 | 0.011 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.761318e-01 | 0.010 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.761318e-01 | 0.010 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.761318e-01 | 0.010 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.761318e-01 | 0.010 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.761318e-01 | 0.010 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.761318e-01 | 0.010 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.770361e-01 | 0.010 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.777586e-01 | 0.010 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 9.780955e-01 | 0.010 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.781533e-01 | 0.010 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.788323e-01 | 0.009 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.790978e-01 | 0.009 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.792747e-01 | 0.009 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.792917e-01 | 0.009 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.802360e-01 | 0.009 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.803124e-01 | 0.009 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.804608e-01 | 0.009 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.804608e-01 | 0.009 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.820041e-01 | 0.008 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.821978e-01 | 0.008 | 1 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.824809e-01 | 0.008 | 1 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.825556e-01 | 0.008 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.828888e-01 | 0.007 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.835821e-01 | 0.007 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.842637e-01 | 0.007 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.843743e-01 | 0.007 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.843743e-01 | 0.007 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.843743e-01 | 0.007 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.844396e-01 | 0.007 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.845498e-01 | 0.007 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.849981e-01 | 0.007 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.854397e-01 | 0.006 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.854619e-01 | 0.006 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.864326e-01 | 0.006 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.864326e-01 | 0.006 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.873578e-01 | 0.006 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.874110e-01 | 0.006 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.878985e-01 | 0.005 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.882199e-01 | 0.005 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 9.892913e-01 | 0.005 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.893460e-01 | 0.005 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.897720e-01 | 0.004 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.903038e-01 | 0.004 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.904696e-01 | 0.004 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.904696e-01 | 0.004 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.904732e-01 | 0.004 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.908886e-01 | 0.004 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.910959e-01 | 0.004 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.911197e-01 | 0.004 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.917255e-01 | 0.004 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.921301e-01 | 0.003 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.922900e-01 | 0.003 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.923926e-01 | 0.003 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.923926e-01 | 0.003 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.924179e-01 | 0.003 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.924179e-01 | 0.003 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.937629e-01 | 0.003 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.938582e-01 | 0.003 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.942712e-01 | 0.002 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.943604e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.945851e-01 | 0.002 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.949046e-01 | 0.002 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.952128e-01 | 0.002 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.953106e-01 | 0.002 | 1 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.959776e-01 | 0.002 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.960319e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.961975e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.961975e-01 | 0.002 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.961975e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.962731e-01 | 0.002 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.964570e-01 | 0.002 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.964998e-01 | 0.002 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.966989e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.969243e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.971343e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.976822e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.976822e-01 | 0.001 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.978866e-01 | 0.001 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.980163e-01 | 0.001 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.981254e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.982526e-01 | 0.001 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.983728e-01 | 0.001 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.985766e-01 | 0.001 | 1 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.985778e-01 | 0.001 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.987364e-01 | 0.001 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.988217e-01 | 0.001 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.989358e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.989505e-01 | 0.000 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.989505e-01 | 0.000 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.990015e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.990155e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.990763e-01 | 0.000 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.991394e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.991664e-01 | 0.000 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.991982e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.992530e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.992711e-01 | 0.000 | 1 | 0 |
| Neddylation | R-HSA-8951664 | 9.993481e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.994373e-01 | 0.000 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.994373e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.994758e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.996321e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.996485e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.996807e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.996866e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.997182e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.997326e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.997848e-01 | 0.000 | 1 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.997913e-01 | 0.000 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.997913e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.998020e-01 | 0.000 | 1 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.998313e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.998898e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.998986e-01 | 0.000 | 1 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999418e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999600e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999620e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999708e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999762e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999843e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999914e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999919e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999940e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.999944e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999964e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999965e-01 | 0.000 | 1 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999973e-01 | 0.000 | 1 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999974e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999982e-01 | 0.000 | 1 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999986e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.999986e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999987e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999987e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999991e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999996e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999999e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999999e-01 | 0.000 | 1 | 0 |
| Keratinization | R-HSA-6805567 | 9.999999e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 1 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.000000e+00 | 0.000 | 1 | 1 |
| Formation of apoptosome | R-HSA-111458 | 1.000000e+00 | 0.000 | 1 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.000000e+00 | 0.000 | 1 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 1.000000e+00 | 0.000 | 1 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by Activin | R-HSA-1502540 | 1.000000e+00 | 0.000 | 1 | 1 |
| ERKs are inactivated | R-HSA-202670 | 1.000000e+00 | 0.000 | 1 | 1 |
| RSK activation | R-HSA-444257 | 1.000000e+00 | 0.000 | 1 | 1 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 1.000000e+00 | 0.000 | 1 | 1 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.000000e+00 | 0.000 | 1 | 1 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.000000e+00 | 0.000 | 1 | 1 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.000000e+00 | 0.000 | 1 | 1 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.000000e+00 | 0.000 | 1 | 1 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.000000e+00 | 0.000 | 1 | 1 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.000000e+00 | 0.000 | 1 | 1 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.000000e+00 | 0.000 | 1 | 1 |
| Suppression of apoptosis | R-HSA-9635465 | 1.000000e+00 | 0.000 | 1 | 1 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 1.000000e+00 | 0.000 | 1 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.000000e+00 | 0.000 | 1 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.000000e+00 | 0.000 | 1 | 1 |